id:ID(Drug),label,iri,chebi_id,atc_code,drug_type,drug_class,primary_indication,secondary_indications,mechanism_summary,status_overall,approved_regions,source,raw_source_ids
CHEBI:53289,donepezil,http://purl.obolibrary.org/obo/CHEBI_53289,CHEBI:53289,,,,,,,,,ChEBI,CHEBI:53289
CHEBI:64312,memantine,http://purl.obolibrary.org/obo/CHEBI_64312,CHEBI:64312,,,,,,,,,ChEBI,CHEBI:64312
CHEBI:8874,rivastigmine,http://purl.obolibrary.org/obo/CHEBI_8874,CHEBI:8874,,,,,,,,,ChEBI,CHEBI:8874
aab-003,AAB-003,https://www.alzforum.org/therapeutics/aab-003,,,Immunotherapy (passive),Amyloid-Related,Alzheimer's Disease,,AAB-003 is a humanized version of the anti-Aβ mouse antibody 3D6 and a derivative of bapineuzumab (AAB-001). AAB-003 was modified to differ from bapineuzumab in its Fc fraction in hopes of reducing the antibody’s effector function on microglial activation.,discontinued,,AlzForum.Therapeutics,aab-003
aadvac1,AADvac1,https://www.alzforum.org/therapeutics/aadvac1,,,Immunotherapy (active),Tau,"Alzheimer's Disease, Progressive Nonfluent Aphasia",,This is an active vaccine designed to elicit an immune response against pathologically modified forms of tau protein. It targets four similar epitopes in the microtubule binding repeats of the mid-domain of tau.,ongoing,,AlzForum.Therapeutics,aadvac1
aav-gad,AAV-GAD,https://www.alzforum.org/therapeutics/aav-gad,,,DNA/RNA-based,Other Neurotransmitters,Parkinson's Disease,,"AAV-GAD is a gene therapy for Parkinson’s disease. It delivers the glutamic acid decarboxylase (GAD) gene to the subthalamic nucleus, where this enzyme then increases production of the inhibitory neurotransmitter γ-amino-butyric acid (GABA).",ongoing,,AlzForum.Therapeutics,aav-gad
aav2-bdnf,AAV2-BDNF,https://www.alzforum.org/therapeutics/aav2-bdnf,,,DNA/RNA-based,Other,"MCI due to AD, Alzheimer's Disease",,This gene therapy uses an adeno-associated virus serotype 2 (AAV2) vector to carry a gene for human brain-derived neurotrophic factor into the brain. BDNF regulates neuron survival and function in key memory circuits in entorhinal cortex and hippocampus.,ongoing,,AlzForum.Therapeutics,aav2-bdnf
abbv-1088,ABBV-1088,https://www.alzforum.org/therapeutics/abbv-1088,,,Small Molecule,Other,Parkinson's Disease,,ABBV-1088 is an activator of the mitochondrial kinase PINK1. It is being developed as a potential disease-modifying therapy for Parkinson's disease.,ongoing,,AlzForum.Therapeutics,abbv-1088
abbv-552,ABBV-552,https://www.alzforum.org/therapeutics/abbv-552,,,Small Molecule,Other,Alzheimer's Disease,,"Formerly called SDI-118, ABBV-552 is an oral drug that modulates synaptic vesicle glycoprotein 2A (SV2A). It is being investigated for whether it is able to improve cognition in Alzheimer’s and other dementias, as well as in major depression and schizophrenia.",ongoing,,AlzForum.Therapeutics,abbv-552
abbv-916,ABBV-916,https://www.alzforum.org/therapeutics/abbv-916,,,Immunotherapy (passive),Amyloid-Related,Alzheimer's Disease,,"ABBV-916 is a monoclonal antibody to Aβ. It recognizes N-terminal truncated Aβ modified with pyroglutamate at position 3 (N3), a form that is aggregated in amyloid plaques.",discontinued,,AlzForum.Therapeutics,abbv-916
abt-089,ABT-089,https://www.alzforum.org/therapeutics/abt-089,,,Small Molecule,Cholinergic System,Alzheimer's Disease,,,discontinued,,AlzForum.Therapeutics,abt-089
abt-288,ABT-288,https://www.alzforum.org/therapeutics/abt-288,,,Small Molecule,"Cholinergic System, Other Neurotransmitters",Alzheimer's Disease,,"Abbott, now AbbVie, was developing this histamine H3 receptor antagonist for the treatment of cognitive deficits in Alzheimer's and schizophrenia. The rationale was to boost release in the brain of histamine, acetylcholine, noradrenaline, and dopamine in an attempt to enhance cognitive processes.",discontinued,,AlzForum.Therapeutics,abt-288
abt-384,ABT-384,https://www.alzforum.org/therapeutics/abt-384,,,Small Molecule,Other,Alzheimer's Disease,,This is a selective 11-β-hydroxysteroid dehydrogenase type 1 (HSD-1) inhibitor that was evaluated to test the hypothesis that elevated cortisol levels in the brain contribute to cognitive impairment.,discontinued,,AlzForum.Therapeutics,abt-384
abt-418,ABT 418,https://www.alzforum.org/therapeutics/abt-418,,,Small Molecule,Cholinergic System,Alzheimer's Disease,,"Acute administration of nicotine to AD patients improved accuracy of delayed recall, as well as deficits in attention and information processing ( Sahakian et al. 1989 ; Wesnes and Warburton, 1984 ; Jones et al, 1992 ).",discontinued,,AlzForum.Therapeutics,abt-418
abt-957,ABT-957,https://www.alzforum.org/therapeutics/abt-957,,,Small Molecule,Other,Alzheimer's Disease,,"This compound is an inhibitor of the calcium-dependent cysteine protease calpain. This enzyme has long been known to be highly active in Alzheimer’s disease brain ( Saito et al., 1993 ), but its different isoforms, numerous substrates, and pleiotropic effects made drug discovery difficult.",discontinued,,AlzForum.Therapeutics,abt-957
abvac40,ABvac40,https://www.alzforum.org/therapeutics/abvac40,,,Immunotherapy (active),Amyloid-Related,Alzheimer's Disease,,ABvac40 is an investigational vaccine targeting the C terminus of Aβ40. This construct comprises multiple repeats of a synthetic peptide corresponding to amino acids 33-40 of Aβ40.,ongoing,,AlzForum.Therapeutics,abvac40
acd856,ACD856,https://www.alzforum.org/therapeutics/acd856,,,Small Molecule,Other,Alzheimer's Disease,,"This small molecule is a positive allosteric modulator of Trk receptors, which mediate the effects of BDNF, NGF, and other neurotrophic factors. ACD856 increases the kinase activity of Trk receptors and enhances the effects of BDNF or NGF on survival, neuronal function, and synaptic plasticity.",ongoing,,AlzForum.Therapeutics,acd856
acetyl-l-carnitine-hci,Acetyl-l-carnitine HCI,https://www.alzforum.org/therapeutics/acetyl-l-carnitine-hci,,,"Supplement, Dietary",Other,Alzheimer's Disease,,"ALCAR is a naturally occurring substance. It can be metabolized to acetyl-COA by the carnitine transferase reaction and may serve as an alternative source of fuel for the citric-acid cycle, thus promoting aerobic energy metabolism, reducing tissue acidosis.",discontinued,,AlzForum.Therapeutics,acetyl-l-carnitine-hci
aci-24060,ACI-24.060,https://www.alzforum.org/therapeutics/aci-24060,,,Immunotherapy (active),Amyloid-Related,"Alzheimer's Disease, Down's Syndrome",,"ACI-24 is a liposome vaccine designed to elicit an antibody response against aggregated Aβ peptides without concomitant pro-inflammatory T cell activation. This vaccine grew out of work with tetrapalmitoylated preparations of N-terminal Aβ fragments, which rapidly stimulated anti-Aβ antibodies that dissolve amyloid fibers in vitro and in vivo.",ongoing,,AlzForum.Therapeutics,aci-24060
aci-3024,ACI-3024,https://www.alzforum.org/therapeutics/aci-3024,,,Small Molecule,Tau,"Alzheimer's Disease, Other Tauopathy",,"ACI-3024 is a small-molecule inhibitor of tau aggregation. It originated from screening of AC Immune’s proprietary compound library of low-molecular-weight compounds that disrupt Aβ-sheet structures ( Kroth et al., 2012 ).",ongoing,,AlzForum.Therapeutics,aci-3024
aci-7104056,ACI-7104.056,https://www.alzforum.org/therapeutics/aci-7104056,,,Immunotherapy (active),alpha-synuclein,"Parkinson's Disease, Multiple System Atrophy",,"PD01A is an active vaccine to α-synuclein. The immunogen is an eight amino acid peptide that mimics an epitope in the C-terminal region of human α-synuclein, but with a different amino acid sequence.",ongoing,,AlzForum.Therapeutics,aci-7104056
acitretin,Acitretin,https://www.alzforum.org/therapeutics/acitretin,,,Small Molecule,Amyloid-Related,Alzheimer's Disease,Psoriasis in US,"Acitretin is a retinoid drug used primarily to treat severe psoriasis. It can cause birth defects and other side effects typical of vitamin A overdose, including hair loss, elevated triglyceride levels, and drying of mucosal membranes, and therefore is used only in patients who do not respond to less-toxic psoriasis drugs.",ongoing,,AlzForum.Therapeutics,acitretin
acp-204,ACP-204,https://www.alzforum.org/therapeutics/acp-204,,,Small Molecule,Other Neurotransmitters,Alzheimer's Disease,,ACP-204 acts as an inverse agonist at the 5-HT2A serotonin receptor. It is currently being developed for the treatment of Alzheimer’s disease psychosis.,ongoing,,AlzForum.Therapeutics,acp-204
adel-y01,ADEL-Y01,https://www.alzforum.org/therapeutics/adel-y01,,,Immunotherapy (passive),Tau,Alzheimer's Disease,,"ADEL-Y01 is a humanized IgG1 monoclonal antibody that binds tau protein modified by acetylation at lysine residue 280. Tau acetylation at lysine residues is associated with protein aggregation and pathology in various tauopathies, including Alzheimer’s disease (e.g.",ongoing,,AlzForum.Therapeutics,adel-y01
aduhelm,Aduhelm,https://www.alzforum.org/therapeutics/aduhelm,,,Immunotherapy (passive),Amyloid-Related,Alzheimer's Disease,,"BIIB037 is a high-affinity, fully human IgG1 monoclonal antibody against a conformational epitope found on Aβ. It was originally derived by the biotech company Neurimmune in Schlieren, Switzerland, from healthy, aged donors who were cognitively normal.",approved,,AlzForum.Therapeutics,aduhelm
af-102b,AF 102B,https://www.alzforum.org/therapeutics/af-102b,,,Small Molecule,Cholinergic System,Alzheimer's Disease,Treatment of dry mouth in Sjogren's syndrome.,Hypo-activity of the cholinergic system is associated AD and cognitive decline. Two different strategies have been used to increase cholinergic acitvity in the AD brain: 1) acetylcholinesterase inhibitors and 2) direct stimulation of cholinergic receptors.,discontinued,,AlzForum.Therapeutics,af-102b
affitope-ad02,Affitope AD02,https://www.alzforum.org/therapeutics/affitope-ad02,,,Immunotherapy (active),Amyloid-Related,Alzheimer's Disease,,"Affitope AD02 is a synthetic peptide of six amino acids that mimics the N-terminus of Aβ. AFFiRiS hypothesizes that this fragment enables exclusive recognition of Aβ without cross-reacting with APP, and hence may have a favorable safety profile.",discontinued,,AlzForum.Therapeutics,affitope-ad02
agb101,AGB101,https://www.alzforum.org/therapeutics/agb101,,,Small Molecule,Amyloid-Related,MCI-AD,,"AGB101 is a proprietary, once-daily, extended-release, low-dose formulation of the FDA-approved atypical anti-convulsant medication levetiracetam. According to AgeneBio, AGB101 corresponds to roughly 1/12 of the dose typically prescribed for epilepsy, and the drug's mechanism of action is inhibition of the synaptic protein SV2A.",ongoing,,AlzForum.Therapeutics,agb101
ait-101,AIT-101,https://www.alzforum.org/therapeutics/ait-101,,,Small Molecule,Other,Amyotrophic Lateral Sclerosis,,"AIT-101 is a proprietary oral formulation of apilimod, an inhibitor of the phosphatidylinositol phosphate kinase PIKfyve. This lipid kinase phosphorylates signaling molecules in early endosomes that control endosomal function and fusion with lysosomes.",ongoing,,AlzForum.Therapeutics,ait-101
akst4290,AKST4290,https://www.alzforum.org/therapeutics/akst4290,,,Small Molecule,Inflammation,Parkinson's Disease,,AKST4290 is an antagonist of the G protein-coupled C-C chemokine receptor type 3 (CCR3). Blocking CCR3 is expected to have broad anti-inflammatory and immune-modulating effects.,ongoing,,AlzForum.Therapeutics,akst4290
al002,AL002,https://www.alzforum.org/therapeutics/al002,,,Immunotherapy (passive),Inflammation,Alzheimer's Disease,,"This humanized monoclonal IgG1 antibody was being developed in a partnership between Alector and AbbVie. It binds the microglial receptor TREM2 and activates signaling, increasing phosphorylation of TREM2's downstream effector Syk, and inducing microglia proliferation.",discontinued,,AlzForum.Therapeutics,al002
al003,AL003,https://www.alzforum.org/therapeutics/al003,,,Immunotherapy (passive),Inflammation,Alzheimer's Disease,,"AL003 is a monoclonal antibody that was being co-developed by Alector and Abbvie. According to Alector, it counteracts the function of sialic acid binding immunoglobulin-like lectin 3, aka Siglec-3, an inhibitory microglial transmembrane receptor that reportedly interacts with TREM2 ( Oct 2015 news ).",discontinued,,AlzForum.Therapeutics,al003
al044,AL044,https://www.alzforum.org/therapeutics/al044,,,Immunotherapy (passive),Inflammation,Alzheimer's Disease,,"AL044 is an antibody targeting the MSA4 family of transmembrane cell surface proteins expressed on microglia. MS4A gene variants are associated with the risk of late-onset Alzheimer’s disease ( Hollingworth et al., 2011 ; Antúnez et al., 2011 ; Zhu et al., 2017 ; Ma et al., 2019 ).",ongoing,,AlzForum.Therapeutics,al044
al101,AL101,https://www.alzforum.org/therapeutics/al101,,,Immunotherapy (passive),Other,Alzheimer's Disease,,"AL101 is a monoclonal antibody to sortilin (SORT1), a trans-Golgi sorting receptor abundantly expressed in the nervous system. This IgG1 antibody is being developed to treat Alzheimer’s disease.",ongoing,,AlzForum.Therapeutics,al101
alia-1758,ALIA-1758,https://www.alzforum.org/therapeutics/alia-1758,,,Immunotherapy (passive),Amyloid-Related,Alzheimer's Disease,,ALIA-1758 is a bispecific antibody construct. It comprises an anti-Aβ antibody fused with a transferrin receptor antibody that facilitates entry into the brain.,ongoing,,AlzForum.Therapeutics,alia-1758
allopregnanolone,Allopregnanolone,https://www.alzforum.org/therapeutics/allopregnanolone,,,Small Molecule,"Other Neurotransmitters, Other","Alzheimer's Disease, Parkinson's Disease",,"Allopregnanolone is a neurosteroid metabolite of progesterone. It is an allosteric modulator of inhibitory γ-aminobutyric acid (GABA-A) receptors on neural stem cells and other cell types in the brain ( Luchetti et al., 2011 ).",ongoing,,AlzForum.Therapeutics,allopregnanolone
alpha-tocopherol,Alpha-Tocopherol,https://www.alzforum.org/therapeutics/alpha-tocopherol,,,"Supplement, Dietary",Other,Alzheimer's Disease,,Vitamin E is a lipophilic monophenolic compound that can donate a hydrogen atom to saturate and detoxify the unpaired electron of a free radical. It is thought to protect against brain cell damage by destroying toxic free radicals.,ongoing,,AlzForum.Therapeutics,alpha-tocopherol
alx-001,ALX-001,https://www.alzforum.org/therapeutics/alx-001,,,Small Molecule,"Amyloid-Related, Other Neurotransmitters",Alzheimer's Disease,,"ALX-001 is an allosteric modulator of the metabotropic glutamate receptor type 5 (mGluR5). Originally developed by Bristol Myers Squibb as a potential treatment for schizophrenia, the compound is now in testing for AD.",ongoing,,AlzForum.Therapeutics,alx-001
alz-101,ALZ-101,https://www.alzforum.org/therapeutics/alz-101,,,Immunotherapy (active),Amyloid-Related,Alzheimer's Disease,,"This candidate vaccine is designed to provoke an immune response specific to soluble oligomeric Aβ assemblies, but not to monomeric or fibrillar Aβ. A proprietary protein-engineering technology uses disulfide bonds to cross-link Aβ peptides into a conformation that assembles into stable, soluble oligomers or protofibrils ( Sandberg et al., 2010 ; Dubnovitsky et al., 2013 ).",ongoing,,AlzForum.Therapeutics,alz-101
alz-801,ALZ-801,https://www.alzforum.org/therapeutics/alz-801,,,Small Molecule,Amyloid-Related,Alzheimer's Disease,,"This is a prodrug of homotaurine, a modified amino acid previously developed under the names tramiprosate and Alzhemed™. ALZ-801 is converted to homotaurine in vivo, but is more easily absorbed and lasts longer in the blood than tramiprosate.",ongoing,,AlzForum.Therapeutics,alz-801
alzhemedtm,Alzhemed™,https://www.alzforum.org/therapeutics/alzhemedtm,,,"Supplement, Dietary",Amyloid-Related,Alzheimer's Disease,,"Alzhemed was designed as an anti-amyloid therapy. It is a patented variant of the amino acid taurine, which is reported to inhibit the interaction of Aβ with endogenous glycosaminoglycans and thereby prevent β-sheet formation.",discontinued,,AlzForum.Therapeutics,alzhemedtm
alzt-op1,ALZT-OP1,https://www.alzforum.org/therapeutics/alzt-op1,,,"Combination, Small Molecule","Amyloid-Related, Inflammation",Alzheimer's Disease,,"ALZT-OP1 is a combination regimen of two FDA-approved drugs, cromolyn (designated ALZT OP1a) and ibuprofen (designated ALZT OP1b). In the ALZT-OP1 regimen, cromolyn is delivered via an oral, dry-powder inhaler; ibuprofen is swallowed separately as an oral tablet.",ongoing,,AlzForum.Therapeutics,alzt-op1
ambroxol,Ambroxol,https://www.alzforum.org/therapeutics/ambroxol,,,Small Molecule,"alpha-synuclein, Other","Parkinson's Disease, Parkinson's Disease Dementia, Dementia with Lewy Bodies",,"Ambroxol is a mucolytic compound and the main ingredient of over-the-counter cough medicines sold in many countries. Syrup, tablet, and other forms are used at doses of 30 to 120 mg per day to reduce or thin mucous secretions and ease sore throat pain.",ongoing,,AlzForum.Therapeutics,ambroxol
amilomotide,Amilomotide,https://www.alzforum.org/therapeutics/amilomotide,,,Immunotherapy (active),Amyloid-Related,Alzheimer's Disease,,"This is an active vaccination strategy that aims to elicit a strong antibody response while avoiding inflammatory T cell activation (reviewed in Lemere and Masliah, 2010 ). CAD106 combines multiple copies of Aβ1-6 peptide derived from the N-terminal B cell epitope of Aβ, coupled to a Qβ virus-like particle.",unknown,,AlzForum.Therapeutics,amilomotide
an-1792,AN-1792,https://www.alzforum.org/therapeutics/an-1792,,,Immunotherapy (active),Amyloid-Related,Alzheimer's Disease,,AN-1792 was the first active immunotherapy strategy for Alzheimer's disease. AN-1792 consists of synthetic full-length Aβ peptide with QS-21 adjuvant.,discontinued,,AlzForum.Therapeutics,an-1792
anpd001,ANPD001,https://www.alzforum.org/therapeutics/anpd001,,,Other,Other Neurotransmitters,Parkinson's Disease,,ANPD001 is a dopaminergic neuron replacement therapy derived from a patient’s own tissue. Fibroblasts from a skin biopsy are converted into pluripotent stem cells and then differentiated into dopaminergic neuron precursor cells.,ongoing,,AlzForum.Therapeutics,anpd001
anx005,ANX005,https://www.alzforum.org/therapeutics/anx005,,,Immunotherapy (passive),"Inflammation, Other",Amyotrophic Lateral Sclerosis,,"ANX005 is a humanized IgG4 monoclonal antibody that binds with high affinity to the complement C1q protein and inhibits initiation of the classical complement cascade. Given by intravenous infusion, the antibody is in development to treat autoimmune and neurodegenerative disorders.",ongoing,,AlzForum.Therapeutics,anx005
apabetalone,Apabetalone,https://www.alzforum.org/therapeutics/apabetalone,,,Small Molecule,Other,MCI-VaD,,"Apabetalone binds and inhibits bromodomain and extra-terminal domain (BET) proteins, preventing them from binding acetylated lysines in histones to activate gene transcription. In published papers, apabetalone is reported to increase expression of ApoA-1 and suppress genes associated with kidney disease and vascular calcification ( McLure et al., 2013 ; Wasiak et al., 2018 ; Gilham et al., 2019 ).",ongoing,,AlzForum.Therapeutics,apabetalone
apnmab005,APNmAb005,https://www.alzforum.org/therapeutics/apnmab005,,,Immunotherapy (passive),Tau,Alzheimer's Disease,,"This is a humanized monoclonal anti-tau IgG antibody that recognizes a conformational epitope in tau oligomers. It was generated by immunizing mice with oligomers encapsulated in artificial lipid vesicles, in an effort to elicit antibodies that would bind to, and clear, tau oligomers from synapses.",ongoing,,AlzForum.Therapeutics,apnmab005
aqneursa,AQNEURSA,https://www.alzforum.org/therapeutics/aqneursa,,,Small Molecule,"Inflammation, Other","Niemann-Pick Diseases, Ataxia, Lysosomal Storage Diseases, Nervous System",Neurological symptoms of Niemann-Pick Disease Type C,"N-acetyl-L-leucine is a modified derivative and prodrug of the naturally occurring essential amino acid leucine. In September 2024, the FDA approved this formulation of the pure L-leucine isomer to treat neurologic symptoms of the lysosomal storage disease Niemann-Pick type C in adults and children.",approved,,AlzForum.Therapeutics,aqneursa
aqw051,AQW051,https://www.alzforum.org/therapeutics/aqw051,,,Small Molecule,Cholinergic System,"Alzheimer's Disease, Parkinson's Disease, Schizophrenia",,"AQW 051 is an α7 nicotinic acetylcholine receptor (nAChR) agonist for the oral treatment of cognitive deficits in schizophrenia, Alzheimer's, and Parkinson's diseases. Very little is known about this drug.",ongoing,,AlzForum.Therapeutics,aqw051
ar1001,AR1001,https://www.alzforum.org/therapeutics/ar1001,,,Small Molecule,Other,Alzheimer's Disease,,"Ar1001 is a selective inhibitor of phosphodiesterase 5. This new pyrrolo-pyrimidinone was first developed for treatment of erectile dysfunction in South Korea, and is now being tested for Alzheimer’s disease.",ongoing,,AlzForum.Therapeutics,ar1001
arimoclomol,Arimoclomol,https://www.alzforum.org/therapeutics/arimoclomol,,,Small Molecule,"Cholesterol, Other","Niemann-Pick Diseases, Amyotrophic Lateral Sclerosis, Gaucher Disease",Niemann-Pick Disease Type C,"Arimoclomol is a small molecule that improves lysosome function. By stimulating normal cellular protein processing and repair pathways, it affects protein aggregation and clearance of misfolded proteins.",approved,,AlzForum.Therapeutics,arimoclomol
aripiprazole,Aripiprazole,https://www.alzforum.org/therapeutics/aripiprazole,,,Small Molecule,Other Neurotransmitters,"Alzheimer's Disease, Schizophrenia",,"Aripiprazole is an antipsychotic medication that was FDA-approved in 2002 for the treatment of schizophrenia and is widely used for related affective disorders, as well. Generic versions started becoming available in 2015.",approved,,AlzForum.Therapeutics,aripiprazole
arv-102,ARV-102,https://www.alzforum.org/therapeutics/arv-102,,,Small Molecule,Other,Parkinson's Disease,,"ARV-102 is an oral, brain-penetrant small molecule that induces the degradation of leucine-rich repeat kinase 2 (LRRK2) protein. Increased LRRK2 expression and kinase activity impair lysosome function, promote neuroinflammation, and contribute to neurodegeneration and the pathogenesis of Parkinson’s disease.",ongoing,,AlzForum.Therapeutics,arv-102
asn51,ASN51,https://www.alzforum.org/therapeutics/asn51,,,Small Molecule,Tau,Alzheimer's Disease,,"ASN51 is a small-molecule inhibitor of O-GlycNAcase (OGA), the glycoside hydrolase enzyme that removes O-linked N-acetylglucosamine (N-GlcNAc) from proteins. Asceneuron was developing ASN51 as a potential treatment for Alzheimer’s and Parkinson’s diseases.",unknown,,AlzForum.Therapeutics,asn51
asn90,ASN90,https://www.alzforum.org/therapeutics/asn90,,,Small Molecule,Tau,Progressive Supranuclear Palsy,,"ASN90 is an inhibitor of O-GlcNAcase, the glycoside hydrolase enzyme that removes O-linked N-acetylglucosamine (N-GlcNAc) from proteins. The function of numerous proteins is regulated by O-linked glycosylation of serine and threonine residues, which is reversed by O-GlcNAcase.",ongoing,,AlzForum.Therapeutics,asn90
atabecestat,Atabecestat,https://www.alzforum.org/therapeutics/atabecestat,,,Small Molecule,Amyloid-Related,Alzheimer's Disease,,"This is a tablet drug affecting amyloid precursor protein (APP) and its processing products. It inhibits APP cleavage by the enzyme BACE, the rate-limiting step in Aβ generation.",discontinued,,AlzForum.Therapeutics,atabecestat
atb2005a,ATB2005A,https://www.alzforum.org/therapeutics/atb2005a,,,Small Molecule,Tau,"Alzheimer's Disease, Progressive Supranuclear Palsy",,"This small molecule combines a tau-binding domain with a peptide that stimulates autophagy to activate degradation of intracellular tau aggregates. It is being investigated as a treatment for tauopathies including Alzheimer’s disease, and progressive supranuclear palsy.",ongoing,,AlzForum.Therapeutics,atb2005a
atomoxetine,Atomoxetine,https://www.alzforum.org/therapeutics/atomoxetine,,,Small Molecule,Other Neurotransmitters,"Alzheimer's Disease, Parkinson's Disease",ADHD in US,Atomoxetine is a norepinephrine uptake inhibitor. It blocks a norepinephrine transporter and boosts noradrenaline levels in the brain.,ongoing,,AlzForum.Therapeutics,atomoxetine
atorvastatin,Atorvastatin,https://www.alzforum.org/therapeutics/atorvastatin,,,Small Molecule,Cholesterol,Alzheimer's Disease,Hypercholesterolaemia,"Atorvastatin is an oral statin drug that was developed by Pfizer’s predecessor, Parke-Davis. It is marketed under different names for hypercholesterolemia worldwide, including the United States, European Union, and Japan.",unknown,,AlzForum.Therapeutics,atorvastatin
atuzaginstat,Atuzaginstat,https://www.alzforum.org/therapeutics/atuzaginstat,,,Small Molecule,Other,Alzheimer's Disease,,"This small molecule is an orally available protease inhibitor targeting the lysine proteases of the periodontal pathogen Porphyromonas gingivalis. Known as gingipains, these proteases penetrate gingival tissue and cause inflammation at the site of periodontitis ( O'Brien-Simpson et al., 2009 ).",discontinued,,AlzForum.Therapeutics,atuzaginstat
autologous-adipose-derived-stem-cells,Autologous Adipose-derived Stem Cells,https://www.alzforum.org/therapeutics/autologous-adipose-derived-stem-cells,,,Other,Other,Alzheimer's Disease,,This approach uses mesenchymal stem cells isolated from a patient’s own fat tissue to treat neurodegenerative diseases. The stem cells are supposed to assist in repair of damaged tissue and regeneration of cells.,ongoing,,AlzForum.Therapeutics,autologous-adipose-derived-stem-cells
av-1959d,AV-1959D,https://www.alzforum.org/therapeutics/av-1959d,,,Immunotherapy (active),Amyloid-Related,Alzheimer's Disease,,AV-1959D is an NIH-funded DNA vaccine designed to elicit antibodies to Aβ peptides without activating potentially harmful autoreactive T cells. This vaccine fuses coding sequences of three copies of Aβ1-11 to 12 T-cell-activating epitopes.,ongoing,,AlzForum.Therapeutics,av-1959d
av-1980ra,AV-1980R/A,https://www.alzforum.org/therapeutics/av-1980ra,,,Immunotherapy (active),Tau,Alzheimer's Disease,,AV-1980R/A is recombinant protein-based tau vaccine designed to elicit antibodies to pathologic tau. It fuses three copies of a tau2-18 peptide to 12 T-cell activating antigens.,ongoing,,AlzForum.Therapeutics,av-1980ra
avagacestat,Avagacestat,https://www.alzforum.org/therapeutics/avagacestat,,,Small Molecule,Amyloid-Related,Alzheimer's Disease,,"This arylsulfonamide γ-secretase inhibitor was reported to selectively block processing of the enzyme's APP substrate, relatively sparing Notch processing. Notch is a transmembrane receptor whose signaling is important for cell-fate decisions in the intestine and in lymphocyte maturation.",discontinued,,AlzForum.Therapeutics,avagacestat
avb-101,AVB-101,https://www.alzforum.org/therapeutics/avb-101,,,DNA/RNA-based,Other,Frontotemporal Dementia,,AVB-101 is a gene therapy designed to deliver a copy of the human progranulin gene to the brain. It is being tested in people with frontotemporal dementia due to pathogenic progranulin mutations.,ongoing,,AlzForum.Therapeutics,avb-101
avp-786,AVP-786,https://www.alzforum.org/therapeutics/avp-786,,,"Combination, Small Molecule",Other Neurotransmitters,"Alzheimer's Disease, Schizophrenia",,"This investigational therapeutic is a deuterated, second-generation version of AVP-923 /Nuedexta, a fixed-dose combination of two approved drugs. Both AVP-923 and AVP-786 contain dextromethorphan, the active ingredient in several brands of cough syrup.",discontinued,,AlzForum.Therapeutics,avp-786
avp-923,AVP-923,https://www.alzforum.org/therapeutics/avp-923,,,"Combination, Small Molecule",Other Neurotransmitters,"Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Parkinson's Disease",,"AVP-923 is a fixed-dose combination of two approved drugs. One is dextromethorphan, the active ingredient in several brands of cough syrup.",ongoing,,AlzForum.Therapeutics,avp-923
axs-05,AXS-05,https://www.alzforum.org/therapeutics/axs-05,,,"Combination, Small Molecule",Other Neurotransmitters,Alzheimer's Disease,Major depressive disorder,"AXS-05 is a fixed-dose combination of two approved drugs being developed for the treatment of agitation in people with Alzheimer’s disease. One component, dextromethorphan, is the active ingredient in several brands of cough syrup.",ongoing,,AlzForum.Therapeutics,axs-05
azd1446,AZD1446,https://www.alzforum.org/therapeutics/azd1446,,,Small Molecule,Cholinergic System,Alzheimer's Disease,,AZD1446 selectively activates the α4β2 subtype of nicotinic acetylcholine receptor.,discontinued,,AlzForum.Therapeutics,azd1446
azd3293,Lanabecestat,https://www.alzforum.org/therapeutics/azd3293,,,Small Molecule,Amyloid-Related,Alzheimer's Disease,,"AZD3293 is an inhibitor of BACE1, the β-secretase sheddase that cleaves the APP protein to release APP's C99 fragment. This fragment then becomes a substrate for subsequent γ-secretase cleavage and Aβ peptide generation.",discontinued,,AlzForum.Therapeutics,azd3293
azd3480,AZD3480,https://www.alzforum.org/therapeutics/azd3480,,,Small Molecule,Cholinergic System,Alzheimer's Disease,,,unknown,,AlzForum.Therapeutics,azd3480
azeliragon,Azeliragon,https://www.alzforum.org/therapeutics/azeliragon,,,Small Molecule,"Amyloid-Related, Inflammation",Alzheimer's Disease,,"Azeliragon is an oral, small-molecule inhibitor of RAGE, a cell-surface receptor of the immunoglobulin superfamily. Expressed on multiple cell types, RAGE binds advanced glycation end products (AGEs); these are modified forms of lipids and proteins that become glycated when exposed to sugars.",discontinued,,AlzForum.Therapeutics,azeliragon
bapineuzumab,Bapineuzumab,https://www.alzforum.org/therapeutics/bapineuzumab,,,Immunotherapy (passive),Amyloid-Related,Alzheimer's Disease,,"Bapineuzumab is a humanized form of murine monoclonal antibody 3D6, which targets the N-terminal region of Aβ. The rationale of this passive immunotherapy approach is that antibody binding will clear excess Aβ.",discontinued,,AlzForum.Therapeutics,bapineuzumab
baricitinib,Baricitinib,https://www.alzforum.org/therapeutics/baricitinib,,,Small Molecule,Inflammation,"Alzheimer's Disease, Amyotrophic Lateral Sclerosis","Rheumatoid arthritis, Eczema (Europe, Japan only)",Baricitinib is an inhibitor of Janus kinase (JAK). It is approved in the U.S.,ongoing,,AlzForum.Therapeutics,baricitinib
bemdaneprocel,Bemdaneprocel,https://www.alzforum.org/therapeutics/bemdaneprocel,,,Other,"Other Neurotransmitters, Other",Parkinson's Disease,,"This cell-based therapy consists of a neuron graft for the treatment of Parkinson’s disease. The grafting cells are derived from human embryonic pluripotent stem cells, and converted in the lab to dopamine-producing neuron progenitors.",ongoing,,AlzForum.Therapeutics,bemdaneprocel
benfotiamine,Benfotiamine,https://www.alzforum.org/therapeutics/benfotiamine,,,"Supplement, Dietary","Inflammation, Other",Alzheimer's Disease,,"Benfotiamine is a synthetic, fat-soluble precursor of Vitamin B1 with high bioavailability. Taken orally, benfotiamine produces supra-physiological blood levels of the active coenzyme form of thiamine.",ongoing,,AlzForum.Therapeutics,benfotiamine
bepranemab,Bepranemab,https://www.alzforum.org/therapeutics/bepranemab,,,Immunotherapy (passive),Tau,"Progressive Supranuclear Palsy, Alzheimer's Disease",,"This humanized, monoclonal IgG4 antibody binds to the central region of tau, recognizing amino acids 235–250 near tau's microtubule-binding domain. The rationale of this approach is that mid-region antibodies will more potently interfere with the cell-to-cell propagation of pathogenic, aggregated tau than do N-terminally targeted anti-tau antibodies.",ongoing,,AlzForum.Therapeutics,bepranemab
besipirdine-hcl,Besipirdine HCl,https://www.alzforum.org/therapeutics/besipirdine-hcl,,,Small Molecule,Other Neurotransmitters,Alzheimer's Disease,,"Besipirdine was designed to address two biochemical deficits commonly observed in the AD brain: cholinergic and adrenergic activity. This drug has been shown to enhance the activity of both systems ( Klein et al., 1996 ).",discontinued,,AlzForum.Therapeutics,besipirdine-hcl
bexarotene,Bexarotene,https://www.alzforum.org/therapeutics/bexarotene,,,Small Molecule,"Amyloid-Related, Unknown",Alzheimer's Disease,Cutaneous T-cell Lymphoma in US,"This retinoid drug is approved by the FDA and EMA to treat T cell lymphoma of the skin. It is an agonist of a nuclear transcription factor called retinoid X receptor, which forms heterodimers with peroxisome proliferator-activated receptor γ (PPARγ) or liver X receptors (LXRs) to aid in the formation of ApoE lipoprotein particles.",ongoing,,AlzForum.Therapeutics,bexarotene
bezisterim,Bezisterim,https://www.alzforum.org/therapeutics/bezisterim,,,Small Molecule,"Inflammation, Other","Alzheimer's Disease, Parkinson's Disease",,"NE3107 is a derivative of β-androstenetriol, a naturally occurring adrenal sterol metabolite. The parent compound has been chemically modified to increase oral bioavailability and stability.",ongoing,,AlzForum.Therapeutics,bezisterim
bi-1181181,BI 1181181,https://www.alzforum.org/therapeutics/bi-1181181,,,Small Molecule,Amyloid-Related,Alzheimer's Disease,,"This compound is an inhibitor targeted to the catalytic site of the enzymes BACE1 and BACE2. It was discovered by the biotechnology company Vitae Pharmaceuticals using Contour®, its structure-based drug design platform, and is being clinically developed with the pharmaceutical firm Boehringer Ingelheim.",discontinued,,AlzForum.Therapeutics,bi-1181181
bi-409306,BI 409306,https://www.alzforum.org/therapeutics/bi-409306,,,Small Molecule,"Other Neurotransmitters, Other","Alzheimer's Disease, Schizophrenia",,BI 409306 is an inhibitor of phosphodiesterase 9A. PDE9A is a drug target for cognitive decline in Alzheimer's and other diseases because this enzyme reduces brain levels of the second messenger cyclic guanosine monophosphate.,discontinued,,AlzForum.Therapeutics,bi-409306
bifidobacterium-breve-a1,Bifidobacterium breve A1,https://www.alzforum.org/therapeutics/bifidobacterium-breve-a1,,,"Supplement, Dietary",Other,Mild Cognitive Impairment,,"Bifidobacterium breve A1 is a proprietary strain of probiotic bacteria isolated from the intestinal tract of an infant. A main component of the human gut microbiome, Bifidobacteria species form part of many probiotic supplements widely used to treat gastrointestinal and other ailments (see WebMD ).",ongoing,,AlzForum.Therapeutics,bifidobacterium-breve-a1
biib076,BIIB076,https://www.alzforum.org/therapeutics/biib076,,,Immunotherapy (passive),Tau,Alzheimer's Disease,,"BIIB076 is a human recombinant, monoclonal anti-tau IgG1 antibody generated by Neurimmune's reverse translational medicine platform. Biogen acquired it in 2010.",discontinued,,AlzForum.Therapeutics,biib076
biib078,BIIB078,https://www.alzforum.org/therapeutics/biib078,,,DNA/RNA-based,Other,Amyotrophic Lateral Sclerosis,,"BIIB078 is an antisense oligonucleotide targeting the chromosome 9 open reading frame 72 (C9ORF72) gene mRNA. It was being developed for ALS caused by hexanucleotide repeat expansions in C9ORF72 ( van Blitterswijk et al, 2012 ).",discontinued,,AlzForum.Therapeutics,biib078
biib080,BIIB080,https://www.alzforum.org/therapeutics/biib080,,,DNA/RNA-based,Tau,Alzheimer's Disease,,"This investigational therapeutic is the first antisense oligonucleotide (ASO) targeting tau expression to enter clinical trials. Developed by IONIS in collaboration with Timothy Miller at Washington University, St.",ongoing,,AlzForum.Therapeutics,biib080
biib100,BIIB100,https://www.alzforum.org/therapeutics/biib100,,,Small Molecule,"Inflammation, Other",Amyotrophic Lateral Sclerosis,,"BIIB100 is an inhibitor of Exportin 1 (XPO1), a protein that mediates export of many proteins and RNA from the cell nucleus. Abnormal movement of proteins and RNA molecules in and out of the nucleus plays a role in neurodegenerative and other diseases.",discontinued,,AlzForum.Therapeutics,biib100
biib105,BIIB105,https://www.alzforum.org/therapeutics/biib105,,,DNA/RNA-based,Other,Amyotrophic Lateral Sclerosis,,"BIIB105 is an antisense oligonucleotide (ASO). It binds the mRNA for ataxin-2 and mediates its degradation, which results in lower ataxin-2 protein levels.",discontinued,,AlzForum.Therapeutics,biib105
biib113,BIIB113,https://www.alzforum.org/therapeutics/biib113,,,Small Molecule,Tau,Alzheimer's Disease,,"BIIB113 is a small molecule inhibitor of O-GlcNACase, or OGA, an enzyme that catalyzes the removal of O-GlcNAc sugar modifications from proteins. OGA inhibitors promote glycosylation of tau, which prevents its aggregation and appears to stabilize the protein in a soluble, non-pathogenic form (e.g., see Yuzwa et al., 2012 ).",discontinued,,AlzForum.Therapeutics,biib113
biib118,BIIB118,https://www.alzforum.org/therapeutics/biib118,,,Small Molecule,Other,"Alzheimer's Disease, Parkinson's Disease",,"PF-05251749 is an inhibitor of Casein kinase 1 delta and epsilon (CK1δ and ε). It was being developed by Pfizer for the treatment of Alzheimer's disease, and is now owned by Biogen.",ongoing,,AlzForum.Therapeutics,biib118
blarcamesine,Blarcamesine,https://www.alzforum.org/therapeutics/blarcamesine,,,Small Molecule,Other,"Alzheimer's Disease, Parkinson's Disease Dementia, Parkinson's Disease",,"This compound is an agonist of the intracellular sigma-1 chaperone protein. Specifically, it is a mixed ligand for sigma1/muscarinic receptors.",ongoing,,AlzForum.Therapeutics,blarcamesine
bms-986446,BMS-986446,https://www.alzforum.org/therapeutics/bms-986446,,,Immunotherapy (passive),Tau,Alzheimer's Disease,,"PRX005 is Prothena’s anti-tau IgG1 humanized antibody. It recognizes an epitope in the R1, R2, and R3 repeats in the microtubule binding region MTBR.",ongoing,,AlzForum.Therapeutics,bms-986446
bosutinib,Bosutinib,https://www.alzforum.org/therapeutics/bosutinib,,,Small Molecule,Other,"Alzheimer's Disease, Dementia with Lewy Bodies",Chronic myeloid leukemia,"Bosutinib is an oral inhibitor of Abl and Src tyrosine kinases that has been approved since 2012 for the treatment of chronic myeloid leukemia. At the therapeutic dose of 500 mg/day, its common side effects are diarrhea, nausea, and vomiting.",ongoing,,AlzForum.Therapeutics,bosutinib
bpn14770,BPN14770,https://www.alzforum.org/therapeutics/bpn14770,,,Small Molecule,"Cholinergic System, Other",Alzheimer's Disease,,"BPN14770 is an allosteric inhibitor of phosphodiesterase 4D (PDE4D), a regulator of the intracellular second messenger cAMP in neurons. Inhibitors of PDE4D raise cAMP levels, which has been reported to support cognition and protect neurons.",ongoing,,AlzForum.Therapeutics,bpn14770
brexpiprazole,Brexpiprazole,https://www.alzforum.org/therapeutics/brexpiprazole,,,Small Molecule,Other Neurotransmitters,"Alzheimer's Disease, Schizophrenia",,"Brexpiprazole is an orally available dopamine receptor D2 partial agonist, and an atypical antipsychotic. This quinolinone derivative is a successor to aripiprazole (Abilify, Aripiprex), an approved, widely used drug that is also a dopamine D2 receptor partial agonist.",approved,,AlzForum.Therapeutics,brexpiprazole
bryostatin-1,Bryostatin 1,https://www.alzforum.org/therapeutics/bryostatin-1,,,Other,Other,Alzheimer's Disease,,Bryostatin 1 is a natural product derived from the marine invertebrate Bugula neritina. It has potent and broad antitumor activity.,ongoing,,AlzForum.Therapeutics,bryostatin-1
bt-267,BT-267,https://www.alzforum.org/therapeutics/bt-267,,,Small Molecule,Other,Parkinson's Disease,,"BT-267 is a selective, brain-penetrant small molecule inhibitor of leucine-rich repeat kinase LRRK2. It is designed to maximize CNS exposure and minimize peripheral activity, to reduce off-target and systemic effects.",ongoing,,AlzForum.Therapeutics,bt-267
buntanetap,Buntanetap,https://www.alzforum.org/therapeutics/buntanetap,,,Small Molecule,"Amyloid-Related, alpha-synuclein","Alzheimer's Disease, Parkinson's Disease",,"Buntanetap, previously known as posiphen or ANVS-401, is the pure (+) enantiomer, i.e. mirror image, of phenserine.",ongoing,,AlzForum.Therapeutics,buntanetap
bxcl501,BXCL501,https://www.alzforum.org/therapeutics/bxcl501,,,Small Molecule,Other,Alzheimer's Disease,Acute Agitation in Schizophrenia and Bipolar Disorder,BXCL501 is an orally dissolvable film formulation of the α2A adrenergic receptor agonist dexmedetomidine. It is approved to treat acute agitation associated with schizophrenia or bipolar disorder in people under medical supervision.,ongoing,,AlzForum.Therapeutics,bxcl501
candesartan,Candesartan,https://www.alzforum.org/therapeutics/candesartan,,,Small Molecule,Other,"Mild Cognitive Impairment, Alzheimer's Disease","Hypertension, congestive heart failure","Candesartan is an angiotensin II receptor antagonist used around the world to treat elevated blood pressure and congestive heart failure. Approved in 1997, the drug is available in generic form.",ongoing,,AlzForum.Therapeutics,candesartan
cannabidiol,Cannabidiol,https://www.alzforum.org/therapeutics/cannabidiol,,,Small Molecule,Other Neurotransmitters,Alzheimer's Disease,"Seizures in Dravet syndrome, Lennox-Gastaut syndrome or tuberous sclerosis complex","Cannabidiol is a major active compound of the cannabis plant. It is structurally related to tetrahydrocannabinol (THC), but does not produce a high.",ongoing,,AlzForum.Therapeutics,cannabidiol
carvedilol,Carvedilol,https://www.alzforum.org/therapeutics/carvedilol,,,Small Molecule,Unknown,Alzheimer's Disease,"Hypertension, heart failure, angina pectoris",Carvedilol phosphate is a non-selective α/β-adrenergic receptor antagonist and vasodilator. This drug has been available in the United States and many other countries since the mid-1990s.,ongoing,,AlzForum.Therapeutics,carvedilol
cdnf,CDNF,https://www.alzforum.org/therapeutics/cdnf,,,"Procedural Intervention, Other",Other,Parkinson's Disease,,"The neurotrophic peptide CDNF promotes survival of midbrain dopaminergic neurons, which degenerate in Parkinson’s disease. The peptide does not cross the blood-brain barrier.",ongoing,,AlzForum.Therapeutics,cdnf
celecoxib,Celecoxib,https://www.alzforum.org/therapeutics/celecoxib,,,Small Molecule,Inflammation,Alzheimer's Disease,"Pain, Arthritis","The NSAID celecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor, whose anti-inflammatory and analgesic effects partly result from the inhibition of prostaglandin synthesis. In Alzheimer's research, interest in NSAIDs arose when epidemiological studies started reporting lower rates of Alzheimer's disease, or protection of cognition, among people who had been taking these drugs over long periods of time for the chronic treatment of inflammatory conditions (e.g., Mar 1997 news story; in't Veld et al., 1998; Nov 2001 news story; Vlad et al., 2008; Obermann et al., 2013).",discontinued,,AlzForum.Therapeutics,celecoxib
ceperognastat,Ceperognastat,https://www.alzforum.org/therapeutics/ceperognastat,,,Small Molecule,Tau,Alzheimer's Disease,,"This inhibitor of the O-GlcNAcase (OGA) enzyme was being developed as a potential treatment for tauopathies, including Alzheimer's disease. O-GlcNAcylation, i.e., addition of N-acetylglucosamine to serine and threonine residues, is a post-translational modification that regulates the function of many proteins.",discontinued,,AlzForum.Therapeutics,ceperognastat
cere-110,CERE-110,https://www.alzforum.org/therapeutics/cere-110,,,DNA/RNA-based,Other,Alzheimer's Disease,,"CERE-110 was a gene-therapy approach for neuroprotective treatment of Alzheimer's disease. It employed injection of an AAV2-based vector for expression of the gene encoding the trophic protein nerve growth factor (NGF) into the nucleus basalis of Meynert, a cholinergic brain area that degenerates in the disease.",discontinued,,AlzForum.Therapeutics,cere-110
cerebrolysin,Cerebrolysin,https://www.alzforum.org/therapeutics/cerebrolysin,,,Other,Other,Alzheimer's Disease,,,ongoing,,AlzForum.Therapeutics,cerebrolysin
chf-5074,CHF 5074,https://www.alzforum.org/therapeutics/chf-5074,,,Small Molecule,"Amyloid-Related, Inflammation, Other","Mild Cognitive Impairment, Alzheimer's Disease",,"This compound was initially reported as a γ-secretase modulator but is now portrayed as acting on multiple targets, particularly microglia. Long-term use of NSAIDs confers some protection against incident Alzheimer’s, and a widely noted finding that certain NSAIDs lower Aβ42 production independent of their action on the Cox enzymes prompted widespread research into NSAID derivatives of similar function (see Weggen et al., 2001 ).",ongoing,,AlzForum.Therapeutics,chf-5074
cinpanemab,Cinpanemab,https://www.alzforum.org/therapeutics/cinpanemab,,,Immunotherapy (passive),alpha-synuclein,Parkinson's Disease,,Cinpanemab is a human-derived monoclonal antibody directed against α-synuclein. Genetic and pathology evidence implicate this protein in the molecular pathogenesis of Parkinson's disease (PD) and other α-synucleinopathies such as dementia with Lewy bodies (DLB).,discontinued,,AlzForum.Therapeutics,cinpanemab
circadin,Circadin,https://www.alzforum.org/therapeutics/circadin,,,Small Molecule,Other,Alzheimer's Disease,Insomnia,"Circadin is an extended-release formulation of melatonin, a hormone that is released by the pineal gland into the CSF at night to regulate circadian rhythms and induce sleepiness. Circadin is being marketed for insomnia in the European Union, Israel, Australia, and countries in Asia and elsewhere.",ongoing,,AlzForum.Therapeutics,circadin
citalopram,Citalopram,https://www.alzforum.org/therapeutics/citalopram,,,Small Molecule,Other Neurotransmitters,"Alzheimer's Disease, Preclinical Alzheimer's Disease","Depression, generalized anxiety disorder",Citalopram is a selective serotonin reuptake inhibitor used to treat depression and anxiety. It is a chiral molecule that exists as two enantiomers.,ongoing,,AlzForum.Therapeutics,citalopram
clioquinol,Clioquinol,https://www.alzforum.org/therapeutics/clioquinol,,,Small Molecule,"Amyloid-Related, Metals",Alzheimer's Disease,,Clioquinol is an old drug that was used to treat fungal and protozoal infections but was found to be neurotoxic when used chronically at high doses. A one-time epidemic of subacute-myelo-optico-neuropathy in Japan prompted its removal or restrictions on its use in many countries.,discontinued,,AlzForum.Therapeutics,clioquinol
cnm-au8,CNM-Au8,https://www.alzforum.org/therapeutics/cnm-au8,,,Other,"Metals, Other","Parkinson's Disease, Amyotrophic Lateral Sclerosis",,"CNM-Au8 is a preparation of pure elemental gold nanoparticles in a drinkable bicarbonate solution. The faceted crystals have a median diameter of 13 nm, slightly smaller than a ribosome.",ongoing,,AlzForum.Therapeutics,cnm-au8
cocoa-flavanols,Cocoa Flavanols,https://www.alzforum.org/therapeutics/cocoa-flavanols,,,"Supplement, Dietary","Inflammation, Other",Mild Cognitive Impairment,,"Flavanols are naturally occurring bioactive plant products in tea, wine, and chocolate. The predominant flavanols in cocoa include catechin, epicatechin, and procyanidins, which are thought to give these foods heart and other health benefits.",unknown,,AlzForum.Therapeutics,cocoa-flavanols
cognishunt%E2%84%A2,COGNIShunt™,https://www.alzforum.org/therapeutics/cognishunt%E2%84%A2,,,Procedural Intervention,Other,Alzheimer's Disease,,"The accumulation of amyloid plaques, neurofibrillary tangles, and neurodegeneration is thought to be due at least in part to the failure to clear circulating soluble Aβ and tau. CSF shunts have been used for decades to treat hydrocephalus, and were proposed as a possible way to clear toxic species from the body, especially because aging is associated with reduced CSF turnover ( May et al., 1990 ).",unknown,,AlzForum.Therapeutics,cognishunt%E2%84%A2
continuous-positive-airway-pressure,Continuous Positive Airway Pressure,https://www.alzforum.org/therapeutics/continuous-positive-airway-pressure,,,Procedural Intervention,Unknown,Alzheimer's Disease,Sleep Apnea in US,Continuous Positive Airway Pressure (CPAP) is an approved treatment using a machine and nasal mask to deliver continuous air flow and help keep the airways open during sleep. Sleep-disordered breathing and obstructive sleep apnea cause sleep fragmentation and nighttime hypoxia.,ongoing,,AlzForum.Therapeutics,continuous-positive-airway-pressure
coya-302,COYA 302,https://www.alzforum.org/therapeutics/coya-302,,,"Combination, Other",Inflammation,"Amyotrophic Lateral Sclerosis, Frontotemporal Dementia",,"This immunomodulatory therapy combines low-dose interleukin-2 with an antibody to the cytotoxic T lymphocyte antigen 4 (CTLA4-Ig). Marketed as Abatacept, CTLA4-Ig is used to modulate inflammation in autoimmune diseases.",ongoing,,AlzForum.Therapeutics,coya-302
cpg-1018r,CpG 1018®,https://www.alzforum.org/therapeutics/cpg-1018r,,,"Immunotherapy (active), DNA/RNA-based","Amyloid-Related, Inflammation",Alzheimer's Disease,,"CpG 1018 is a proprietary immune adjuvant made up of short, unmethylated cytosine-phosphate-guanine oligodeoxynucleotides (CpG ODNs). Its components mimic bacterial DNA to activate innate immunity through binding to the toll-like receptor 9 (TLR9).",ongoing,,AlzForum.Therapeutics,cpg-1018r
crenezumab,Crenezumab,https://www.alzforum.org/therapeutics/crenezumab,,,Immunotherapy (passive),Amyloid-Related,Alzheimer's Disease,,"Crenezumab represents a passive immunotherapy approach in which patients are treated with monoclonal antibodies that specifically recognize Aβ peptides. Crenezumab recognizes multiple forms of aggregated Aβ, including oligomeric and fibrillar species with high affinity, and monomeric Aβ with low affinity.",discontinued,,AlzForum.Therapeutics,crenezumab
cs6253,CS6253,https://www.alzforum.org/therapeutics/cs6253,,,Small Molecule,"Amyloid-Related, Cholesterol",Alzheimer's Disease,,"This agonist peptide increases the activity of the adenosine triphosphate-binding cassette transporter A1 (ABCA1), which regulates cholesterol efflux from cells. ABCA1 transfers lipids to ApoE, and thus facilitates clearance of amyloid peptides from the brain.",ongoing,,AlzForum.Therapeutics,cs6253
cst-103,CST-103,https://www.alzforum.org/therapeutics/cst-103,,,Small Molecule,Other Neurotransmitters,"Mild Cognitive Impairment, Parkinson's Disease, Amyotrophic Lateral Sclerosis","Asthma, in countries outside the U.S.","CST-103 is CuraSen’s name for clenbuterol, a β2-adrenergic receptor agonist. Clenbuterol is related to common asthma drugs such as albuterol but is not approved for use in the U.S.",ongoing,,AlzForum.Therapeutics,cst-103
cst-2032,CST-2032,https://www.alzforum.org/therapeutics/cst-2032,,,Small Molecule,Other Neurotransmitters,"Mild Cognitive Impairment, Parkinson's Disease",,"CST-2032 is a proprietary, brain-penetrant β2-adrenergic receptor agonist. Like clenbuterol , CST-2032 activates norepinephrine receptors in cortical and limbic brain regions to compensate for the loss of this neurotransmitter in neurodegenerative diseases.",ongoing,,AlzForum.Therapeutics,cst-2032
curcumin,Curcumin,https://www.alzforum.org/therapeutics/curcumin,,,"Supplement, Dietary","Other, Unknown",Alzheimer's Disease,,"Curcumin, the natural polyphenol that provides the yellow hue to turmeric, has been used in Indian Ayurvedic as well as traditional Chinese and Southeast Asian medicines for centuries to treat a wide variety of ailments. Animal models have demonstrated diverse beneficial effects of the compound, including anti-inflammatory and antioxidant properties as well as inhibiting Aβ aggregation ( Yang et al., 2005 ).",ongoing,,AlzForum.Therapeutics,curcumin
cx516,CX516,https://www.alzforum.org/therapeutics/cx516,,,Small Molecule,Other Neurotransmitters,Alzheimer's Disease,,"CX516 is a so-called ampakine, a molecule that potentiates currents mediated by AMPA-type glutamate receptors. As a class, these drugs enhance AMPA-receptor activity by slowing deactivation and attenuating desensitization of AMPA receptor currents, thus increasing synaptic responses and enhancing long-term potentiation (reviewed in Arai and Kessler, 2007 ).",discontinued,,AlzForum.Therapeutics,cx516
cy6463,CY6463,https://www.alzforum.org/therapeutics/cy6463,,,Small Molecule,Inflammation,Alzheimer's Disease,,"CY6463 is a brain-penetrant, positive allosteric modulator of the soluble guanylate cyclase (sGC). It amplifies endogenous nitrous oxide signaling to increase production of the second message cGMP.",ongoing,,AlzForum.Therapeutics,cy6463
dapagliflozin,Dapagliflozin,https://www.alzforum.org/therapeutics/dapagliflozin,,,Small Molecule,Other,Alzheimer's Disease,,Dapagliflozin is a once-daily prescription pill that is FDA-approved to treat Type 2 diabetes and reduce risk of heart failure in people with diabetes. It belongs to the gliflozin class of glucose-lowering agents that includes empagliflozin.,ongoing,,AlzForum.Therapeutics,dapagliflozin
dapsone,Dapsone,https://www.alzforum.org/therapeutics/dapsone,,,Small Molecule,Other,Alzheimer's Disease,"Leprosy, malaria, some bacterial skin infections","Dapsone is a small molecule with anti-inflammatory immunosuppressive properties as well as antibacterial and antibiotic properties. It is used clinically to treat leprosy and malaria, and is being investigated for the treatment of a variety of skin infections.",unknown,,AlzForum.Therapeutics,dapsone
dasatinib-quercetin,Dasatinib + Quercetin,https://www.alzforum.org/therapeutics/dasatinib-quercetin,,,"Combination, Small Molecule, Supplement, Dietary","Tau, Other",Alzheimer's Disease,,"Dasatinib is a cancer drug, sold under the name Sprycel® to treat certain types of leukemia in adults and children. Its side effects include low blood cell counts, anemia, rash, and diarrhea.",ongoing,,AlzForum.Therapeutics,dasatinib-quercetin
davunetide,Davunetide,https://www.alzforum.org/therapeutics/davunetide,,,Other,Tau,"Mild Cognitive Impairment, Progressive Supranuclear Palsy, Schizophrenia, Frontotemporal Dementia, Autism Spectrum Disorder",,"Davunetide is an intranasal neuropeptide therapy derived from a growth factor called activity-dependent neurotrophic protein (ADNP). Released by glial cells, ADNP contains within it a peptide of the eight amino acids Asn-Ala-Pro-Val-Ser-Ile-Pro-Gln.",ongoing,,AlzForum.Therapeutics,davunetide
dayvigo,Dayvigo,https://www.alzforum.org/therapeutics/dayvigo,,,Small Molecule,Other,Alzheimer's Disease,Insomnia,"Dayvigo is the brand name of lemborexant, a brain-penetrant, small-molecule orexin/hypocretin receptor antagonist used to treat insomnia. The neuropeptide orexin regulates wakefulness; inhibiting orexin receptor signaling promotes sleep.",ongoing,,AlzForum.Therapeutics,dayvigo
deep-brain-stimulation-fornix,Deep Brain Stimulation-fornix,https://www.alzforum.org/therapeutics/deep-brain-stimulation-fornix,,,Procedural Intervention,Unknown,Alzheimer's Disease,,"Deep Brain Stimulation (DBS) is an invasive treatment where pairs of electrodes are surgically implanted in the brain, and connected to a pulse generator placed under the skin on the chest. DBS-fornix places electrodes in the fiber tract that connects the hippocampus to other parts of the limbic system, and is intended to modulate or ease dysfunction of memory circuits in the brain.",ongoing,,AlzForum.Therapeutics,deep-brain-stimulation-fornix
deep-brain-stimulation-nucleus-basalis-meynert,Deep Brain Stimulation-nucleus basalis of Meynert,https://www.alzforum.org/therapeutics/deep-brain-stimulation-nucleus-basalis-meynert,,,Procedural Intervention,"Cholinergic System, Other",Alzheimer's Disease,,Deep Brain Stimulation (DBS) is an invasive treatment. Pairs of electrodes are surgically implanted in the brain and connected to a pulse generator placed under the skin on the chest.,ongoing,,AlzForum.Therapeutics,deep-brain-stimulation-nucleus-basalis-meynert
deferiprone,Deferiprone,https://www.alzforum.org/therapeutics/deferiprone,,,Small Molecule,Metals,"Alzheimer's Disease, Parkinson's Disease, Amyotrophic Lateral Sclerosis",Iron overload due to thalassemia syndromes,"Deferiprone is an orally available, brain-penetrant iron chelator that removes iron from the brain and other tissues. It is a second-line treatment for iron overload due to repeated blood transfusions in people with thalassemia who do not respond to or cannot take other chelators.",ongoing,,AlzForum.Therapeutics,deferiprone
dexpramipexole,Dexpramipexole,https://www.alzforum.org/therapeutics/dexpramipexole,,,Small Molecule,"Other Neurotransmitters, Other","Alzheimer's Disease, Amyotrophic Lateral Sclerosis",,"Dexpramipexole is an ( R )-(+) optical enantiomer of pramipexole, a marketed dopamine agonist by Boehringer Ingelheim that is used in many countries around the world for the treatment of Parkinson's disease and restless leg syndrome. R-pramipexole has a lower affinity for dopamine receptors than pramipexole, and thus it can be administered and studied at a wider dose range.",discontinued,,AlzForum.Therapeutics,dexpramipexole
dimebon,Dimebon,https://www.alzforum.org/therapeutics/dimebon,,,Small Molecule,"Other Neurotransmitters, Unknown","Alzheimer's Disease, Huntington's Disease",Anti-histamine use in Russia,Dimebon is an antihistamine that has been used in Russia since the 1980s to treat allergic rhinitis. Dimebon is a pleiotropic drug with activities beyond blocking H1 histamine receptors.,discontinued,,AlzForum.Therapeutics,dimebon
dipraglurant,Dipraglurant,https://www.alzforum.org/therapeutics/dipraglurant,,,Small Molecule,Other Neurotransmitters,Parkinson's Disease,,"This is a negative allosteric modulator of the mGluR5 metabotropic glutamate receptor, taken by mouth. It is being developed for the treatment of levodopa-induced dyskinesia (LID) associated with Parkinson’s disease.",discontinued,,AlzForum.Therapeutics,dipraglurant
dnl151,DNL151,https://www.alzforum.org/therapeutics/dnl151,,,Small Molecule,"Inflammation, Other",Parkinson's Disease,,"DNL151 is an orally available, brain-penetrant inhibitor of the leucine-rich repeat kinase 2 (LRRK2). It started out as a backup to Denali’s lead LRRK2 inhibitor, DNL201 ; but it is now its lead candidate after development of DNL201 was stopped in 2020.",ongoing,,AlzForum.Therapeutics,dnl151
dnl201,DNL201,https://www.alzforum.org/therapeutics/dnl201,,,Small Molecule,"Inflammation, Other",Parkinson's Disease,,"DNL201 is an orally available, brain-penetrant inhibitor of the leucine-rich repeat kinase 2 (LRRK2). It was being developed to treat Parkinson’s disease.",unknown,,AlzForum.Therapeutics,dnl201
dnl343,DNL343,https://www.alzforum.org/therapeutics/dnl343,,,Small Molecule,Other,Amyotrophic Lateral Sclerosis,,DNL343 is a brain-penetrant activator of the eukaryotic initiation factor EIF2b. It inhibits the cell's unfolded protein response in an attempt to restore protein synthesis.,discontinued,,AlzForum.Therapeutics,dnl343
dnl593,DNL593,https://www.alzforum.org/therapeutics/dnl593,,,Other,Other,Frontotemporal Dementia,,"DNL593 is a replacement therapy for frontotemporal dementia caused by granulin gene mutations. In this type of FTD, a deficit of brain progranulin protein interferes with proper lysosomal function, leading to build-up of toxic proteins, neuroinflammation, and neurodegeneration (e.g., Sept 2017 news ).",ongoing,,AlzForum.Therapeutics,dnl593
dnl747,DNL747,https://www.alzforum.org/therapeutics/dnl747,,,Small Molecule,Inflammation,"Alzheimer's Disease, Amyotrophic Lateral Sclerosis",,"DNL747 is a brain-penetrant, small-molecule inhibitor of RIPK1, i.e., receptor-interacting serine/threonine-protein kinase 1. Originally developed in the laboratory of Junying Yuan at Harvard Medical School, the compound was licensed to Denali Therapeutics, which has partnered with Sanofi to develop it for the treatment of AD, ALS, and MS.",unknown,,AlzForum.Therapeutics,dnl747
dnl788,DNL788,https://www.alzforum.org/therapeutics/dnl788,,,Small Molecule,Inflammation,Amyotrophic Lateral Sclerosis,,"This small molecule is a brain-penetrant inhibitor of RIPK1, i.e., receptor-interacting serine/threonine-protein kinase 1. It comes in tablet form, to be taken by mouth.",discontinued,,AlzForum.Therapeutics,dnl788
dnl919,DNL919,https://www.alzforum.org/therapeutics/dnl919,,,Immunotherapy (passive),"Amyloid-Related, Inflammation",Alzheimer's Disease,,This TREM2 agonist antibody activates microglia to phagocytose amyloid. DNL919 contains a transferrin-receptor binding sequence engineered into its Fc domain.,discontinued,,AlzForum.Therapeutics,dnl919
docosahexaenoic-acid-dha,Docosahexaenoic acid (DHA),https://www.alzforum.org/therapeutics/docosahexaenoic-acid-dha,,,"Supplement, Dietary",Other,Alzheimer's Disease,,"Docosahexaenoic acid (DHA) is one of the most abundant polyunsaturated fatty acids in the human brain. Epidemiological research has linked high DHA consumption with a lower risk of Alzheimer's disease (e.g., Morris et al., 2003 , Zhang et al., 2016 ).",ongoing,,AlzForum.Therapeutics,docosahexaenoic-acid-dha
donepezil,Donepezil,https://www.alzforum.org/therapeutics/donepezil,,,Small Molecule,Cholinergic System,"Alzheimer's Disease, Dementia with Lewy Bodies, Down's Syndrome, Parkinson's Disease Dementia","Alzheimer's Disease, Dementia with Lewy Bodies (Japan)","Donepezil is approved in more than 90 countries around the world for the treatment of mild to moderate Alzheimer's disease, and is approved for the treatment of severe AD in the United States, Japan, Canada, and several other countries. The effect size of donepezil's benefit is small, though one patient-level analysis has suggested greater benefit in early responders than in non-responders ( Levine et al., 2022 ).",approved,,AlzForum.Therapeutics,donepezil
dronabinol,Dronabinol,https://www.alzforum.org/therapeutics/dronabinol,,,Small Molecule,Other Neurotransmitters,Alzheimer's Disease,Anorexia and weight loss in people with AIDS; Second-line treatment of nausea and vomiting due to chemotherapy,"Dronabinol is synthetic delta-9-tetrahydrocannabinol, aka THC, the major psychoactive compound of cannabis. It is an agonist of CB1 and CB2 cannabinoid receptors found in the brain and in peripheral tissues.",ongoing,,AlzForum.Therapeutics,dronabinol
e2511,E2511,https://www.alzforum.org/therapeutics/e2511,,,Small Molecule,Cholinergic System,Alzheimer's Disease,,E2511 is Eisai’s positive allosteric modulator of the tropomyosin receptor kinase A. TrkA activation by nerve growth factor is required for the survival and function of cholinergic neurons.,ongoing,,AlzForum.Therapeutics,e2511
edaravone,Edaravone,https://www.alzforum.org/therapeutics/edaravone,,,Small Molecule,Other,Amyotrophic Lateral Sclerosis,Amyotrophic Lateral Sclerosis,"Edaravone is an antioxidant drug marketed to treat amyotrophic lateral sclerosis. A pyrazolone free-radical scavenger, it reduces oxidative damage, which is believed to contribute to neuron death in ALS.",ongoing,,AlzForum.Therapeutics,edaravone
edicotinib,Edicotinib,https://www.alzforum.org/therapeutics/edicotinib,,,Small Molecule,Inflammation,Alzheimer's Disease,,"JNJ-40346527 is an oral, selective inhibitor of the colony-stimulating factor-1 receptor (CSF-1R) tyrosine kinase (for details, see on MedChemExpress). CSF-1R ligands promote survival, proliferation, and differentiation of macrophages and microglia; they also spur the growth of some cancers.",ongoing,,AlzForum.Therapeutics,edicotinib
edonerpic,Edonerpic,https://www.alzforum.org/therapeutics/edonerpic,,,Small Molecule,"Other, Unknown",Alzheimer's Disease,,"T-817MA is an orally available neurotrophic agent being developed for the treatment of Alzheimer's disease by Toyama Chemical, a company of the Fujifilm Group. T-817MA reportedly activates sigma receptors.",discontinued,,AlzForum.Therapeutics,edonerpic
efavirenz,Efavirenz,https://www.alzforum.org/therapeutics/efavirenz,,,Small Molecule,"Amyloid-Related, Tau, Cholesterol",Alzheimer's Disease,HIV infection,"Efavirenz is an FDA-approved anti-retroviral medication used for human immunodeficiency virus infection. A non-nucleoside reverse transcriptase inhibitor, it is taken in pill form.",ongoing,,AlzForum.Therapeutics,efavirenz
eht-0202,EHT 0202,https://www.alzforum.org/therapeutics/eht-0202,,,Small Molecule,Other,Alzheimer's Disease,,,ongoing,,AlzForum.Therapeutics,eht-0202
elenbecestat,Elenbecestat,https://www.alzforum.org/therapeutics/elenbecestat,,,Small Molecule,Amyloid-Related,Alzheimer's Disease,,"Elenbecestat is a small-molecule inhibitor of BACE, aka the β-secretase enzyme. It was developed with the rationale of interfering with the amyloid cascade upstream of Aβ peptide generation.",discontinued,,AlzForum.Therapeutics,elenbecestat
elnd005,ELND005,https://www.alzforum.org/therapeutics/elnd005,,,Small Molecule,Amyloid-Related,Alzheimer's Disease,,"Originally developed by Transition Therapeutics, ELND005 was temporarily taken over by Elan Corporation, Speranza's parent company. In 2014, ELND005 reverted to Transition Therapeutics, which was acquired by Opko Health in 2016.",unknown,,AlzForum.Therapeutics,elnd005
empagliflozin,Empagliflozin,https://www.alzforum.org/therapeutics/empagliflozin,,,Small Molecule,Other,Alzheimer's Disease,"Type 2 Diabetes, Cardiovascular disease",Empagliflozin is a once-daily prescription pill that is FDA-approved to treat Type 2 diabetes and reduce risk of cardiovascular death in adults with the illness ( 2016 FDA press release ). Empagliflozin belongs to the gliflozin class of glucose-lowering agents that includes dapagliflozin.,ongoing,,AlzForum.Therapeutics,empagliflozin
emrusolmin,Emrusolmin,https://www.alzforum.org/therapeutics/emrusolmin,,,Small Molecule,"Tau, alpha-synuclein, Other","Parkinson's Disease, Multiple System Atrophy",,"Anle138b is an oral, brain-penetrant, general inhibitor of protein aggregation. It was identified in a high-throughput screen for small-molecule inhibitors of α-synuclein and prion protein oligomerization.",ongoing,,AlzForum.Therapeutics,emrusolmin
emtricitabine,Emtricitabine,https://www.alzforum.org/therapeutics/emtricitabine,,,"Small Molecule, DNA/RNA-based",Inflammation,Alzheimer's Disease,"HIV infection, Hepatitis B infection","This nucleoside analog reverse transcriptase inhibitor is used for the prevention and treatment of HIV infection. It is taken as capsules or an oral solution, and is always combined with other antiretrovirals.",ongoing,,AlzForum.Therapeutics,emtricitabine
encenicline,Encenicline,https://www.alzforum.org/therapeutics/encenicline,,,Small Molecule,Cholinergic System,"Alzheimer's Disease, Schizophrenia",,"Encenicline hydrochloride is a partial, selective agonist of the α-7 nicotinic acetylcholine receptor (α7-nAChR). It is being developed for the treatment of cognitive deficits in schizophrenia and Alzheimer's disease.",discontinued,,AlzForum.Therapeutics,encenicline
engensis-0,Engensis,https://www.alzforum.org/therapeutics/engensis-0,,,DNA/RNA-based,Other,Amyotrophic Lateral Sclerosis,,This gene therapy involves intramuscular injection of a proprietary DNA plasmid encoding the two natural isoforms of hepatocyte growth factor. HGF is a multifunctional peptide with neurotrophic and angiogenic activity.,ongoing,,AlzForum.Therapeutics,engensis-0
epigallocatechin-gallate-egcg,Epigallocatechin Gallate (EGCG),https://www.alzforum.org/therapeutics/epigallocatechin-gallate-egcg,,,"Supplement, Dietary","Amyloid-Related, Inflammation, Other","Alzheimer's Disease, Down's Syndrome, Multiple System Atrophy",,EGCG is a polyphenolic flavonoid extracted from green tea leaves and widely considered to be the key bioactive ingredient of green tea. It has been reported to have beneficial effects ranging from antitumor and anti-inflammatory to neuroprotective.,ongoing,,AlzForum.Therapeutics,epigallocatechin-gallate-egcg
epothilone-d,Epothilone D,https://www.alzforum.org/therapeutics/epothilone-d,,,Small Molecule,Tau,Alzheimer's Disease,,BMS-241027 is a small-molecule microtubule stabilizer for the treatment of Alzheimer's disease. One of tau's physiological cellular functions is to bind and stabilize microtubules.,discontinued,,AlzForum.Therapeutics,epothilone-d
eptastigmine,Eptastigmine,https://www.alzforum.org/therapeutics/eptastigmine,,,Small Molecule,Cholinergic System,Alzheimer's Disease,,Eptastigmine is a centrally acting cholinesterase inhibitor.,discontinued,,AlzForum.Therapeutics,eptastigmine
estrogen,Estrogen,https://www.alzforum.org/therapeutics/estrogen,,,Other,Other,Alzheimer's Disease,Hormone Replacement Therapy,"There are a number of biological mechanisms through which estrogens might exert neuroprotective effects. These include the promotion of cholinergic activity ( Gibbs, 2010 ), increase in the morphological complexity of neurons associated with learning and memory (Brinton et al., 2000 ), protection from toxic insult ( Brinton et al., 2000 ), stimulation of neuron formation ( Tanapat et al., 1999 ), and reduction of the formation of Aβ ( Pike et al., 2009 ).",discontinued,,AlzForum.Therapeutics,estrogen
etalanetug,Etalanetug,https://www.alzforum.org/therapeutics/etalanetug,,,Immunotherapy (passive),Tau,Alzheimer's Disease,,"This humanized, monoclonal IgG1 antibody recognizes an HVPGG epitope in the microtubule-binding domain near the mid-domain of tau. This region is a predominant component of tau tangles and is involved in seeding and spreading pathological tau aggregates.",ongoing,,AlzForum.Therapeutics,etalanetug
etanercept,Etanercept,https://www.alzforum.org/therapeutics/etanercept,,,Immunotherapy (passive),Inflammation,Alzheimer's Disease,"Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondilysis",Etanercept inhibits the function of a pro-inflammatory cytokine called tumor necrosis factor alpha (TNF-α). Etanercept is a fusion protein consisting of two copies of the TNF-α receptor and the Fc end of the immunoglobulin G (IgG) antibody.,ongoing,,AlzForum.Therapeutics,etanercept
evp-0962,EVP-0962,https://www.alzforum.org/therapeutics/evp-0962,,,Small Molecule,Amyloid-Related,"Alzheimer's Disease, Mild Cognitive Impairment",,EVP-0962 is a γ-secretase modulator. The rationale behind this approach is that γ-secretase modulators affect the enzyme complex differently than inhibitors: They shift its processive cleavage mechanism away from generating Aβ42 and other long forms of this peptide and toward generation of Aβ38 and other short forms of Aβ.,discontinued,,AlzForum.Therapeutics,evp-0962
exenatide,Exenatide,https://www.alzforum.org/therapeutics/exenatide,,,Small Molecule,Other,"Alzheimer's Disease, Parkinson's Disease",Diabetes mellitus in US,Exenatide is an analog of the hormone glucagon-like peptide-1. GLP-1 stimulates the pancreas to release insulin in response to food intake.,ongoing,,AlzForum.Therapeutics,exenatide
exidavnemab,Exidavnemab,https://www.alzforum.org/therapeutics/exidavnemab,,,Immunotherapy (passive),alpha-synuclein,"Parkinson's Disease, Multiple System Atrophy",,This is a humanized monoclonal antibody targeting α-synuclein originally developed by the Swedish company BioArctic. Genetic and pathology evidence implicate aggregated forms of α-synuclein in the molecular pathogenesis of Parkinson’s disease and other α-synucleinopathies such as dementia with Lewy bodies (DLB).,ongoing,,AlzForum.Therapeutics,exidavnemab
ezeprogind,Ezeprogind,https://www.alzforum.org/therapeutics/ezeprogind,,,Small Molecule,"Tau, Inflammation, Other",Progressive Supranuclear Palsy,,"This small molecule is reported to increase levels of the neurotrophic factor progranulin ( Verwaerde and Defert, 2025 ). According to information from its maker, AZP2006 binds to prosaposin, a cofactor for progranulin processing.",ongoing,,AlzForum.Therapeutics,ezeprogind
flurizan,Flurizan™,https://www.alzforum.org/therapeutics/flurizan,,,Small Molecule,Amyloid-Related,Alzheimer's Disease,,"Flurizan™ is the R-enantiomer of the nonsteroidal anti-inflammatory flurbiprofen, an NSAID that is structurally and pharmacologically related to ibuprofen and is used to treat several inflammatory conditions. As a selective Aβ42-lowering agent (aka SALA), Flurizan™ would have been the first in its class to treat Alzheimer's disease.",discontinued,,AlzForum.Therapeutics,flurizan
focused-ultrasound-blood-brain-barrier,Focused Ultrasound – Blood-Brain Barrier,https://www.alzforum.org/therapeutics/focused-ultrasound-blood-brain-barrier,,,Procedural Intervention,"Amyloid-Related, Other","Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Mild Cognitive Impairment, Parkinson's Disease",,Focused ultrasound with microbubbles is a noninvasive procedure that transiently opens the blood-brain barrier (BBB) using low-intensity sound waves. The openings reseal within 24 hours.,ongoing,,AlzForum.Therapeutics,focused-ultrasound-blood-brain-barrier
foralumab,Foralumab,https://www.alzforum.org/therapeutics/foralumab,,,Immunotherapy (passive),Inflammation,"Alzheimer's Disease, Amyotrophic Lateral Sclerosis",,"Foralumab is a human monoclonal IgG antibody to the CD3 T cell antigen receptor. It modulates the immune system to promote immunosuppressive and anti-inflammatory responses, in part by stimulating the production of regulatory T cells.",ongoing,,AlzForum.Therapeutics,foralumab
fosgonimeton,Fosgonimeton,https://www.alzforum.org/therapeutics/fosgonimeton,,,Small Molecule,Other,"Alzheimer's Disease, Dementia with Lewy Bodies, Parkinson's Disease Dementia",,"NDX-1017 is a brain-penetrant small molecule that activates signaling via the hepatocyte growth factor (HGF)/MET receptor system ( Moebius and Church, 2023 ). HGF promotes proliferation and survival of neurons, enhances hippocampal synaptic plasticity, and boosts learning and memory ( Akimoto et al., 2004 ; Kato et al., 2012 ).",discontinued,,AlzForum.Therapeutics,fosgonimeton
fosigotifator,Fosigotifator,https://www.alzforum.org/therapeutics/fosigotifator,,,Small Molecule,Other,Amyotrophic Lateral Sclerosis,,"ABBV-CLS-7262 is an activator of the eukaryotic initiation factor EIF2b, which participates in starting up protein synthesis from mRNA. In some neurodegenerative diseases, accumulation of misfolded proteins in the endoplasmic reticulum shuts down protein production by inhibiting EIF2b as part of the so-called unfolded protein response, or integrated stress response (for example, see Stutzbach et al., 2013 ).",discontinued,,AlzForum.Therapeutics,fosigotifator
frm-0334,FRM-0334,https://www.alzforum.org/therapeutics/frm-0334,,,Small Molecule,Other,Frontotemporal Dementia,,FRM-0334 is a histone deacetylase (HDAC) inhibitor. HDACs are key enzymes in the epigenetic regulation of gene function.,discontinued,,AlzForum.Therapeutics,frm-0334
g-csf,G-CSF,https://www.alzforum.org/therapeutics/g-csf,,,Small Molecule,Other,Alzheimer's Disease,Neutropenia in US,,ongoing,,AlzForum.Therapeutics,g-csf
galantamine,Galantamine,https://www.alzforum.org/therapeutics/galantamine,,,Small Molecule,Cholinergic System,Alzheimer's Disease,Mild to Moderate Alzheimer's disease,"Discovered in the 1950s, g alantamine is an alkaloid isolated from Galanthus nivalis , the common snowdrop. Galantamine crosses the blood-brain barrier and has been used in humans for decades in anaesthesia and the treatment of neuropathic pain.",approved,,AlzForum.Therapeutics,galantamine
gammagardr,Gammagard®,https://www.alzforum.org/therapeutics/gammagardr,,,Immunotherapy (passive),"Amyloid-Related, Inflammation",Alzheimer's Disease,Immunodeficiency conditions,Gammagard® is a preparation of pooled human plasma antibodies from blood donations. It has an established safety record from human use in immunodeficiency and certain autoimmune conditions.,discontinued,,AlzForum.Therapeutics,gammagardr
gamunex,Gamunex,https://www.alzforum.org/therapeutics/gamunex,,,"Combination, Immunotherapy (passive)","Amyloid-Related, Inflammation",Alzheimer's Disease,"Immunodeficiency, chronic inflammatory demyelinating neuropathy","This immunoglobulin preparation is used in obstetric indications to prevent and treat blood conditions related to rhesus factor incompatibility. It is one of several IVIg products being tested clinically as an Alzheimer's treatment following Phase 1 and 2 results for Baxter Healthcare's IVIg product, Gammagard™.",ongoing,,AlzForum.Therapeutics,gamunex
gantenerumab,Gantenerumab,https://www.alzforum.org/therapeutics/gantenerumab,,,Immunotherapy (passive),Amyloid-Related,Alzheimer's Disease,,Gantenerumab is a fully human IgG1 antibody designed to bind with subnanomolar affinity to a conformational epitope on Aβ fibrils. It encompasses both N-terminal and central amino acids of Aβ.,discontinued,,AlzForum.Therapeutics,gantenerumab
gc021109,GC021109,https://www.alzforum.org/therapeutics/gc021109,,,Small Molecule,Inflammation,Alzheimer's Disease,,"GC021109 is one of the first compounds in Alzheimer's clinical research that specifically target microglial cells. Mediators of microglial responses in neurodegenerative diseases with an inflammatory component have attracted renewed interest in drug development research, years after several NSAIDs failed clinical trials.",ongoing,,AlzForum.Therapeutics,gc021109
gemfibrozil,Gemfibrozil,https://www.alzforum.org/therapeutics/gemfibrozil,,,Small Molecule,Cholesterol,Alzheimer's Disease,Hyperlipidemia,"Gemfibrozil is an old member of the fibrate class of drugs. These drugs activate peroxisome proliferator-activated receptor-α (PPARα), nuclear receptors involved in lipid metabolism.",ongoing,,AlzForum.Therapeutics,gemfibrozil
gosuranemab,Gosuranemab,https://www.alzforum.org/therapeutics/gosuranemab,,,Immunotherapy (passive),Tau,"Progressive Supranuclear Palsy, Alzheimer's Disease",,"This is a humanized IgG4 monoclonal anti-tau antibody. In April 2014, Bristol-Myers Squibb acquired iPierian, a biotechnology company that had developed IPN007, an antibody against extracellular, N-terminal fragments of tau (eTau) that were originally isolated from familial AD patient-derived pluripotent stem cells.",discontinued,,AlzForum.Therapeutics,gosuranemab
grf6019,GRF6019,https://www.alzforum.org/therapeutics/grf6019,,,Other,"Inflammation, Other, Unknown",Alzheimer's Disease,,"GRF6019 is a proprietary plasma fraction of about 400 proteins, developed by Alkahest and manufactured by Grifols. It represents a second-generation product of earlier clinical research infusing young adult plasma to treat age-related neurodegenerative disease (see Young Plasma ).",ongoing,,AlzForum.Therapeutics,grf6019
grf6021,GRF6021,https://www.alzforum.org/therapeutics/grf6021,,,Other,"Inflammation, Other, Unknown",Parkinson's Disease Dementia,,"GRF6021 is a proprietary plasma fraction, developed by Alkahest and manufactured by Grifols. Its development follows GRF6019 , a fraction in Phase 2 testing for Alzheimer’s disease.",ongoing,,AlzForum.Therapeutics,grf6021
gsk239512,GSK239512,https://www.alzforum.org/therapeutics/gsk239512,,,Small Molecule,"Cholinergic System, Other Neurotransmitters",Alzheimer's Disease,,"GSK was developing this histamine H3 receptor antagonist for the treatment of Alzheimer's, schizophrenia, and multiple sclerosis. The rationale was to boost release in the brain of histamine, acetylcholine, noradrenaline, and dopamine in an attempt to enhance cognitive processes.",discontinued,,AlzForum.Therapeutics,gsk239512
gsk2647544,GSK2647544,https://www.alzforum.org/therapeutics/gsk2647544,,,Small Molecule,Cholesterol,Alzheimer's Disease,,GSK2647544 is an inhibitor of lipoprotein-associated phospholipase A2. Lp-PLA2 is a circulating enzyme secreted by monocytes and linked primarily to low-density lipoprotein in atherosclerotic plaques.,ongoing,,AlzForum.Therapeutics,gsk2647544
gsk933776,GSK933776,https://www.alzforum.org/therapeutics/gsk933776,,,Immunotherapy (passive),Amyloid-Related,Alzheimer's Disease,,GSK933776 is a humanized mouse IgG1 monoclonal antibody directed against the N-terminus of the Aβ peptide. Its Fc region has been engineered to reduce FC-receptor binding and complement activation; this was done in an effort to weaken the antibody's effector function and minimize risk of side effects such as ARIA.,unknown,,AlzForum.Therapeutics,gsk933776
gt-02287,GT-02287,https://www.alzforum.org/therapeutics/gt-02287,,,Small Molecule,"alpha-synuclein, Other",Parkinson's Disease,,"GT-02287 is a brain-penetrant, small molecule allosteric regulator of the lysosomal enzyme glucocerebrosidase (GCase). Mutations in the GBA1 gene encoding GCase are the most common genetic cause of Parkinson’s disease.",ongoing,,AlzForum.Therapeutics,gt-02287
guanfacine,Guanfacine,https://www.alzforum.org/therapeutics/guanfacine,,,Small Molecule,Other Neurotransmitters,Alzheimer's Disease,"Attention-deficit hyperactivity disorder, hypertension",This drug is an α2A adrenergic receptor agonist. It acts in the central nervous system and is used to treat high blood pressure and attention-deficit/hyperactivity disorder (ADHD).,ongoing,,AlzForum.Therapeutics,guanfacine
gv-971,GV-971,https://www.alzforum.org/therapeutics/gv-971,,,Small Molecule,"Amyloid-Related, Inflammation",Alzheimer's Disease,,"This mixture of acidic linear oligosaccharides is derived from brown algae. The mechanism of action of the preparation remains unclear, although several different mechanisms have been proposed by the same research group between 2003 and 2013.",unknown,,AlzForum.Therapeutics,gv-971
gv1001,GV1001,https://www.alzforum.org/therapeutics/gv1001,,,Immunotherapy (active),Other,Alzheimer's Disease,Pancreatic cancer (Korea),"Originally developed as a cancer vaccine, GV1001 is a 16-amino-acid peptide comprising a sequence from the human enzyme telomerase reverse transcriptase (TERT). Most cancers highly express TERT, and immunization with GV1001 aims to activate the immune system to recognize and kill cancer cells.",ongoing,,AlzForum.Therapeutics,gv1001
hf0220,HF0220,https://www.alzforum.org/therapeutics/hf0220,,,Small Molecule,Inflammation,Alzheimer's Disease,,,discontinued,,AlzForum.Therapeutics,hf0220
hmtm,HMTM,https://www.alzforum.org/therapeutics/hmtm,,,Small Molecule,Tau,"Alzheimer's Disease, Frontotemporal Dementia",Methylene Blue predates FDA. Used for treatment of malaria and methemoglobinemia.,"TRx0237 (LMTX™) is a second-generation tau protein aggregation inhibitor for the treatment of Alzheimer's disease (AD) and frontotemporal dementia. It is a replacement formulation for Rember ® , the first company's first proprietary formulation of methylthioninium chloride (MTC).",ongoing,,AlzForum.Therapeutics,hmtm
htl0018318,HTL0018318,https://www.alzforum.org/therapeutics/htl0018318,,,Small Molecule,Cholinergic System,"Alzheimer's Disease, Dementia with Lewy Bodies",,"This small-molecule drug selectively activates the muscarinic acetylcholine receptor M1, which is expressed in the central nervous system and peripheral secretory glands. HTL0018318 was developed by Heptares Therapeutics, a subsidiary of the Sosei Group Corporation, headquartered in Tokyo.",unknown,,AlzForum.Therapeutics,htl0018318
huperzine,Huperzine A,https://www.alzforum.org/therapeutics/huperzine,,,"Small Molecule, Supplement, Dietary",Cholinergic System,Alzheimer's Disease,,Huperzine A is an alkaloid extract derived from the Chinese club moss Huperzia serrata. Huperzine A for many years has been widely used in traditional Chinese medicine to enhance memory and to treat fever and inflammation.,unknown,,AlzForum.Therapeutics,huperzine
ibc-ab002,IBC-Ab002,https://www.alzforum.org/therapeutics/ibc-ab002,,,Immunotherapy (passive),"Amyloid-Related, Inflammation, Other",Alzheimer's Disease,,"This humanized IgG1 antibody inhibits an immune checkpoint protein called programmed death ligand, aka PD-L1, stimulating the immune system. Checkpoint inhibitors, including other antibodies, are approved to treat cancer, where they release tumor-induced immunosuppression and allow immune attack on malignant cells.",ongoing,,AlzForum.Therapeutics,ibc-ab002
ibuprofen,Ibuprofen,https://www.alzforum.org/therapeutics/ibuprofen,,,Small Molecule,"Amyloid-Related, Inflammation",Alzheimer's Disease,Pain and Fever,Ibuprofen is an over-the-counter non-steroidal anti-inflammatory drug (NSAID). It inhibits cyclooxygenase activity and reduces inflammation through reduced prostaglandin synthesis.,discontinued,,AlzForum.Therapeutics,ibuprofen
iclepertin,Iclepertin,https://www.alzforum.org/therapeutics/iclepertin,,,Small Molecule,Other Neurotransmitters,"Alzheimer's Disease, Schizophrenia",,"This compound is a glycine transporter inhibitor that was being develped for the treatment of Alzheimer's disease, then discontinued; it remains in development for schizophrenia. The rationale behind this approach is that abnormalities in glutamatergic signaling downstream of neuronal NMDA receptors contribute to cognitive impairment in both these diseases, hence boosting NMDA receptor function might benefit synaptic plasticity and cognition ( Lakhan et al., 2013 ; Rosenbrock et al., 2022 ).",discontinued,,AlzForum.Therapeutics,iclepertin
idalopirdine,Idalopirdine,https://www.alzforum.org/therapeutics/idalopirdine,,,Small Molecule,Other Neurotransmitters,"Alzheimer's Disease, Schizophrenia",,"This orally available drug is an antagonist of the serotonin 6 (5-HT6) receptor. This receptor subtype is expressed primarily in the brain, particularly in the cerebral cortex and hippocampus, where it has been proposed to play a role in cognitive impairments associated with schizophrenia and Alzheimer's disease.",discontinued,,AlzForum.Therapeutics,idalopirdine
idebenone,Idebenone,https://www.alzforum.org/therapeutics/idebenone,,,Small Molecule,Other,Alzheimer's Disease,,"Idebenone, a synthetic analogue of coenzyme Q10, has potent antioxidant activity and facilitates the flux of electrons along the mitochondrial electron transport chain, increasing the production of ATP.",discontinued,,AlzForum.Therapeutics,idebenone
intepirdine,Intepirdine,https://www.alzforum.org/therapeutics/intepirdine,,,Small Molecule,Other Neurotransmitters,"Alzheimer's Disease, Dementia with Lewy Bodies",,"Originally developed by GSK under the name SB-742457, RVT-101/intepirdine is an antagonist of the serotonin receptor 6 (5-HT)6, a largely CNS-specific member of the serotonin receptor subfamily. The serotonergic neurotransmitter system is impaired as Alzheimer’s develops and progresses, and modulating it is seen as a potential therapeutic avenue ( Upton et al., 2008 ).",discontinued,,AlzForum.Therapeutics,intepirdine
intranasal-oxytocin,Intranasal oxytocin,https://www.alzforum.org/therapeutics/intranasal-oxytocin,,,Other,Other,Frontotemporal Dementia,,"Oxytocin is a peptide hormone involved in social bonding, reproduction, and childbirth. Defects in oxytocin biology have been implicated in neurodegenerative disorders ranging from frontotemporal dementia to Huntington's disease (e.g.",ongoing,,AlzForum.Therapeutics,intranasal-oxytocin
inzomelid,Inzomelid,https://www.alzforum.org/therapeutics/inzomelid,,,Small Molecule,Inflammation,"Alzheimer's Disease, Parkinson's Disease",,"Inzomelid is an oral, brain-penetrant inhibitor of inflammasomes containing NLRP3, or nod-like receptor family, pyrin domain-containing protein 3. Inflammasomes are multiprotein, cytosolic complexes that function as sensors in the innate immune system.",discontinued,,AlzForum.Therapeutics,inzomelid
ion464,ION464,https://www.alzforum.org/therapeutics/ion464,,,DNA/RNA-based,alpha-synuclein,Multiple System Atrophy,,"ION464 is an antisense oligonucleotide targeting α-synuclein mRNA to block production of the protein. It was being developed as a potential therapy for Parkinson’s disease, multiple system atrophy, and related synucleinopathies.",discontinued,,AlzForum.Therapeutics,ion464
ion859,ION859,https://www.alzforum.org/therapeutics/ion859,,,DNA/RNA-based,"Inflammation, Other",Parkinson's Disease,,This drug is an antisense oligonucleotide (ASO). It binds the mRNA for leucine-rich repeat kinase 2 and mediates its degradation.,discontinued,,AlzForum.Therapeutics,ion859
irsenontrine,Irsenontrine,https://www.alzforum.org/therapeutics/irsenontrine,,,Small Molecule,Other,Dementia with Lewy Bodies,,"Irsenontrine is a selective inhibitor of phosphodiesterase 9. PDE9 is an enzyme that breaks down cyclicGMP, cGMP, which serves as a second messenger in synaptic function and memory.",ongoing,,AlzForum.Therapeutics,irsenontrine
iti-1284,ITI-1284,https://www.alzforum.org/therapeutics/iti-1284,,,Small Molecule,Other Neurotransmitters,Alzheimer's Disease,,"ITI-1284 is a deuterated derivative of the antipsychotic drug lumateperone. Deuteration involves replacing hydrogen atoms with the stable isotope deuterium, and is intended to slow metabolism and extend the half-life of drugs.",ongoing,,AlzForum.Therapeutics,iti-1284
jnj-64042056,JNJ-64042056,https://www.alzforum.org/therapeutics/jnj-64042056,,,Immunotherapy (active),Tau,Alzheimer's Disease,,ACI-35 is a liposome-based vaccine. The rationale behind it is that the vaccine will treat tauopathy in Alzheimer’s disease by eliciting an immune response targeted to certain pathological conformers of phosphorylated tau without also mounting autoimmune B cell or T cell responses against physiological forms of this ubiquitous intracellular protein.,ongoing,,AlzForum.Therapeutics,jnj-64042056
karxt,KarXT,https://www.alzforum.org/therapeutics/karxt,,,"Combination, Small Molecule",Cholinergic System,Alzheimer's Disease,Schizophrenia,KarXT is xanomeline with trospium. Xanomeline is an M1/M4-preferring muscarinic acetylcholine receptor activator that acts throughout the body.,ongoing,,AlzForum.Therapeutics,karxt
ketasyn,Ketasyn,https://www.alzforum.org/therapeutics/ketasyn,,,"Supplement, Dietary",Other,Alzheimer's Disease,,"This is a nutritional beverage. Ketasyn/AC-1202 was tested in Phase 1 and 2 safety/dosing trials, but in Phase 2 missed its primary endpoint and was not advanced to Phase 3 efficacy trials.",ongoing,,AlzForum.Therapeutics,ketasyn
kisunla,Kisunla,https://www.alzforum.org/therapeutics/kisunla,,,Immunotherapy (passive),Amyloid-Related,Alzheimer's Disease,,"Donanemab, aka N3pG, is a humanized IgG1 monoclonal antibody developed from mouse mE8-IgG2a. This biologic drug recognizes Aβ(p3-42), a pyroglutamate form of Aβ that is aggregated in amyloid plaques.",approved,,AlzForum.Therapeutics,kisunla
kmct-ons,kMCT-ONS,https://www.alzforum.org/therapeutics/kmct-ons,,,"Supplement, Dietary",Other,Alzheimer's Disease,,"kMCT-ONS is a nutritional drink that raises blood ketone concentrations. The brain uses ketones as an energy source when glucose is limited, and inducing mild ketosis has emerged as a strategy to overcome the decline in glucose uptake that occurs in people with Alzheimer’s disease.",unknown,,AlzForum.Therapeutics,kmct-ons
kp405,KP405,https://www.alzforum.org/therapeutics/kp405,,,Small Molecule,Other,Parkinson's Disease,,KP405 is a dual incretin receptor agonist that is being developed to treat Parkinson’s disease. It acts on the glucagon-like peptide 1 (GLP-1) receptor and the gastric inhibitory peptide (GIP) receptor.,ongoing,,AlzForum.Therapeutics,kp405
kynmobi,Kynmobi,https://www.alzforum.org/therapeutics/kynmobi,,,Small Molecule,Other Neurotransmitters,Parkinson's Disease,,"APL-130277 is a sublingual thin film formulation of apomorphine, a dopamine receptor agonist with anti-parkinsonian actions similar to levodopa. In May 2020, the FDA approved Kynmobi for on-demand treatment of Parkinson’s OFF episodes ( company press release ).",approved,,AlzForum.Therapeutics,kynmobi
ladostigil,Ladostigil,https://www.alzforum.org/therapeutics/ladostigil,,,Small Molecule,Cholinergic System,"Mild Cognitive Impairment, Alzheimer's Disease",,"Ladostigil is a multimodal, or multifunctional, (MFC) compound that combines two pharmacophores taken from rivastigmine and rasagiline. This ""dirty"" drug has been reported to be an inhibitor of the enzymes acetylcholinesterase, butyrylcholinesterase, and monoamine oxidases A and B, and to have neuroprotective and antidepressant effects ( Weinreb et al.",discontinued,,AlzForum.Therapeutics,ladostigil
lamivudine,Lamivudine,https://www.alzforum.org/therapeutics/lamivudine,,,DNA/RNA-based,Inflammation,Alzheimer's Disease,"HIV infection, Hepatitis B infection",Lamivudine is an antiretroviral therapy used to treat human immunodeficiency virus and Hepatitis B infections. It is one of several reverse transcriptase inhibitors being studied for neurodegenerative diseases.,ongoing,,AlzForum.Therapeutics,lamivudine
latozinemab,Latozinemab,https://www.alzforum.org/therapeutics/latozinemab,,,Immunotherapy (passive),Other,"Frontotemporal Dementia, Amyotrophic Lateral Sclerosis",,"AL001 is a recombinant human anti-human sortilin (SORT1) monoclonal IgG1 developed by Alector in partnership with Abbvie. In June 2018, this antibody received orphan drug designation from the U.S.",discontinued,,AlzForum.Therapeutics,latozinemab
lenalidomide,Lenalidomide,https://www.alzforum.org/therapeutics/lenalidomide,,,Small Molecule,"Amyloid-Related, Inflammation",Alzheimer's Disease,"Multiple myeloma, lymphoma, myelodysplastic syndromes","Lenalidomide is an anti-cancer drug with pleiotropic anti-inflammatory, anti-angiogenic, and immune stimulatory activities. Sold under the brand name Revlimid, lenalidomide has been used since 2006 to treat multiple myeloma, lymphoma, and myelodysplastic syndromes.",ongoing,,AlzForum.Therapeutics,lenalidomide
leqembi,Leqembi,https://www.alzforum.org/therapeutics/leqembi,,,Immunotherapy (passive),Amyloid-Related,Alzheimer's Disease,,"BAN2401 is the humanized IgG1 version of the mouse monoclonal antibody mAb158, which selectively binds to large, soluble Aβ protofibrils. This therapeutic antibody grew out of the discovery of the “Arctic” mutation in APP, which leads to a form of clinically typical Alzheimer's disease that is marked by particularly high levels of Aβ protofibrils and relative absence of amyloid plaques (see Nilsberth et al., 2001 ).",approved,,AlzForum.Therapeutics,leqembi
leucettinib-21,Leucettinib-21,https://www.alzforum.org/therapeutics/leucettinib-21,,,Small Molecule,Other,"Alzheimer's Disease, Down's Syndrome",,"Leucettinib-21 is a small-molecule inhibitor of the dual-specific, tyrosine phosphorylation-regulated kinase DYRK1A ( Lindberg and Meijer 2021 ). Abnormally active DYRK1A has been implicated in memory and learning problems in Alzheimer’s disease and Down's syndrome.",ongoing,,AlzForum.Therapeutics,leucettinib-21
leuprolide,Leuprolide,https://www.alzforum.org/therapeutics/leuprolide,,,Other,Other,Alzheimer's Disease,Advanced prostate cancer,"Leuprolide acetate is a synthetic nonapeptide analog of naturally occurring gonadotropin-releasing hormone (GnRH). It acts as an agonist at pituitary GnRH receptors; however, by interrupting the normal pulsatile stimulation of the receptors, it indirectly downregulates the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH).",ongoing,,AlzForum.Therapeutics,leuprolide
levetiracetam,Levetiracetam,https://www.alzforum.org/therapeutics/levetiracetam,,,Small Molecule,"Amyloid-Related, Other","Alzheimer's Disease, Parkinson's Disease","Epilepsy and Partial Seizures in U.S., European Union, plus about 20 other countries","Levetiracetam is an atypical anti-convulsant medication and a modulator of the synaptic vesicle protein modulator SV2A. It was developed for the treatment of epilepsy but, as a pyrrolidone acetamide, is chemically unrelated to most other anti-convulsives.",discontinued,,AlzForum.Therapeutics,levetiracetam
levodopa,Levodopa,https://www.alzforum.org/therapeutics/levodopa,,,Small Molecule,Other Neurotransmitters,Parkinson's Disease,,"This dopamine replacement therapy is the mainstay of treatment for motor symptoms of Parkinson’s disease. Levodopa eases tremors, stiffness, and slowness of movement caused by loss of dopaminergic neurons.",approved,,AlzForum.Therapeutics,levodopa
linopirdine,Linopirdine,https://www.alzforum.org/therapeutics/linopirdine,,,Small Molecule,Other,Alzheimer's Disease,,,discontinued,,AlzForum.Therapeutics,linopirdine
liraglutide,Liraglutide,https://www.alzforum.org/therapeutics/liraglutide,,,Other,Other,"Alzheimer's Disease, Parkinson's Disease","Diabetes, weight loss","Liraglutide is an analog of glucagon-like peptide 1. GLP-1 is a hormone that is produced in the gut and activates receptors in the gut, liver, and pancreas to control blood-sugar levels and reduce insulin resistance.",ongoing,,AlzForum.Therapeutics,liraglutide
lithium,Lithium,https://www.alzforum.org/therapeutics/lithium,,,Other,"Amyloid-Related, Tau, Metals, Other","Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, Mild Cognitive Impairment, Parkinson's Disease",Bipolar disorder,"Lithium has been used for decades to treat mood disorders, and is now mainly prescribed for bipolar disorder. Common side effects are nausea, excessive thirst and urination, tremor, weight gain, and cognitive dulling.",ongoing,,AlzForum.Therapeutics,lithium
lixisenatide,Lixisenatide,https://www.alzforum.org/therapeutics/lixisenatide,,,Other,Other,Parkinson's Disease,Type 2 diabetes,Lixisenatide is an analog of the hormone glucagon-like peptide-1. GLP-1 stimulates the pancreas to release insulin in response to food intake.,ongoing,,AlzForum.Therapeutics,lixisenatide
lm11a-31-bhs,LM11A-31-BHS,https://www.alzforum.org/therapeutics/lm11a-31-bhs,,,Small Molecule,Other,Alzheimer's Disease,,"LM11A-31 is an orally available, brain-penetrant, small-molecule ligand of the p75 neurotrophic receptor. P75NTF binds nerve growth factor, brain-derived growth factor, and other neurotrophins.",ongoing,,AlzForum.Therapeutics,lm11a-31-bhs
lomecel-b,Lomecel-B,https://www.alzforum.org/therapeutics/lomecel-b,,,Other,"Inflammation, Other",Alzheimer's Disease,,"Lomecel-B is a preparation of multipotent stem and progenitor cells isolated from donated bone marrow of young healthy adults, and expanded in culture. The cells are administered by intravenous infusion and are claimed to travel to sites of tissue damage to quell inflammation and stimulate repair.",ongoing,,AlzForum.Therapeutics,lomecel-b
lornoxicam,Lornoxicam,https://www.alzforum.org/therapeutics/lornoxicam,,,Small Molecule,Inflammation,"Alzheimer's Disease, Mild Cognitive Impairment",Pain in US,,discontinued,,AlzForum.Therapeutics,lornoxicam
losartan,Losartan,https://www.alzforum.org/therapeutics/losartan,,,Small Molecule,Other,Alzheimer's Disease,"Hypertension, diabetic neuropathy",Losartan is an angiotensin II receptor blocker used to treat high blood pressure. It reduces the risk of stroke in people with hypertension and an enlarged heart.,ongoing,,AlzForum.Therapeutics,losartan
low-dose-interleukin-2,Low Dose Interleukin-2,https://www.alzforum.org/therapeutics/low-dose-interleukin-2,,,Other,Inflammation,"Alzheimer's Disease, Amyotrophic Lateral Sclerosis",,Low dose interleukin 2 is being tested as an immunomodulatory approach in neurodegenerative diseases. It increases the number and activity of regulatory T cells (Tregs) that suppress inflammation.,ongoing,,AlzForum.Therapeutics,low-dose-interleukin-2
low-intensity-focused-ultrasound,Low-Intensity Focused Ultrasound,https://www.alzforum.org/therapeutics/low-intensity-focused-ultrasound,,,Procedural Intervention,"Other, Unknown","Alzheimer's Disease, Mild Cognitive Impairment, Parkinson's Disease",,"Low-intensity transcranial focused ultrasound is a noninvasive, targeted neuromodulation technology. It uses mid- or low-frequency sound waves delivered from arrays applied to the outside of the head to change activity in brain circuits.",ongoing,,AlzForum.Therapeutics,low-intensity-focused-ultrasound
lti-291,LTI-291,https://www.alzforum.org/therapeutics/lti-291,,,Small Molecule,Other,Parkinson's Disease,,"LTI-291 is a small-molecule activator of glucocerebrosidase (GCase), a lysosomal enzyme involved in the breakdown of glycosphingolipids. Mutations in GBA1, the gene encoding GCase, are the leading genetic risk factor for the synucleinopathies Parkinson’s disease and dementia with Lewy bodies.",ongoing,,AlzForum.Therapeutics,lti-291
lu-af20513,Lu AF20513,https://www.alzforum.org/therapeutics/lu-af20513,,,Immunotherapy (active),Amyloid-Related,Alzheimer's Disease,,This active vaccine was designed to overcome the weak immune system of aged populations while avoiding auto-immune T cell responses. The Lu AF20513 epitope intersperses three repeats of the first 12 amino acids of the Aβ peptide with sequences of tetanus toxin.,discontinued,,AlzForum.Therapeutics,lu-af20513
lu-af82422,LU AF82422,https://www.alzforum.org/therapeutics/lu-af82422,,,Immunotherapy (passive),alpha-synuclein,"Parkinson's Disease, Multiple System Atrophy",,LU AF82422 is a humanized monoclonal IgG1 antibody targeting the C-terminal of α-synuclein. Genetic and pathology evidence implicate aggregated forms of this protein in the molecular pathogenesis of Parkinson’s disease and other α-synucleinopathies such as dementia with Lewy bodies (DLB).,ongoing,,AlzForum.Therapeutics,lu-af82422
lu-af87908,Lu AF87908,https://www.alzforum.org/therapeutics/lu-af87908,,,Immunotherapy (passive),Tau,Alzheimer's Disease,,Lu AF87908 is a humanized mouse IgG1 monoclonal antibody to phosphorylated tau protein. It was generated by immunization of mice with a tau peptide spanning residues 386-408 and phosphorylated at serine 396 and 404.,ongoing,,AlzForum.Therapeutics,lu-af87908
lu-af88434,Lu AF88434,https://www.alzforum.org/therapeutics/lu-af88434,,,Small Molecule,Other,Mild Cognitive Impairment,,"This small molecule is a potent and selective PDE-1 phosphodiesterase inhibitor that increases neuronal levels of cyclic nucleotide second messengers. Lu AF88434 is intended to enhance neuroplasticity, intracellular signaling, and cognitive functioning.",discontinued,,AlzForum.Therapeutics,lu-af88434
lu25-109,LU25-109,https://www.alzforum.org/therapeutics/lu25-109,,,Small Molecule,Cholinergic System,Alzheimer's Disease,,LU25-109 is a selective partial M1 agonist and an M2/M3 antagonist.,discontinued,,AlzForum.Therapeutics,lu25-109
lumateperone,Lumateperone,https://www.alzforum.org/therapeutics/lumateperone,,,Small Molecule,Other Neurotransmitters,"Alzheimer's Disease, Schizophrenia, Bipolar Disorder",,"This serotonin 5-HT2A receptor antagonist was originally developed by Bristol Myers Squibb, and was licensed to Intra-Cellular Therapies in 2005. In 2019, the U.S.",approved,,AlzForum.Therapeutics,lumateperone
lx1001,LX1001,https://www.alzforum.org/therapeutics/lx1001,,,DNA/RNA-based,Amyloid-Related,Alzheimer's Disease,,This gene-therapy approach uses a viral vector to drive expression of human apolipoprotein E2 protein (APOE2) in the central nervous system. The serotype rh.10 adeno-associated virus with APOE2 cDNA is surgically injected into the spinal canal so that it reaches the cerebrospinal fluid and brain.,ongoing,,AlzForum.Therapeutics,lx1001
ly2599666,LY2599666,https://www.alzforum.org/therapeutics/ly2599666,,,Immunotherapy (passive),Amyloid-Related,Alzheimer's Disease,,"LY2599666 is an Fc-less, antigen-binding fragment of a monoclonal anti-Aβ antibody linked to polyethylene glycol. It targets soluble Aβ monomer and is delivered by subcutaneous injection.",discontinued,,AlzForum.Therapeutics,ly2599666
ly2886721,LY2886721,https://www.alzforum.org/therapeutics/ly2886721,,,Small Molecule,Amyloid-Related,"Alzheimer's Disease, Mild Cognitive Impairment",,"LY2886721 was the first BACE inhibitor to reach Phase 2 clinical research. Prior compounds by Lilly and many other pharmaceutical companies had lacked sufficient brain penetrance, exposure, or other key pharmacological characteristics.",discontinued,,AlzForum.Therapeutics,ly2886721
ly3202626,LY3202626,https://www.alzforum.org/therapeutics/ly3202626,,,Small Molecule,Amyloid-Related,Alzheimer's Disease,,"LY3202626 is a potent small-molecule inhibitor of BACE1, the β-secretase enzyme that cleaves the APP protein to release its C99 fragment. C99 gives rise to various species of Aβ peptide during its subsequent cleavage by γ-secretase.",discontinued,,AlzForum.Therapeutics,ly3202626
ly3884961,LY3884961,https://www.alzforum.org/therapeutics/ly3884961,,,DNA/RNA-based,Other,Parkinson's Disease,,"PR001 is a gene-replacement therapy that uses adeno-associated virus 9 (AAV9) to deliver a functional copy of the GBA1 gene to the brain. GBA1 encodes the enzyme glucocerebrosidase (GCase), a lysosomal enzyme involved in the breakdown of glycosphingolipids.",ongoing,,AlzForum.Therapeutics,ly3884961
ly3884963,LY3884963,https://www.alzforum.org/therapeutics/ly3884963,,,DNA/RNA-based,Other,Frontotemporal Dementia,,PR006 is a gene-replacement therapy that uses adeno-associated virus 9 (AAV9) to deliver a functional copy of the progranulin gene GRN to the brain. Progranulin mutations are a frequent cause of familial frontotemporal dementia.,ongoing,,AlzForum.Therapeutics,ly3884963
ly3954068,LY3954068,https://www.alzforum.org/therapeutics/ly3954068,,,DNA/RNA-based,Tau,Alzheimer's Disease,,LY3954068 is a small interfering RNA (siRNA) that targets expression of the microtubule-associated binding protein tau. No information is available about the makeup of LY3954068.,ongoing,,AlzForum.Therapeutics,ly3954068
ly3962681,LY3962681,https://www.alzforum.org/therapeutics/ly3962681,,,DNA/RNA-based,alpha-synuclein,Parkinson's Disease,,"LY3962681 is a small interfering RNA (siRNA) that binds α-synuclein messenger RNA and causes its degradation. This siRNA is currently being developed as a treatment for Parkinson’s disease, where accumulation of aberrant forms of α-synuclein leads to neurodegeneration.",ongoing,,AlzForum.Therapeutics,ly3962681
masitinib,Masitinib,https://www.alzforum.org/therapeutics/masitinib,,,Small Molecule,Other,"Alzheimer's Disease, Amyotrophic Lateral Sclerosis",,"Masitinib is an orally available inhibitor of the protein tyrosine kinase c-kit, which is expressed on cancer cells. Masitinib also inhibits PDGF and FGF receptors, and fyn and lyn kinases ( Dubreuil et al., 2009 ).",ongoing,,AlzForum.Therapeutics,masitinib
masupirdine,Masupirdine,https://www.alzforum.org/therapeutics/masupirdine,,,Small Molecule,Other Neurotransmitters,Alzheimer's Disease,,"Developed by Suven Inc., the Delaware-based subsidiary of Indian company Suven Life Sciences, SUVN-502 is an orally available, brain-penetrant, selective antagonist of the 5-HT6 serotonin receptor ( Nirogi et al., 2017 ). This G protein-coupled receptor is expressed mostly in the brain, where it mediates neurotransmission for functions including cognition and memory.",ongoing,,AlzForum.Therapeutics,masupirdine
medi1814,MEDI1814,https://www.alzforum.org/therapeutics/medi1814,,,Immunotherapy (passive),Amyloid-Related,Alzheimer's Disease,,"Developed originally at MedImmune, now part of AstraZeneca, this antibody is being developed jointly by AstraZeneca and Eli Lilly. MEDI1814 binds to monomeric Aβ42.",discontinued,,AlzForum.Therapeutics,medi1814
melatonin,Melatonin,https://www.alzforum.org/therapeutics/melatonin,,,"Supplement, Dietary",Other,Alzheimer's Disease,,,ongoing,,AlzForum.Therapeutics,melatonin
mem-1003,MEM 1003,https://www.alzforum.org/therapeutics/mem-1003,,,Small Molecule,Other,"Alzheimer's Disease, Mild Cognitive Impairment, Vascular Dementia, Bipolar Disorder",,MEM 1003 is a dihydropyridine compound related to nimodipine. It is a Ca2 channel antagonist.,discontinued,,AlzForum.Therapeutics,mem-1003
memantine,Memantine,https://www.alzforum.org/therapeutics/memantine,,,Small Molecule,Other Neurotransmitters,Alzheimer's Disease,Alzheimer's Disease,"Memantine is marketed for the treatment of moderate to severe Alzheimer's disease in the United States, Canada, Europe, China, and other countries, and for the treatment of dementia in Germany, where it has been on the market since 1989 under the name Akatinol. Memantine received European marketing approval in 2002 and U.S.",approved,,AlzForum.Therapeutics,memantine
memorem-transcranial-electromagnetic-treatment,MemorEM Transcranial Electromagnetic Treatment,https://www.alzforum.org/therapeutics/memorem-transcranial-electromagnetic-treatment,,,Procedural Intervention,"Amyloid-Related, Other",Alzheimer's Disease,,"MemorEM™ is a patented, noninvasive technology that delivers ultrahigh radio frequency electromagnetic waves to the brain. The device consists of a cap with eight embedded transmitters and a control box worn in an arm strap.",ongoing,,AlzForum.Therapeutics,memorem-transcranial-electromagnetic-treatment
metformin,Metformin,https://www.alzforum.org/therapeutics/metformin,,,Small Molecule,Other,Alzheimer's Disease,Type 2 Diabetes,Metformin is a prescription drug widely used to treat Type 2 diabetes. It lowers blood glucose and restores insulin sensitivity.,ongoing,,AlzForum.Therapeutics,metformin
methylphenidate,Methylphenidate,https://www.alzforum.org/therapeutics/methylphenidate,,,Small Molecule,Other Neurotransmitters,Alzheimer's Disease,"Attention-deficit hyperactivity disorder (ADHD), narcolepsy","This drug is a mild CNS stimulant that is being tested as a treatment for apathy in people with Alzheimer’s disease. It increases dopamine levels in the brain, and improves memory and attention.",ongoing,,AlzForum.Therapeutics,methylphenidate
metrifonate,Metrifonate,https://www.alzforum.org/therapeutics/metrifonate,,,Small Molecule,Cholinergic System,Alzheimer's Disease,,Metrifonate is a long-acting irreversible cholinesterase inhibitor. It was originally used to treat schistosomiasis.,discontinued,,AlzForum.Therapeutics,metrifonate
mevidalen,Mevidalen,https://www.alzforum.org/therapeutics/mevidalen,,,Small Molecule,Other Neurotransmitters,"Parkinson's Disease Dementia, Dementia with Lewy Bodies",,"LY3154207 is a small-molecule, positive allosteric modulator of the dopamine receptor D1 (D1 PAM). The drug increases affinity of the D1 receptor for dopamine, and is thought to improve dementia symptoms by amplifying the effect of endogenous dopamine.",ongoing,,AlzForum.Therapeutics,mevidalen
milameline,Milameline,https://www.alzforum.org/therapeutics/milameline,,,Small Molecule,Cholinergic System,Alzheimer's Disease,,"Milameline is a muscarinic receptor agonist with approximately equal affinities determined at the five subtypes of human muscarinic receptors (hM1–hM5) ( Schwarz et al., 1999 ).",discontinued,,AlzForum.Therapeutics,milameline
minocycline,Minocycline,https://www.alzforum.org/therapeutics/minocycline,,,Small Molecule,Other,Alzheimer's Disease,,"This second-generation tetracycline antibiotic has been in use for more than 30 years. It also has anti-inflammatory activity, crosses the blood-brain barrier, and inhibits microglia activation.",discontinued,,AlzForum.Therapeutics,minocycline
minzasolmin,Minzasolmin,https://www.alzforum.org/therapeutics/minzasolmin,,,Small Molecule,alpha-synuclein,Parkinson's Disease,,"Minzasolmin is a small-molecule α-synuclein aggregation inhibitor. Oligomerization and aggregation of α-synuclein is implicated in Parkinson’s disease, dementia with Lewy bodies, and multiple-system atrophy.",discontinued,,AlzForum.Therapeutics,minzasolmin
mirtazapine,Mirtazapine,https://www.alzforum.org/therapeutics/mirtazapine,,,Small Molecule,Other Neurotransmitters,Alzheimer's Disease,,"Mirtazapine is a tricyclic antidepressant. It inhibits central presynaptic α-2-adrenergic receptors, and increases the release of serotonin and norepinephrine.",ongoing,,AlzForum.Therapeutics,mirtazapine
mivelsiran,Mivelsiran,https://www.alzforum.org/therapeutics/mivelsiran,,,DNA/RNA-based,Amyloid-Related,"Alzheimer's Disease, Cerebral Amyloid Angiopathy",,"This gene-silencing approach uses intrathecal injection of a small interfering RNA targeting the amyloid precursor protein mRNA as a potential treatment for Alzheimer’s disease and cerebral amyloid angiopathy. The goal is to reduce expression of APP in the central nervous system and thus depress production of substrates for amyloid deposition, e.g.",ongoing,,AlzForum.Therapeutics,mivelsiran
mk-1167,MK-1167,https://www.alzforum.org/therapeutics/mk-1167,,,Small Molecule,Cholinergic System,Alzheimer's Disease,,"MK-1167 is an α-7 nicotinic acetylcholine receptor positive allosteric modulator. It is being developed for the treatment of cognitive deficits in Alzheimer's disease, schizophrenia, and attention deficit hyperactivity disorder.",ongoing,,AlzForum.Therapeutics,mk-1167
mk-1942,MK-1942,https://www.alzforum.org/therapeutics/mk-1942,,,Small Molecule,Unknown,Alzheimer's Disease,,"Little is known about MK-1942, a small-molecule drug Merck began to develop for treatment-resistant depression in 2021. At that time, Merck partnered with Novamind, a company focusing on clinical applications of psychedelic compounds such as those derived from psilocybin mushrooms or LSD.",discontinued,,AlzForum.Therapeutics,mk-1942
mk-2214,MK-2214,https://www.alzforum.org/therapeutics/mk-2214,,,Immunotherapy (passive),Tau,Alzheimer's Disease,,"MK-2214 is an anti-tau monoclonal antibody. This is likely an antibody to phosphorylated tau created at Teijin Pharma in Japan, and licensed by Merck in 2017 ( press release ).",ongoing,,AlzForum.Therapeutics,mk-2214
mk-7622,MK-7622,https://www.alzforum.org/therapeutics/mk-7622,,,Small Molecule,Unknown,Alzheimer's Disease,,Merck is developing MK-7622 as an add-on therapy to the cholinesterase inhibitor donepezil for the treatment of Alzheimer's disease. No studies have been published on this compound in the peer-reviewed literature or other publicly available documents.,discontinued,,AlzForum.Therapeutics,mk-7622
mk-8189,MK-8189,https://www.alzforum.org/therapeutics/mk-8189,,,Small Molecule,Other Neurotransmitters,Alzheimer's Disease,,MK-8189 is a selective inhibitor of phosphodiesterase 10A (PDE10A). This enzyme catalyzes the breakdown of second messengers cGMP and cAMP.,ongoing,,AlzForum.Therapeutics,mk-8189
mkc-231,MKC-231,https://www.alzforum.org/therapeutics/mkc-231,,,Small Molecule,Unknown,Alzheimer's Disease,,"MKC-231 is reported to enhance high-affinity choline uptake (HACU), a rate-limiting step in acetylcholine synthesis ( Takashina et al., 2008 ).",unknown,,AlzForum.Therapeutics,mkc-231
montelukast,Montelukast,https://www.alzforum.org/therapeutics/montelukast,,,Small Molecule,Inflammation,"Alzheimer's Disease, Parkinson's Disease",Asthma,Montelukast is a leukotriene receptor antagonist used to treat asthma and allergy symptoms. Leukotrienes are inflammatory mediators released by white blood cells.,ongoing,,AlzForum.Therapeutics,montelukast
msdc-0160,MSDC-0160,https://www.alzforum.org/therapeutics/msdc-0160,,,Small Molecule,Other,Alzheimer's Disease,,,ongoing,,AlzForum.Therapeutics,msdc-0160
multivitamin-mineral-supplement,Multivitamin-mineral Supplement,https://www.alzforum.org/therapeutics/multivitamin-mineral-supplement,,,"Supplement, Dietary",Other,Mild Cognitive Impairment,,"Multivitamin deficiencies in older adults may increase risk for cognitive decline and dementia ( Littlejohns et al., 2014 ; Mohajeri et al., 2015 ). In the only large, randomized trial completed to date, a daily multivitamin produced no cognitive benefit in nearly 6,000 male physicians followed for 12 years ( Grodstein et al., 2013 ).",unknown,,AlzForum.Therapeutics,multivitamin-mineral-supplement
mw150-0,MW150,https://www.alzforum.org/therapeutics/mw150-0,,,Small Molecule,"Inflammation, Other",Alzheimer's Disease,,"MW150 is a CNS-penetrant, selective inhibitor of the alpha isoform of the mitogen-activated serine/threonine protein kinase p38 MAPK. It is taken by mouth.",ongoing,,AlzForum.Therapeutics,mw150-0
mw151,MW151,https://www.alzforum.org/therapeutics/mw151,,,Small Molecule,Inflammation,Alzheimer's Disease,,"MW151 is an orally available, brain-penetrant, anti-inflammatory compound. Its target is undisclosed.",ongoing,,AlzForum.Therapeutics,mw151
na-831,NA-831,https://www.alzforum.org/therapeutics/na-831,,,Small Molecule,Cholinergic System,Alzheimer's Disease,,"This small molecule is claimed to activate AMPA receptors and increase the production of brain-derived neurotrophic factor in neurons. According to company information, it promotes neurogenesis and cognitive function.",ongoing,,AlzForum.Therapeutics,na-831
nabilone,Nabilone,https://www.alzforum.org/therapeutics/nabilone,,,Small Molecule,Other Neurotransmitters,"Alzheimer's Disease, Parkinson's Disease",Nausea associated with cancer chemotherapy (US and other countries); pain spasticity in multiple sclerosis (Canada and other countries).,"Nabilone is a synthetic compound sold by Bausch Health, formerly Valeant Pharmaceuticals. Nabilone is related to delta-9-tetrahydrocannabinol, aka THC, the major psychoactive compound of cannabis.",ongoing,,AlzForum.Therapeutics,nabilone
naproxen,Naproxen,https://www.alzforum.org/therapeutics/naproxen,,,Small Molecule,Inflammation,Alzheimer's Disease,"Over-the-counter drug for reduction of pain, fever, inflammation, and stiffness.","Naproxen is an over-the-counter nonsteroidal anti-inflammatory drug (NSAID). It inhibits COX-1 and COX-2, both isoforms of the cyclooxygenase enzyme, and reduces inflammation through reduced prostaglandin synthesis.",discontinued,,AlzForum.Therapeutics,naproxen
nasal-insulin,Nasal Insulin,https://www.alzforum.org/therapeutics/nasal-insulin,,,"Small Molecule, Other","Amyloid-Related, Other","Alzheimer's Disease, Mild Cognitive Impairment, Parkinson's Disease, Multiple System Atrophy",Diabetes,"Insulin is the peptide hormone that is standard treatment for the management of Type 1 diabetes. In a new therapeutic approach, various forms of commercially available insulin are being atomized into a spray and inhaled through the nose.",ongoing,,AlzForum.Therapeutics,nasal-insulin
nb-4746,NB-4746,https://www.alzforum.org/therapeutics/nb-4746,,,Small Molecule,Other,Amyotrophic Lateral Sclerosis,,"NB-4746 is an oral, brain-penetrant, small molecule inhibitor of the nicotinamide adenine dinucleotide (NAD) hydrolase SARM1. SARM1 activation is required for axon degeneration after nerve injury, and SARM1 inhibitors have the potential to prevent or slow neurodegenerative diseases that involve axon loss.",ongoing,,AlzForum.Therapeutics,nb-4746
nefiracetam,Nefiracetam,https://www.alzforum.org/therapeutics/nefiracetam,,,Small Molecule,Cholinergic System,Alzheimer's Disease,,"Nefiracetam is a pyrrolidone-type agent that affects multiple neurotransmitter systems including: aminergic, glutaminergic, and cholinergic. It has been shown to stimulate α4β2-type neuronal nicotinic acetylcholine receptors, activating protein kinase C, and reducing magnesium block of the NMDA receptor 13—19.",discontinued,,AlzForum.Therapeutics,nefiracetam
neflamapimod,Neflamapimod,https://www.alzforum.org/therapeutics/neflamapimod,,,Small Molecule,Inflammation,"Alzheimer's Disease, Dementia with Lewy Bodies, Huntington's Disease",,"Neflamapimod selectively inhibits the alpha isoform of the mitogen-activated serine/threonine protein kinase p38 MAPK, a ""stress kinase"" considered a drug target in CNS diseases ( Duffy et al., 2011 ). Previously called VX-745, neflamapimod has been repurposed for evaluation in neurodegenerative diseases.",discontinued,,AlzForum.Therapeutics,neflamapimod
nelonicline,Nelonicline,https://www.alzforum.org/therapeutics/nelonicline,,,Small Molecule,Cholinergic System,"Alzheimer's Disease, Schizophrenia",,"ABT-126 is an α-7 nicotinic acetylcholine receptor (α7-nAChR) allosteric modulator that was being developed to treat cognitive deficits in schizophrenia and Alzheimer's disease. Cholinergic function declines in Alzheimer's, and currently approved acetylcholinesterase-inhibitor therapies modestly improve cognitive deficits in patients with AD by way of boosting cholinergic transmission.",discontinued,,AlzForum.Therapeutics,nelonicline
nelotanserin,Nelotanserin,https://www.alzforum.org/therapeutics/nelotanserin,,,Small Molecule,Other Neurotransmitters,Dementia with Lewy Bodies,,"Nelotanserin is a serotonin, aka 5HT, 2A receptor inverse agonist. Originally called ADP-125, the compound was developed by Arena Pharmaceuticals as a treatment for insomnia, but failed efficacy measures for this indication in Phase 2.",discontinued,,AlzForum.Therapeutics,nelotanserin
neotrofin,NeoTrofin,https://www.alzforum.org/therapeutics/neotrofin,,,Small Molecule,Unknown,Alzheimer's Disease,,"NeoTrofin is a derivative of the purine hypoxanthin. It was found to stimulate the production mRNA for NGF, neurotrophin-3, and bFGF in cultured mouse astrocytes (Glasky et al., 1995).",discontinued,,AlzForum.Therapeutics,neotrofin
neramexane,Neramexane,https://www.alzforum.org/therapeutics/neramexane,,,Small Molecule,Other Neurotransmitters,Alzheimer's Disease,,"Similar to memantine, neramexane is an NMDA receptor channel blocker with moderate affinity. It displays voltage dependency, and rapid unblocking kinetics ( Gilling et al., 2007 ).",discontinued,,AlzForum.Therapeutics,neramexane
neu-411,NEU-411,https://www.alzforum.org/therapeutics/neu-411,,,Small Molecule,"Inflammation, Other",Parkinson's Disease,,NEU-411 is a small molecule that enters the brain and inhibits the leucine-rich repeat kinase LRRK2. It is being developed to treat Parkinson’s disease.,ongoing,,AlzForum.Therapeutics,neu-411
neuroad,NeuroAD,https://www.alzforum.org/therapeutics/neuroad,,,Procedural Intervention,Other,Alzheimer's Disease,,"NeuroADTM rTMS is a non-invasive neuromodulation system. It combines brief trains of 10 Hz electric pulses to brain regions affected in AD, i.e., frontal, temporal, and parietal regions, alternating with sessions of computerized cognitive training designed to engage those same regions.",unknown,,AlzForum.Therapeutics,neuroad
nic5-15,NIC5-15,https://www.alzforum.org/therapeutics/nic5-15,,,"Small Molecule, Supplement, Dietary","Amyloid-Related, Other",Alzheimer's Disease,,"NIC5-15 is pinitol, a naturally occurring cyclic sugar alcohol. It is found in soy and several other plants and fruits.",ongoing,,AlzForum.Therapeutics,nic5-15
nicotinamide-riboside,Nicotinamide Riboside,https://www.alzforum.org/therapeutics/nicotinamide-riboside,,,"Supplement, Dietary",Other,"Alzheimer's Disease, Parkinson's Disease, Mild Cognitive Impairment",,"Nicotinamide riboside (NR) is a patented analog of nicotinamide or Vitamin B3, and is sold as a dietary supplement under the brand name Tru Niagen. Cells use NR to synthesize NAD+, an essential cofactor for many processes including ATP generation and DNA repair, and a key sensor of cellular metabolism.",ongoing,,AlzForum.Therapeutics,nicotinamide-riboside
nilotinib,Nilotinib,https://www.alzforum.org/therapeutics/nilotinib,,,Small Molecule,Other,"Parkinson's Disease, Dementia with Lewy Bodies, Alzheimer's Disease",Chronic myeloid leukemia,"Nilotinib is an oral Abl tyrosine kinase inhibitor used to treat chronic myeloid leukemia. Nilotinib induces autophagy, leading to death of rapidly dividing cells ( Salomoni and Calabretta, 2009 ).",ongoing,,AlzForum.Therapeutics,nilotinib
nilvadipine,Nilvadipine,https://www.alzforum.org/therapeutics/nilvadipine,,,Small Molecule,Other,Alzheimer's Disease,,Nilvadipine is a dihydropyridine calcium channel blocker. It has been prescribed in Europe and Japan to treat hypertension since the 1990s and has accumulated a strong safety record.,unknown,,AlzForum.Therapeutics,nilvadipine
nimodipine,Nimodipine,https://www.alzforum.org/therapeutics/nimodipine,,,Small Molecule,Metals,Frontotemporal Dementia,Subarachnoid hemorrhage,"Nimodipine is a calcium channel blocker. It is prescribed to prevent vasospasm and possible subsequent stroke in people who have suffered a hemorrhage in the subarachnoid space, the compartment surrounding the brain.",discontinued,,AlzForum.Therapeutics,nimodipine
nio752,NIO752,https://www.alzforum.org/therapeutics/nio752,,,DNA/RNA-based,Tau,"Progressive Supranuclear Palsy, Alzheimer's Disease",,"NIO752 is an antisense oligonucleotide to tau, designed to reduce the levels of this protein by interfering with translation of tau mRNA. The antisense strategy assumes that decreasing the abundance of tau will slow the formation of tau aggregates and progression of tau pathology.",ongoing,,AlzForum.Therapeutics,nio752
nivegacetor,Nivegacetor,https://www.alzforum.org/therapeutics/nivegacetor,,,Small Molecule,Amyloid-Related,Alzheimer's Disease,,"This second-generation γ-secretase modulator is in development for the treatment of Alzheimer's disease. The rationale is that, unlike γ-secretase inhibitors, which inhibit the enzyme complex outright, modulators shift APP cleavage toward production of shorter Aβ peptides and away from production of longer, aggregation-prone peptides such as Aβ42 and Aβ43, while sparing γ-secretase's physiological cleavages of substrates such as notch (e.g.",ongoing,,AlzForum.Therapeutics,nivegacetor
nmra-511,NMRA-511,https://www.alzforum.org/therapeutics/nmra-511,,,Small Molecule,Other,Alzheimer's Disease,,"NMRA-511 is an oral, selective, brain-penetrant antagonist of the vasopressin 1a receptor (V1aR). The V1aR is expressed in multiple areas of the brain, and plays a role in social behaviors, anxiety, and threat processing.",ongoing,,AlzForum.Therapeutics,nmra-511
npt520-34,NPT520-34,https://www.alzforum.org/therapeutics/npt520-34,,,Small Molecule,"alpha-synuclein, Inflammation, Other","Amyotrophic Lateral Sclerosis, Parkinson's Disease",,"This orally available, small-molecule antagonist of toll-like receptor 2 (TLR2) is in development for the treatment of Parkinson’s disease and ALS. TLR2 is a pattern-recognition, innate immune receptor expressed on neurons and glial cells.",ongoing,,AlzForum.Therapeutics,npt520-34
ns2330,NS2330,https://www.alzforum.org/therapeutics/ns2330,,,Small Molecule,Other Neurotransmitters,Alzheimer's Disease,,"NS2330 is a monoamine uptake inhibitor that inhibits norepinephrine, serotonin, and dopamine reuptake. Tesofensine inhibits the presynaptic uptake of these monoamine neurotransmitters and stimulates the cholinergic system indirectly ( Lehr et al., 2008 ).",discontinued,,AlzForum.Therapeutics,ns2330
nsc001,NSC001,https://www.alzforum.org/therapeutics/nsc001,,,Small Molecule,Cholinergic System,Alzheimer's Disease,,Insufficient activity of the cholinergic system is associated with AD and cognitive decline. Two different strategies have been used to increase cholinergic activity in the AD brain: 1) acetylcholinesterase inhibitors and 2) direct stimulation of cholinergic receptors.,ongoing,,AlzForum.Therapeutics,nsc001
nt-0796,NT-0796,https://www.alzforum.org/therapeutics/nt-0796,,,Small Molecule,Inflammation,Parkinson's Disease,,"NT-0796 is an oral, brain-penetrant inhibitor of inflammasomes that contain NLRP3, aka nod-like receptor family pyrin domain-containing protein 3. Inflammasomes are multiprotein, cytosolic complexes that function as sensors in the innate immune system.",ongoing,,AlzForum.Therapeutics,nt-0796
ntrx-07,NTRX-07,https://www.alzforum.org/therapeutics/ntrx-07,,,Small Molecule,"Inflammation, Other",Alzheimer's Disease,,"NTRX-07 is a cannabinoid receptor agonist. It enters the central nervous system and activates receptors on microglia, reportedly to reduce neuroinflammation.",ongoing,,AlzForum.Therapeutics,ntrx-07
nuplazid,Nuplazid,https://www.alzforum.org/therapeutics/nuplazid,,,Small Molecule,Other Neurotransmitters,"Alzheimer's Disease, Schizophrenia, Dementia, Depression",Parkinson's psychosis,"Pimavanserin is a serotonergic agent, specifically a selective serotonin (5-HT) 2A receptor inverse agonist. In April 2016, the FDA approved this once-daily atypical antipsychotic to treat the delusions and hallucinations that are a feature of psychosis in Parkinson's disease, and it came on the market in the U.S.",discontinued,,AlzForum.Therapeutics,nuplazid
nurowntm,NurOwn™,https://www.alzforum.org/therapeutics/nurowntm,,,Other,Other,Amyotrophic Lateral Sclerosis,,"NurOwn™ comprises mesenchymal stem cells enriched from patients’ own bone marrow, propagated in the lab, and induced to secrete neurotrophic factors. The cells are transplanted back into the patients’ spinal cord and muscle, where the neurotrophic factors are expected to promote neuron survival, and slow down disease progression.",ongoing,,AlzForum.Therapeutics,nurowntm
nuz-001,NUZ-001,https://www.alzforum.org/therapeutics/nuz-001,,,Small Molecule,Other,Amyotrophic Lateral Sclerosis,Deworming sheep,"NUZ-001, also known as monepantel, is used worldwide in veterinary medicine to control intestinal nematodes, especially in sheep. Its target, a nematode-specific nicotinic acetylcholine receptor subunit, is not present in humans.",ongoing,,AlzForum.Therapeutics,nuz-001
nx210c,NX210c,https://www.alzforum.org/therapeutics/nx210c,,,Small Molecule,Other,"Amyotrophic Lateral Sclerosis, Parkinson's Disease",,NX210c is a cyclized 12-amino-acid peptide derived from a protein involved in embryonic neuronal development. It is delivered by intravenous injection.,ongoing,,AlzForum.Therapeutics,nx210c
nyx-458,NYX-458,https://www.alzforum.org/therapeutics/nyx-458,,,Small Molecule,Other Neurotransmitters,PD-MCI,,"NYX-458 is an oral NMDA receptor modulator with pro-cognitive and antidepressant actions. It was being developed to treat cognitive impairment in people with Parkinson’s disease, where it was intended to mitigate NMDA receptor dysregulation caused by a lack of dopamine.",discontinued,,AlzForum.Therapeutics,nyx-458
obicetrapib,Obicetrapib,https://www.alzforum.org/therapeutics/obicetrapib,,,Small Molecule,Cholesterol,Alzheimer's Disease,,This cholesteryl ester transfer protein (CETP) inhibitor is being developed primarily as a cholesterol-targeted therapy to reduce cardiovascular disease. CETP inhibitors block the transfer of cholesteryl esters from high-density lipoprotein (HDL) into other lipoproteins; in this way they promote removal of cholesterol by HDL.,ongoing,,AlzForum.Therapeutics,obicetrapib
octagam%C2%AE,Octagam®10%,https://www.alzforum.org/therapeutics/octagam%C2%AE,,,Immunotherapy (passive),"Amyloid-Related, Inflammation","Alzheimer's Disease, Mild Cognitive Impairment",Immunodeficiency disorders,NewGam/Octagam® is an intravenous immunoglobulin preparation by the Switzerland-based company Octapharma. It is a marketed product.,unknown,,AlzForum.Therapeutics,octagam%C2%AE
olx-07010,OLX-07010,https://www.alzforum.org/therapeutics/olx-07010,,,Small Molecule,Tau,Alzheimer's Disease,,"OLX-07010 is a small-molecule inhibitor of tau self-association that is being tested for Alzheimer’s disease. The rationale for this approach is that blocking this initial step in tau aggregation will prevent the acute toxicity of oligomers (e.g., Fá et al., 2016 ; Tian et al., 2013 ), as well as the subsequent formation of fibrils and tangles, and propagation of pathology through the brain.",ongoing,,AlzForum.Therapeutics,olx-07010
opm-201,OPM-201,https://www.alzforum.org/therapeutics/opm-201,,,Small Molecule,Other,Parkinson's Disease,,"This small molecule, brain-penetrant inhibitor of the leucine-rich repeat kinase LRRK2 is being developed as a treatment for Parkinson’s disease. LRRK2, also known as Dardarin, is a large, multidomain protein containing serine and threonine kinase activity.",ongoing,,AlzForum.Therapeutics,opm-201
orm-12741,ORM-12741,https://www.alzforum.org/therapeutics/orm-12741,,,Small Molecule,Other Neurotransmitters,Alzheimer's Disease,,ORM-12741 is an orally available α 2c adrenergic receptor antagonist being developed for Alzheimer's disease by the Finnish company Orion. The role of the α 2c adrenergic receptor in Alzheimer's disease is poorly understood.,ongoing,,AlzForum.Therapeutics,orm-12741
pbft02,PBFT02,https://www.alzforum.org/therapeutics/pbft02,,,DNA/RNA-based,Other,Frontotemporal Dementia,,PBFT02 is a gene-replacement therapy that uses adeno-associated virus serotype 1 (AAV1) to deliver a functional copy of the progranulin gene GRN to the brain. Progranulin mutations are a frequent cause of familial frontotemporal dementia.,ongoing,,AlzForum.Therapeutics,pbft02
pbt2,PBT2,https://www.alzforum.org/therapeutics/pbt2,,,Small Molecule,"Amyloid-Related, Metals","Alzheimer's Disease, Huntington's Disease",,PBT2 is a metal protein-attenuating compound (MPAC) being developed for treatment of both Alzheimer's and Huntington's diseases. It is an 8-hydroxyquinoline derivative that disrupts the interaction between metals and the Aβ peptide in the brain.,unknown,,AlzForum.Therapeutics,pbt2
pepinemab,Pepinemab,https://www.alzforum.org/therapeutics/pepinemab,,,Immunotherapy (passive),Inflammation,"Alzheimer's Disease, Huntington's Disease",,"Pepinemab is a humanized IgG4 monoclonal antibody to semaphorin 4D, a multifunctional membrane glycoprotein expressed by oligodendrocytes and astrocytes in the central nervous system. In response to stress or injury, neurons release soluble Sema4D, which binds to receptors on glia and activates inflammatory cytokine release.",ongoing,,AlzForum.Therapeutics,pepinemab
pf-05212377,PF-05212377,https://www.alzforum.org/therapeutics/pf-05212377,,,Small Molecule,Other Neurotransmitters,Alzheimer's Disease,,"SAM-760 is an orally available antagonist of the serotonin 6 receptor (5-HT 6 ). By modulating serotonin levels in the brain, 5-HT 6 antagonists are thought to lead to secondary increases in the levels of the neurotransmitters acetylcholine and glutamate, benefitting learning and memory.",discontinued,,AlzForum.Therapeutics,pf-05212377
pf-06648671,PF-06648671,https://www.alzforum.org/therapeutics/pf-06648671,,,Small Molecule,Amyloid-Related,Alzheimer's Disease,,PF-06648671 is a γ-secretase modulator Pfizer was developing for the treatment of Alzheimer's disease. No preclinical information is publicly available on this compound.,discontinued,,AlzForum.Therapeutics,pf-06648671
pf-06751979,PF-06751979,https://www.alzforum.org/therapeutics/pf-06751979,,,Small Molecule,Amyloid-Related,Alzheimer's Disease,,Pfizer developed the BACE 1 inhibitor PF-06751979 for the treatment of Alzheimer's disease to Phase 1. This inhibitor is selective for BACE1 over BACE2 and the related aspartyl protease Cathepsin D.,discontinued,,AlzForum.Therapeutics,pf-06751979
pf-06852231,PF-06852231,https://www.alzforum.org/therapeutics/pf-06852231,,,Small Molecule,Cholinergic System,Alzheimer's Disease,,PF-06852231 is a small-molecule cholinergic modulator. No preclinical information about this compound is published.,discontinued,,AlzForum.Therapeutics,pf-06852231
phenserine,Phenserine,https://www.alzforum.org/therapeutics/phenserine,,,Small Molecule,Cholinergic System,Alzheimer's Disease,,"Phenserine is a physostigmine analog that inhibits acetylcholinesterase. It has also been shown to inhibit Aβ production by reducing expression of APP ( Klein, 2007 ; Venti et al., 2004 ; Utsuki et al., 2006 ).",unknown,,AlzForum.Therapeutics,phenserine
photobiomodulation,PhotoBioModulation,https://www.alzforum.org/therapeutics/photobiomodulation,,,Procedural Intervention,"Inflammation, Unknown","Alzheimer's Disease, Mild Cognitive Impairment, Parkinson's Disease",,Photobiomodulation is a form of light therapy that exposes tissue to red or near-infrared (NIR) light. Low-energy lasers or light-emitting diodes are placed on or near the skin.,unknown,,AlzForum.Therapeutics,photobiomodulation
physostigmine-salicylate,Physostigmine Salicylate,https://www.alzforum.org/therapeutics/physostigmine-salicylate,,,Small Molecule,Cholinergic System,Alzheimer's Disease,,Physostigmine salicylate is a reversible acetylcholinesterase inhibitor that effectively increases the concentration of acetylcholine and thus the stimulation of both nicotinic and muscarinic receptors due to the increase in available acetylcholine at the synapse.,discontinued,,AlzForum.Therapeutics,physostigmine-salicylate
pioglitazone,Pioglitazone,https://www.alzforum.org/therapeutics/pioglitazone,,,Small Molecule,"Inflammation, Other",Mild Cognitive Impairment,Type 2 diabetes mellitus,Pioglitazone is an insulin sensitizer of the thiazolidinedione class of peroxisome-proliferator activated receptor γ (PPARγ) agonists. Takeda developed pioglitazone as a once-daily treatment of type 2 diabetes.,ongoing,,AlzForum.Therapeutics,pioglitazone
piromelatine,Piromelatine,https://www.alzforum.org/therapeutics/piromelatine,,,Small Molecule,"Other Neurotransmitters, Other",Alzheimer's Disease,,"Piromelatine is a multimodal sleep drug. It acts primarily as an agonist of MT1/MT2/MT3 melatonin receptors and serotonin 5-HT1A and 5-HT1D receptors, but reportedly also is a low-affinity antagonist of 5-HT2B, P2X3, and TRPV1 receptors.",ongoing,,AlzForum.Therapeutics,piromelatine
pmn310,PMN310,https://www.alzforum.org/therapeutics/pmn310,,,Immunotherapy (passive),Amyloid-Related,Alzheimer's Disease,,PMN310 is a humanized IgG1 monoclonal antibody to soluble Aβ oligomers. It was raised against a constrained cyclic peptide derived from amino acids 13–16 (HHQK) of Aβ.,ongoing,,AlzForum.Therapeutics,pmn310
pnt001,PNT001,https://www.alzforum.org/therapeutics/pnt001,,,Immunotherapy (passive),Tau,"Alzheimer's Disease, Traumatic Brain Injury",,"PNT001 is a monoclonal antibody to the cis isomer of tau phosphorylated at threonine 231, a form of pathological tau suspected to play a role in traumatic brain injury, chronic traumatic encephalopathy, vascular dementia, and Alzheimer’s disease. Phosphorylated T231 tau exists in cis and trans conformations, as modulated by the peptidyl-prolyl cis/trans isomerase Pin1 ( Galas et al., 2006 ; Hamdane et al, 2006 ).",unknown,,AlzForum.Therapeutics,pnt001
ponezumab,Ponezumab,https://www.alzforum.org/therapeutics/ponezumab,,,Immunotherapy (passive),Amyloid-Related,"Alzheimer's Disease, Cerebral Amyloid Angiopathy",,"Ponezumab (PF-04360365) is a therapeutic antibody originally developed by the small biotech company Rinat Neuroscience. It is a humanized IgG2δA monoclonal antibody that binds the free carboxy terminal amino acids 33-40 of the Aβ 1-40 peptide (see La Porte et al., 2012 ).",discontinued,,AlzForum.Therapeutics,ponezumab
posdinemab,Posdinemab,https://www.alzforum.org/therapeutics/posdinemab,,,Immunotherapy (passive),Tau,Mild AD,,"This humanized IgG1 monoclonal antibody binds the proline-rich domain of tau, on the rationale that such antibodies will more potently interfere with cell-to-cell propagation of pathogenic, aggregated tau than do antibodies targeting tau's N-terminus. It has high affinity for tau phosphorylated at residue 217.",ongoing,,AlzForum.Therapeutics,posdinemab
prasinezumab,Prasinezumab,https://www.alzforum.org/therapeutics/prasinezumab,,,Immunotherapy (passive),alpha-synuclein,Parkinson's Disease,,"Prasinezumab is a humanized IgG1 monoclonal antibody directed against aggregated α-synuclein. Genetic and pathological evidence suggest that this protein plays a central role in the pathogenesis of Parkinson's disease (PD) and other α-synucleinopathies, such as dementia with Lewy bodies (DLB).",ongoing,,AlzForum.Therapeutics,prasinezumab
prazosin,Prazosin,https://www.alzforum.org/therapeutics/prazosin,,,Small Molecule,Other Neurotransmitters,Alzheimer's Disease,Hypertension,"Prazosin is an α-blocker, that is, an antagonist selective for α-1 adrenergic receptors. These receptors are expressed throughout the brain on vascular smooth muscle cells, where they mediate the vasoconstrictive effect of norepinephrine/adrenaline.",ongoing,,AlzForum.Therapeutics,prazosin
prednisone,Prednisone,https://www.alzforum.org/therapeutics/prednisone,,,Small Molecule,Inflammation,Alzheimer's Disease,,"Prednisone is a corticosteroid drug that is being prescribed in many countries for conditions ranging from severe allergic reactions to arthritis, asthma, and certain autoimmune disorders such as multiple sclerosis and lupus. Prednisone temporarily attracted interest in Alzheimer's research in the late 1990s as a potential treatment option to test the inflammatory hypothesis of Alzheimer's disease.",discontinued,,AlzForum.Therapeutics,prednisone
pri-002,PRI-002,https://www.alzforum.org/therapeutics/pri-002,,,Small Molecule,Amyloid-Related,Alzheimer's Disease,,"This 12-residue, enantiomeric peptide is designed to interfere with oligomerization of Aβ42 by binding to, and stabilizing, Aβ42 monomers. PRI-002 comprises D-amino acids, the optical isomers of natural L forms.",ongoing,,AlzForum.Therapeutics,pri-002
pridopidine,Pridopidine,https://www.alzforum.org/therapeutics/pridopidine,,,Small Molecule,Other,"Amyotrophic Lateral Sclerosis, Huntington's Disease, Parkinson's Disease",,"Pridopidine, formerly called huntexil, is a selective agonist of the sigma1 receptor, a molecular chaperone located in the endoplasmic reticulum in association with mitochondria. Sigma1Rs are highly expressed in the central nervous system, and regulate calcium signaling, ion channel function, and the ER stress response.",ongoing,,AlzForum.Therapeutics,pridopidine
primec,PrimeC,https://www.alzforum.org/therapeutics/primec,,,Combination,"Inflammation, Metals, Other",Alzheimer's Disease,,"PrimeC is a patented combination of two FDA-approved drugs, the antibiotic ciprofloxacin and the non-steroid anti-inflammatory celecoxib. Celecoxib reduces neuroinflammation, while ciprofloxacin regulates gene expression by altering microRNA synthesis, and chelates iron to alleviate oxidative stress.",ongoing,,AlzForum.Therapeutics,primec
propentofylline,Propentofylline,https://www.alzforum.org/therapeutics/propentofylline,,,Small Molecule,Unknown,Alzheimer's Disease,,"Propentofylline is a xanthine derivative that inhibits adenosine uptake and also inhibits phosphodiesterase. It exerts inhibitory activity on the proliferation of microglial cells, the formation of oxygen free radicals, and the release of inflammatory cytokines.",discontinued,,AlzForum.Therapeutics,propentofylline
protollin,Protollin,https://www.alzforum.org/therapeutics/protollin,,,Immunotherapy (active),Inflammation,Alzheimer's Disease,,"Protollin is a nasal vaccine composed of the outer membrane proteins of bacteria complexed with lipopolysaccharides. It was developed as an adjuvant to enhance mucosal immune responses to intranasal flu and other vaccines ( Jones et al., 2004 ).",ongoing,,AlzForum.Therapeutics,protollin
prx-03140,PRX-03140,https://www.alzforum.org/therapeutics/prx-03140,,,Small Molecule,Other,Alzheimer's Disease,,"5-HT4 receptor agonists augment neuronal acetylcholine release ( Ansanay et al., 1995 ; Torres et al., 1995 ) as well as modulate levels of Aβ and soluble amyloid precursor protein alpha (sAPPα) ( Lezoualc’h & Robert., 2003 ; Robert et al., 2001 ).",unknown,,AlzForum.Therapeutics,prx-03140
prx012,PRX012,https://www.alzforum.org/therapeutics/prx012,,,Immunotherapy (passive),Amyloid-Related,Alzheimer's Disease,,"PRX012 is a humanized monoclonal IgG1 antibody to an N-terminal epitope on Aβ. The company reports a 70 picomolar affinity for Aβ fibrils, or about 10-fold greater binding avidity than aducanumab.",unknown,,AlzForum.Therapeutics,prx012
pu-ad,PU-AD,https://www.alzforum.org/therapeutics/pu-ad,,,Small Molecule,Other,Alzheimer's Disease,,"A member of a new class of drugs called epichaperome inhibitors, PU-AD is an oral, brain-permeable inhibitor of the molecular chaperone heat shock protein 90. HSP90 stabilizes mutant or aberrantly modified proteins associated with cancer and multiple neurodegenerative diseases.",ongoing,,AlzForum.Therapeutics,pu-ad
pxt864,PXT864,https://www.alzforum.org/therapeutics/pxt864,,,"Combination, Small Molecule",Other Neurotransmitters,Alzheimer's Disease,,"PXT864 is an example of a repurposed drug combination. It uses baclofen and acamprosate, taken twice a day.",discontinued,,AlzForum.Therapeutics,pxt864
qalsodytm,QALSODY™,https://www.alzforum.org/therapeutics/qalsodytm,,,DNA/RNA-based,Other,Amyotrophic Lateral Sclerosis,ALS,This drug is a second-generation antisense oligonucleotide (ASO) targeting the mRNA for superoxide dismutase 1. It mediates mRNA degradation to prevent SOD1 protein synthesis and reduce levels of SOD1 protein.,approved,,AlzForum.Therapeutics,qalsodytm
qrl-101,QRL-101,https://www.alzforum.org/therapeutics/qrl-101,,,Small Molecule,Other,Amyotrophic Lateral Sclerosis,,"This small molecule is an opener of Kv7.2/7.3 voltage-gated potassium channels, which function to stabilize membrane potential and control neuronal excitability. QRL-101 is being developed to treat amyotrophic lateral sclerosis, with the aim to reduce hyperexcitability-induced motor neuron degeneration.",ongoing,,AlzForum.Therapeutics,qrl-101
qrl-201,QRL-201,https://www.alzforum.org/therapeutics/qrl-201,,,DNA/RNA-based,Other,Amyotrophic Lateral Sclerosis,,"QRL-201 is an antisense oligonucleotide targeting the mRNA of the STMN2 gene. This gene encodes stathmin-2, a microtubule-binding protein abundant in motor neurons and critical for axon stability.",ongoing,,AlzForum.Therapeutics,qrl-201
rasagiline,Rasagiline,https://www.alzforum.org/therapeutics/rasagiline,,,Small Molecule,Other Neurotransmitters,"Alzheimer's Disease, Parkinson's Disease, Amyotrophic Lateral Sclerosis",,"Rasagiline is a selective monoamine oxidase B (MAOB) inhibitor widely used to treat symptoms of Parkinson’s disease. It works by blocking the breakdown of dopamine, thus increasing dopaminergic function in the brain.",approved,,AlzForum.Therapeutics,rasagiline
relyvrio,Relyvrio,https://www.alzforum.org/therapeutics/relyvrio,,,"Combination, Small Molecule",Other,"Amyotrophic Lateral Sclerosis, Alzheimer's Disease, Progressive Supranuclear Palsy",ALS,"AMX0035 is a proprietary, oral combination of two drugs already in use, sodium phenylbutyrate (PB) and tauroursodeoxycholic acid (TUDCA). PB is prescribed under the brand name Buphenyl to treat urea cycle disorders.",discontinued,,AlzForum.Therapeutics,relyvrio
rem0045392,REM0045392,https://www.alzforum.org/therapeutics/rem0045392,,,Small Molecule,Tau,Alzheimer's Disease,,"REM0045392 is a modulator of the cytoskeletal protein septin. It acts as a molecular glue to stabilize the septin cytoskeleton, and normalizes neuronal calcium signaling that is altered by pathological tau.",ongoing,,AlzForum.Therapeutics,rem0045392
rember-tm,Rember TM,https://www.alzforum.org/therapeutics/rember-tm,,,Small Molecule,Tau,Alzheimer's Disease,Methylene Blue predates FDA. Used for treatment of malaria and methemoglobinemia.,"Rember® is a purified, proprietary formulation of methylthioninium chloride (MTC), also known as methylene blue. This old drug predates the FDA.",discontinued,,AlzForum.Therapeutics,rember-tm
remternetug,Remternetug,https://www.alzforum.org/therapeutics/remternetug,,,Immunotherapy (passive),Amyloid-Related,Alzheimer's Disease,,"Remternetug, previously LY3372993, is an investigational monoclonal antibody. Lilly's development pipeline lists it as an N3pG-Aβ mAb, suggesting it recognizes a pyroglutamated form of Aβ that is aggregated in amyloid plaques.",ongoing,,AlzForum.Therapeutics,remternetug
resveratrol,Resveratrol,https://www.alzforum.org/therapeutics/resveratrol,,,"Small Molecule, Supplement, Dietary",Other,"Alzheimer's Disease, Mild Cognitive Impairment",,"Resveratrol is one of many bioactive polyphenols in certain foods, such as red grapes, blueberries, peanuts, and dark chocolate. It has been reported to have neuroprotective effects in cell-based and animal models.",ongoing,,AlzForum.Therapeutics,resveratrol
rg3487,RG3487,https://www.alzforum.org/therapeutics/rg3487,,,Small Molecule,Cholinergic System,Alzheimer's Disease,,RG3487 is a selective nicotinic alpha-7 receptor (α7nAChR) partial agonist. It also has properties of a serotonin 3 receptor antagonist.,unknown,,AlzForum.Therapeutics,rg3487
rg7129,RG7129,https://www.alzforum.org/therapeutics/rg7129,,,Small Molecule,Amyloid-Related,Alzheimer's Disease,,"This is an orally administered inhibitor of the β-secretase BACE1, the sheddase enzyme that cleaves APP and sets up subsequent γ-secretase cleavage leading to generation of Aβ species. The rationale behind this approach is that it will test the amyloid-cascade hypothesis of Alzheimer's disease and act as a disease-modifying therapy.",discontinued,,AlzForum.Therapeutics,rg7129
rg7345,RG7345,https://www.alzforum.org/therapeutics/rg7345,,,Immunotherapy (passive),Tau,Alzheimer's Disease,,"RG7345 is a humanized monoclonal antibody targeting the tau phosphoepitope pS422. Tau phosphorylated at this site is considered a pathological form that has been linked to the relocalization of tau away from microtubules and toward the somato-dendritic compartment of the neuron ( Buée et al., 2000 ).",discontinued,,AlzForum.Therapeutics,rg7345
rilapladib,Rilapladib,https://www.alzforum.org/therapeutics/rilapladib,,,Small Molecule,Other,Alzheimer's Disease,,"Rilapladib is an inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2). Also known as plasma platelet-activating factor acetyl hydrolase, this enzyme is released into the blood by monocytes/macrophages.",discontinued,,AlzForum.Therapeutics,rilapladib
riluzole,Riluzole,https://www.alzforum.org/therapeutics/riluzole,,,Small Molecule,"Other Neurotransmitters, Other","Alzheimer's Disease, Parkinson's Disease, Amyotrophic Lateral Sclerosis, Huntington's Disease",Amyotrophic Lateral Sclerosis in many countries,"Riluzole is the first FDA-approved medication for amyotrophic lateral sclerosis. It has been marketed in dozens of countries around the world since the late 1990s, and generic versions became available in the U.S.",approved,,AlzForum.Therapeutics,riluzole
risvodetinib,Risvodetinib,https://www.alzforum.org/therapeutics/risvodetinib,,,Small Molecule,"alpha-synuclein, Other",Parkinson's Disease,,IkT-148009 is a novel brain-penetrant inhibitor of c-Abl tyrosine kinase. It is a chemical derivative of the commercial anticancer agent Imatinib/Gleevec.,ongoing,,AlzForum.Therapeutics,risvodetinib
rivastigmine,Rivastigmine,https://www.alzforum.org/therapeutics/rivastigmine,,,Small Molecule,Cholinergic System,"Alzheimer's Disease, Parkinson's Disease Dementia",Mild to moderate Alzheimer’s disease and mild to moderate dementia related to Parkinson's disease,"Rivastigmine is a reversible inhibitor of both the acetylcholinesterase and butyrylcholinesterase enzymes. It is widely used for the treatment of Alzheimer's across its mild, moderate, and severe stages, as well as for the treatment of dementia associated with Parkinson's disease (PDD).",approved,,AlzForum.Therapeutics,rivastigmine
rns60,RNS60,https://www.alzforum.org/therapeutics/rns60,,,Other,"Inflammation, Other",Amyotrophic Lateral Sclerosis,,RNS60 is saline containing charged oxygen nanobubbles. It is created by mixing 0.9 percent normal saline with pressurized oxygen using a technique owned by Revalesio.,ongoing,,AlzForum.Therapeutics,rns60
rofecoxib,Rofecoxib,https://www.alzforum.org/therapeutics/rofecoxib,,,Small Molecule,Inflammation,Alzheimer's Disease,Withdrawn from market,The NSAID rofecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor. Its anti-inflammatory and analgesic effects appear to result from the inhibition of prostaglandin synthesis.,discontinued,,AlzForum.Therapeutics,rofecoxib
rosiglitazone,Rosiglitazone,https://www.alzforum.org/therapeutics/rosiglitazone,,,Small Molecule,Other,Alzheimer's Disease,,"Rosiglitazone is an antidiabetic medication that lowers blood glucose by sensitizing pancreatic target cells to insulin. Rosiglitazone belongs to the thiazolidinedione class of peroxisome-proliferator activated receptor γ agonists; PPARγ is a nuclear receptor predominantly expressed in adipose tissue, whose activation influences expression of genes involved in glucose and lipid metabolism.",discontinued,,AlzForum.Therapeutics,rosiglitazone
rotigotine,Rotigotine,https://www.alzforum.org/therapeutics/rotigotine,,,Small Molecule,Other Neurotransmitters,"Alzheimer's Disease, Frontotemporal Dementia","Parkinson's disease, Restless Leg Syndrome","This dopamine receptor agonist is approved to treat Parkinson’s disease and restless legs syndrome in Europe and the U.S. It is formulated as a once-daily transdermal patch, in doses from 1 to 8 mg.",ongoing,,AlzForum.Therapeutics,rotigotine
s-38093,S 38093,https://www.alzforum.org/therapeutics/s-38093,,,Small Molecule,"Cholinergic System, Other Neurotransmitters",Alzheimer's Disease,,"This histamine H3 receptor antagonist was being developed for the treatment of Alzheimer's disease in many European, South American, and other countries, though not the United States. Blocking the histamine H3 receptor has been a target of several small-molecule therapeutic programs for cognition disorders at other companies, as well, e.g.",discontinued,,AlzForum.Therapeutics,s-38093
s-equol,S-Equol,https://www.alzforum.org/therapeutics/s-equol,,,Small Molecule,Other,Alzheimer's Disease,,"S-Equol is a selective agonist of the estrogen receptor-β, which is expressed on mitochondria. This compound is not a hormone, but rather the S-enantiomeric metabolite of daidzein, a soy-based isoflavone ( Setchell et al., 2005 ).",ongoing,,AlzForum.Therapeutics,s-equol
s47445,S47445,https://www.alzforum.org/therapeutics/s47445,,,Small Molecule,Other Neurotransmitters,Alzheimer's Disease,,"S47445 is an agonist of AMPA receptors for glutamate, the major excitatory neurotransmitter in the brain. S47445 is being developed for the treatment of Alzheimer’s disease and depression.",discontinued,,AlzForum.Therapeutics,s47445
s603,AS-S603,https://www.alzforum.org/therapeutics/s603,,,Small Molecule,"Amyloid-Related, Tau","Alzheimer's Disease, Mild Cognitive Impairment",,AS-S603 is a small molecule said to dissociate amyloid and tau protein aggregates. It was discovered by compound screening to identify inhibitors of Aβ oligomerization and aggregation.,ongoing,,AlzForum.Therapeutics,s603
sabeluzole,Sabeluzole,https://www.alzforum.org/therapeutics/sabeluzole,,,Small Molecule,Unknown,Alzheimer's Disease,,"Sabeluzole has been reported to reduce glutatmate toxicity in part by reducing NMDA-induced inward current ( Van der Valk et al., 1993 ). It also has been shown to affect cytoskeletal stability ( Geerts et al., 1996 ) and tau expression ( Uberti et al., 1997 ).",unknown,,AlzForum.Therapeutics,sabeluzole
sabirnetug,Sabirnetug,https://www.alzforum.org/therapeutics/sabirnetug,,,Immunotherapy (passive),Amyloid-Related,Alzheimer's Disease,,"This humanized IgG2 monoclonal antibody selectively binds soluble Aβ oligomers, aka Aβ-derived diffusible ligands (ADDLs). Though they constitute a minor fraction of Aβ in the brain, soluble oligomers are believed to be the most neurotoxic, and to be responsible for memory loss and neuronal death (e.g., Gong et al., 2003 ; Hong et al., 2018 ).",ongoing,,AlzForum.Therapeutics,sabirnetug
safinamide,Safinamide,https://www.alzforum.org/therapeutics/safinamide,,,Small Molecule,Other Neurotransmitters,"Multiple System Atrophy, Parkinson's Disease",,"Safinamide is a reversible monoamine oxidase B inhibitor, taken as a pill by mouth. MAO-B degrades the neurotransmitter dopamine, and safinamide raises dopamine levels in synapses.",approved,,AlzForum.Therapeutics,safinamide
sage-718,SAGE-718,https://www.alzforum.org/therapeutics/sage-718,,,Small Molecule,Other Neurotransmitters,"Alzheimer's Disease, Parkinson's Disease, Huntington's Disease",,"SAGE-718 is a derivative of the endogenous steroid 24(S)-hydroxycholesterol. It is a positive allosteric modulator of the NMDA receptor, whose activity induces long-term potentiation of synapses, and thus is essential for learning and memory.",discontinued,,AlzForum.Therapeutics,sage-718
sar110894d,SAR110894D,https://www.alzforum.org/therapeutics/sar110894d,,,Small Molecule,Other,Alzheimer's Disease,,,ongoing,,AlzForum.Therapeutics,sar110894d
sar228810,SAR228810,https://www.alzforum.org/therapeutics/sar228810,,,Immunotherapy (passive),Amyloid-Related,Alzheimer's Disease,,This is a monoclonal antibody directed primarily against soluble protofibrillar and fibrillar species of Aβ. It is relatively inactive against Aβ monomers and small oligomeric aggregates.,discontinued,,AlzForum.Therapeutics,sar228810
sar446159,SAR446159,https://www.alzforum.org/therapeutics/sar446159,,,Immunotherapy (passive),alpha-synuclein,Parkinson's Disease,,"SAR446159 is an IgG monoclonal antibody to α-synuclein, with an insulin-like growth factor receptor (IGF1R) binding domain acting as a shuttle to transport it across the blood-brain barrier. The shuttle platform was invented at ABL Bio, and the antibody is being developed in collaboration with Sanofi.",ongoing,,AlzForum.Therapeutics,sar446159
saracatinib,Saracatinib,https://www.alzforum.org/therapeutics/saracatinib,,,Small Molecule,Other,"Alzheimer's Disease, Parkinson's Disease",,"Saracatinib is an inhibitor of the Src/abl family of kinases. It was originally developed by AstraZeneca for various types of cancer, but discontinued in Phase 2 for lack of efficacy.",discontinued,,AlzForum.Therapeutics,saracatinib
sargramostim,Sargramostim,https://www.alzforum.org/therapeutics/sargramostim,,,Other,"Inflammation, Other, Unknown","Alzheimer's Disease, Parkinson's Disease",Bone Marrow Stimulation,"GM-CSF leukine, aka sargramostim, is a synthetic form of the hematopoietic growth factor granulocyte-macrophage colony-stimulating factor. It is a 127-amino-acid glycoprotein produced by recombinant DNA technology in yeast.",ongoing,,AlzForum.Therapeutics,sargramostim
sb-202026,SB 202026,https://www.alzforum.org/therapeutics/sb-202026,,,Small Molecule,Other Neurotransmitters,Alzheimer's Disease,,SB 202026 is a selective muscarinic M1 receptor partial agonist.,discontinued,,AlzForum.Therapeutics,sb-202026
selnoflast,Selnoflast,https://www.alzforum.org/therapeutics/selnoflast,,,Small Molecule,Inflammation,Parkinson's Disease,,"Selnoflast is an inhibitor of inflammasomes containing NLRP3, or nod-like receptor family, pyrin domain-containing protein 3. Inflammasomes are multiprotein, cytosolic complexes that function as sensors in the innate immune system.",ongoing,,AlzForum.Therapeutics,selnoflast
seltorexant,Seltorexant,https://www.alzforum.org/therapeutics/seltorexant,,,Small Molecule,Other,Alzheimer's Disease,,Seltorexant is a selective antagonist of the human orexin-2 receptor. The neuropeptide orexin regulates wakefulness; inhibiting orexin receptor signaling promotes sleep.,discontinued,,AlzForum.Therapeutics,seltorexant
semagacestat,Semagacestat,https://www.alzforum.org/therapeutics/semagacestat,,,Small Molecule,Amyloid-Related,Alzheimer's Disease,,Semagacestat is a γ-secretase inhibitor that reduces Aβ40 and 42 production and secretion by the γ-secretase enzyme complex. The rationale is that reducing the formation of Aβ from its substrate APP targets an upstream event in the amyloid cascade and represents a direct test of the amyloid hypothesis.,discontinued,,AlzForum.Therapeutics,semagacestat
semaglutide,Semaglutide,https://www.alzforum.org/therapeutics/semaglutide,,,Other,Other,"Alzheimer's Disease, Parkinson's Disease","Type 2 Diabetes, Obesity, Protection against myocardial infarction and stroke","Semaglutide is a synthetic, long-acting analog of glucagon-like peptide-1, used to treat diabetes. Ozempic TM is a once-per-week injection formulation, while Rybelsus TM is is a daily pill.",ongoing,,AlzForum.Therapeutics,semaglutide
sembragiline,Sembragiline,https://www.alzforum.org/therapeutics/sembragiline,,,Small Molecule,"Other Neurotransmitters, Other",Alzheimer's Disease,,"Sembragiline is an inhibitor of monoamine oxidase B (MAOB), a mitochondrial enzyme that inactivates the neurotransmitter dopamine, and in the process generates reactive free oxygen radicals. MAOB expression is increased in Alzheimer's brain, particularly in reactive astrocytes near amyloid plaques ( Saura et al., 1994 ; Gulyas et al., 2011 ).",discontinued,,AlzForum.Therapeutics,sembragiline
semorinemab,Semorinemab,https://www.alzforum.org/therapeutics/semorinemab,,,Immunotherapy (passive),Tau,Alzheimer's Disease,,"This is an anti-tau IgG4 antibody that grew out of a research collaboration between AC Immune and Genentech, part of the Roche Group. The collaboration focused on approaches that target extracellular, not intracellular, tau.",unknown,,AlzForum.Therapeutics,semorinemab
sensory-stimulation-systems,Sensory Stimulation Systems,https://www.alzforum.org/therapeutics/sensory-stimulation-systems,,,"Combination, Procedural Intervention","Amyloid-Related, Inflammation, Other","Alzheimer's Disease, Parkinson's Disease, Down's Syndrome",,"Sensory Stimulation Systems, and GENUS, refer to a noninvasive procedure, i.e., a ""digital therapeutic,"" being developed by Cognito Therapeutics. The company developed a wearable GammaSense Stimulation device.",ongoing,,AlzForum.Therapeutics,sensory-stimulation-systems
sgs-742,SGS-742,https://www.alzforum.org/therapeutics/sgs-742,,,Small Molecule,Other Neurotransmitters,Alzheimer's Disease,,SGS742 is a GABA(B) receptor antagonist.,discontinued,,AlzForum.Therapeutics,sgs-742
shr-1707,SHR-1707,https://www.alzforum.org/therapeutics/shr-1707,,,Immunotherapy (passive),Amyloid-Related,Alzheimer's Disease,,"SHR-1707 is a humanized anti-Aβ IgG1 monoclonal antibody that, according to Hengrui Pharmaceuticals, binds to Aβ fibrils and monomers. No preclinical data is published on this antibody, but Hengrui has claimed that SHR-1707 reduced brain Aβ deposition in 5xFAD transgenic mice (e.g.",ongoing,,AlzForum.Therapeutics,shr-1707
simufilam,Simufilam,https://www.alzforum.org/therapeutics/simufilam,,,Small Molecule,Amyloid-Related,Alzheimer's Disease,,"Simufilam binds to filamin, a ubiquitous scaffolding protein and regulator of the actin cytoskeleton. Filamin has been claimed to stabilize the high-affinity interaction of soluble Aβ42 and the α7 nicotinic acetylcholine receptor (α7nAChR), which has been reported to trigger tau phosphorylation and synaptic dysfunction in some experimental systems ( Wang et al., 2000 ; Wang et al., 2003 ; Snyder et al., 2005 ).",discontinued,,AlzForum.Therapeutics,simufilam
simvastatin,Simvastatin,https://www.alzforum.org/therapeutics/simvastatin,,,Small Molecule,Cholesterol,"Alzheimer's Disease, Mild Cognitive Impairment",Hypercholesterolemia and diabetic cardiomyopathy.,"Simvastatin is an oral HMG-CoA reductase inhibitor prescribed extensively throughout the world for the treatment of hypercholesterolemia and diabetic cardiomyopathy. Simvastatin was developed by Merck, Sharp & Dohme.",ongoing,,AlzForum.Therapeutics,simvastatin
snp318,SNP318,https://www.alzforum.org/therapeutics/snp318,,,Small Molecule,Inflammation,Alzheimer's Disease,,"SNP318 inhibits the enzyme lipoprotein-associated phospholipase A2 (Lp-PLA2). Also known as plasma platelet-activating factor acetyl hydrolase, this enzyme produces inflammatory mediators that damage blood vessels and increase the permeability of the blood-brain barrier.",ongoing,,AlzForum.Therapeutics,snp318
solanezumab,Solanezumab,https://www.alzforum.org/therapeutics/solanezumab,,,Immunotherapy (passive),Amyloid-Related,Alzheimer's Disease,,"Solanezumab is a humanized monoclonal IgG1 antibody directed against the mid-domain of the Aβ peptide. It recognizes soluble monomeric, not fibrillar, Aβ.",discontinued,,AlzForum.Therapeutics,solanezumab
solengepras,Solengepras,https://www.alzforum.org/therapeutics/solengepras,,,Small Molecule,Other Neurotransmitters,Parkinson's Disease,,"Cerevance performs single-nuclei RNA sequencing of defined cell types isolated from postmortem brain tissue to identify therapeutic targets for neurologic diseases ( Xu et al., 2018 ). CVN424 is an orally available, brain-penetrant small molecule.",ongoing,,AlzForum.Therapeutics,solengepras
souvenaid,Souvenaid,https://www.alzforum.org/therapeutics/souvenaid,,,"Supplement, Dietary",Other,Alzheimer's Disease,,"Souvenaid is a marketed product. For sale in Australia and some European countries but not the U.S., Souvenaid is a medical food designed to enhance the formation and function of synapses ( Oct 2009 conference news ; de Wilde et al., 2011 ).",unknown,,AlzForum.Therapeutics,souvenaid
spg302,SPG302,https://www.alzforum.org/therapeutics/spg302,,,Small Molecule,Other Neurotransmitters,"Alzheimer's Disease, Amyotrophic Lateral Sclerosis",,SPG302 is a new pegylated benzothiazole derivative that targets an undisclosed regulator of the F-actin-based cytoskeleton to increase synapse numbers. This small molecule promotes the formation of dendritic spines bearing glutamatergic synapses.,ongoing,,AlzForum.Therapeutics,spg302
st101,ST101,https://www.alzforum.org/therapeutics/st101,,,Small Molecule,Unknown,Alzheimer's Disease,,ST101 is an orally active azaindolizinone derivative that has been reported to be a cognitive enhancer. The compound may have pleiotropic effects.,unknown,,AlzForum.Therapeutics,st101
suritozole,Suritozole,https://www.alzforum.org/therapeutics/suritozole,,,Small Molecule,Other Neurotransmitters,Alzheimer's Disease,,"Suritozole is an inverse agonist at the GABA(A) receptor ( Miller et al., 1992 ). GABA(A) receptor activity affects cholinergic function in the hippocampus and cerebral cortex ( Richter et al., 1982 ; Wenk, 1984 ).",discontinued,,AlzForum.Therapeutics,suritozole
suvn-g3031,SUVN-G3031,https://www.alzforum.org/therapeutics/suvn-g3031,,,Small Molecule,"Cholinergic System, Other Neurotransmitters",Alzheimer's Disease,,"SUVN-G3031 is an orally active histamine H3 receptor antagonist being developed to treat cognitive deficits in Alzheimer's disease and schizophrenia. Histamine H3 receptors are widely expressed in healthy and Alzheimer's disease brains ( Medhurst et al., 2009 ).",ongoing,,AlzForum.Therapeutics,suvn-g3031
suvorexant,Suvorexant,https://www.alzforum.org/therapeutics/suvorexant,,,Small Molecule,Other,Alzheimer's Disease,"Insomnia, Insomnia in mild to moderate Alzheimer's disease",This orexin receptor antagonist was approved by the U.S. FDA in 2014 to treat insomnia.,approved,,AlzForum.Therapeutics,suvorexant
t3d-959,T3D-959,https://www.alzforum.org/therapeutics/t3d-959,,,Small Molecule,Other,Alzheimer's Disease,,"T3D-959 is a dual agonist of the peroxisome proliferator activated nuclear receptor delta/gamma, aka PPARδ/γ. It is being developed as an oral therapy for Alzheimer’s disease.",ongoing,,AlzForum.Therapeutics,t3d-959
tacrine,Tacrine,https://www.alzforum.org/therapeutics/tacrine,,,Small Molecule,Cholinergic System,Alzheimer's Disease,,"Tacrine is a reversible acetylcholinesterase inhibitor. Originally developed by Warner-Lambert Co., tacrine was the first such drug to be introduced for the treatment of Alzheimer's disease in a range of countries in South America, Asia, Europe, Australia, and the United States in 1995 and 1996.",approved,,AlzForum.Therapeutics,tacrine
tak-341,TAK-341,https://www.alzforum.org/therapeutics/tak-341,,,Immunotherapy (passive),alpha-synuclein,"Parkinson's Disease, Multiple System Atrophy",,"This is a high-affinity monoclonal antibody to a C-terminal epitope on monomeric and aggregated α-synuclein, originally developed by AstraZeneca. Genetic and pathological evidence implicates α-synuclein in the pathogenesis of Parkinson's disease (PD) and other α-synucleinopathies such as dementia with Lewy bodies (DLB).",ongoing,,AlzForum.Therapeutics,tak-341
tavapadon,Tavapadon,https://www.alzforum.org/therapeutics/tavapadon,,,Small Molecule,Other Neurotransmitters,Parkinson's Disease,,"Tavapadon functions as a partial agonist at dopamine D1 and D5 receptors and is in Phase 3 development for Parkinson’s disease. Nonspecific dopamine receptor agonists currently used to treat PD have significant side effects, including daytime sleepiness, impulse control disorders, confusion, hallucinations, and dyskinesias.",ongoing,,AlzForum.Therapeutics,tavapadon
tb006,TB006,https://www.alzforum.org/therapeutics/tb006,,,Immunotherapy (passive),Inflammation,Alzheimer's Disease,,"This humanized monoclonal antibody targets galactose-specific lectin (galectin) 3, a β-galactosidase-binding protein involved in macrophage activation and antimicrobial immune responses. The rationale for targeting galectin 3 to treat Alzheimer’s disease comes from studies implicating it as a regulator of microglia activation in response to amyloid.",ongoing,,AlzForum.Therapeutics,tb006
telmisartan,Telmisartan,https://www.alzforum.org/therapeutics/telmisartan,,,Small Molecule,Other,Alzheimer's Disease,Hypertension,Telmisartan is an angiotensin II receptor antagonist marketed around the world to treat elevated blood pressure and reduce the possibility of cardiovascular risk associated with chronic hypertension. Telmisartan is an alternative medication for people who are unable to take angiotensin-converting enzyme (ACE) inhibitors.,ongoing,,AlzForum.Therapeutics,telmisartan
thalidomide,Thalidomide,https://www.alzforum.org/therapeutics/thalidomide,,,Small Molecule,"Amyloid-Related, Inflammation",Alzheimer's Disease,,"Thalidomide is an immunomodulatory agent with a spectrum of activity that is only partly characterized. Originally introduced as a nonbarbiturate hypnotic, it was used to treat morning sickness, but numerous instances of severe birth defects led to its withdrawal from the market.",discontinued,,AlzForum.Therapeutics,thalidomide
thn391,THN391,https://www.alzforum.org/therapeutics/thn391,,,Immunotherapy (passive),Inflammation,Alzheimer's Disease,,THN391 is a humanized monoclonal antibody to the blood clotting protein fibrin. THN391 was designed to block fibrin-mediated neuroinflammation without interfering with clotting functions.,ongoing,,AlzForum.Therapeutics,thn391
tideglusib,Tideglusib,https://www.alzforum.org/therapeutics/tideglusib,,,Small Molecule,Tau,"Alzheimer's Disease, Progressive Supranuclear Palsy",,"Tideglusib is an orally available, small-molecule drug of the thiadiazolidinone class. It acts as an inhibitor of glycogen synthase kinase 3 (GSK3-β), a widely studied tau kinase.",discontinued,,AlzForum.Therapeutics,tideglusib
tilavonemab,Tilavonemab,https://www.alzforum.org/therapeutics/tilavonemab,,,Immunotherapy (passive),Tau,"Progressive Supranuclear Palsy, Alzheimer's Disease",,"C2N 8E12 is a humanized IgG4 antibody that was being developed by C2N Diagnostics and AbbVie to treat tauopathies. It recognizes an aggregated, extracellular form of pathological tau, binding to tau's N-terminus.",discontinued,,AlzForum.Therapeutics,tilavonemab
tpi-287,TPI 287,https://www.alzforum.org/therapeutics/tpi-287,,,Small Molecule,Tau,"Alzheimer's Disease, Corticobasal Degeneration, Progressive Supranuclear Palsy",,"TPI 287 is a tubulin-binding and microtubule-stabilizing drug that is being clinically developed by Cortice Biosciences, formerly Archer Biosciences. TPI 287 is an abeo-taxane—a synthetic derivative of the taxane diterpenoid drugs used in cancer therapy, such as paclitaxel.",ongoing,,AlzForum.Therapeutics,tpi-287
tpn-101,TPN-101,https://www.alzforum.org/therapeutics/tpn-101,,,"Small Molecule, DNA/RNA-based",Inflammation,"ALS-FTD, Progressive Supranuclear Palsy",,"This nucleoside analog reverse transcriptase inhibitor was originally developed for the treatment of human immunodeficiency virus infection. It is being repurposed based on recent work implicating the activation of retrotransposons in the pathology of amyotrophic lateral sclerosis, Alzheimer’s, and other neurodegenerative diseases.",ongoing,,AlzForum.Therapeutics,tpn-101
transcutaneous-auricular-vagal-afferent-nerve-stimulation,Transcutaneous auricular vagal afferent nerve stimulation,https://www.alzforum.org/therapeutics/transcutaneous-auricular-vagal-afferent-nerve-stimulation,,,Other,Other Neurotransmitters,"Alzheimer's Disease, Mild Cognitive Impairment, Parkinson's Disease",,This noninvasive approach attempts to modulate the noradrenergic system of the locus coeruleus by stimulating the vagal nerve. It uses electrodes clipped on the outer ear to stimulate the auricular branch of the vagal nerve.,unknown,,AlzForum.Therapeutics,transcutaneous-auricular-vagal-afferent-nerve-stimulation
trappsolr-cyclotm,Trappsol® Cyclo™,https://www.alzforum.org/therapeutics/trappsolr-cyclotm,,,Other,Cholesterol,Alzheimer's Disease,,"Trappsol® Cyclo™ is a proprietary, intravenous formulation of 2-hydroxypropyl-β-cyclodextrin in development to treat diseases associated with impaired cholesterol metabolism, including Alzheimer's disease. This cyclic oligosaccharide sequesters cholesterol, solubilizing it and extracting it from cells.",ongoing,,AlzForum.Therapeutics,trappsolr-cyclotm
trazodone,Trazodone,https://www.alzforum.org/therapeutics/trazodone,,,Small Molecule,Other Neurotransmitters,"Alzheimer's Disease, Mild Cognitive Impairment, Amyotrophic Lateral Sclerosis",Depression,"Trazodone is a phenyl piperazine derivative with agonist and antagonist activity at serotonin receptors, in addition to adrenergic and histaminergic activity and serotonin uptake inhibition. It was approved more than 40 years ago to treat major depressive disorder.",ongoing,,AlzForum.Therapeutics,trazodone
tricaprilin,Tricaprilin,https://www.alzforum.org/therapeutics/tricaprilin,,,"Supplement, Dietary, Other",Other,Alzheimer's Disease,,"Tricaprilin is the follow-up to Accera's AC-1202 /Axona medical food product. It is a proprietary, oral formulation of caprylic triglyceride, which was designed to induce a mild chronic ketosis in order to improve mitochondrial metabolism.",ongoing,,AlzForum.Therapeutics,tricaprilin
troculeucel,Troculeucel,https://www.alzforum.org/therapeutics/troculeucel,,,Other,"Amyloid-Related, Inflammation",Alzheimer's Disease,,"Troculeucel is an immunotherapy consisting of a patient’s own natural killer cells that have been isolated, expanded in the lab, and re-infused. The cells are not genetically modified.",ongoing,,AlzForum.Therapeutics,troculeucel
trontinemab,Trontinemab,https://www.alzforum.org/therapeutics/trontinemab,,,Immunotherapy (passive),Amyloid-Related,Alzheimer's Disease,,"RO7126209 is a new version of the anti-amyloid monoclonal antibody gantenerumab , engineered to more easily cross the blood-brain barrier using Roche’s “brain shuttle” technology. A Fab fragment that binds the human transferrin receptor is attached to the effector (Fc) domain of the gantenerumab monoclonal antibody.",ongoing,,AlzForum.Therapeutics,trontinemab
troriluzole,Troriluzole,https://www.alzforum.org/therapeutics/troriluzole,,,Other,Other Neurotransmitters,Alzheimer's Disease,,"Troriluzole is a prodrug formulation of riluzole , a medication used to treat amyotrophic lateral sclerosis. Following oral administration, aminopeptidases in the blood release riluzole from a tripeptide carrier.",discontinued,,AlzForum.Therapeutics,troriluzole
tw001,TW001,https://www.alzforum.org/therapeutics/tw001,,,Small Molecule,Other,"Alzheimer's Disease, Amyotrophic Lateral Sclerosis",,"TW001 is a new oral formulation of edaravone , an antioxidant drug marketed in the U.S. and Japan to treat amyotrophic lateral sclerosis.",ongoing,,AlzForum.Therapeutics,tw001
ub-311,UB-311,https://www.alzforum.org/therapeutics/ub-311,,,Immunotherapy (active),Amyloid-Related,Alzheimer's Disease,,"UB-311 is a synthetic peptide vaccine developed by United Neuroscience, a spin-off of United Biomedical. UB-311 couples a helper T-cell epitope designed with United Biomedical's UBITh® platform to the Aβ1–14 sequence, packaged in a proprietary vaccine-delivery system.",ongoing,,AlzForum.Therapeutics,ub-311
ub-312,UB-312,https://www.alzforum.org/therapeutics/ub-312,,,Immunotherapy (active),alpha-synuclein,Parkinson's Disease,,"UB-312 is an active vaccine to stimulate an immune response against α-synuclein. A 10-amino-acid fragment from the protein’s C-terminus is fused to a small peptide that activates T-helper cells, and combined with adjuvant for intramuscular injection.",ongoing,,AlzForum.Therapeutics,ub-312
ucb0022,UCB0022,https://www.alzforum.org/therapeutics/ucb0022,,,Small Molecule,Other Neurotransmitters,Parkinson's Disease,,"This oral small molecule is a positive allosteric modulator of dopamine receptor type 1, which enhances the receptor's signaling in the presence of endogenous dopamine. It binds outside the dopamine site on the receptor, and has no intrinsic receptor-activating potential.",ongoing,,AlzForum.Therapeutics,ucb0022
ucb7853,UCB7853,https://www.alzforum.org/therapeutics/ucb7853,,,Immunotherapy (passive),alpha-synuclein,Parkinson's Disease,,UCB7853 is an α-synuclein antibody. No further information is available on its origin or specificity.,ongoing,,AlzForum.Therapeutics,ucb7853
ulefnersen,Ulefnersen,https://www.alzforum.org/therapeutics/ulefnersen,,,DNA/RNA-based,Other,Amyotrophic Lateral Sclerosis,,"ION363 is an antisense oligonucleotide designed to reduce the production of a mutated, neurotoxic form of the Fused in Sarcoma (FUS) protein. FUS mutations have been identified as a cause of familial ALS and frontotemporal lobar degeneration.",ongoing,,AlzForum.Therapeutics,ulefnersen
umibecestat,Umibecestat,https://www.alzforum.org/therapeutics/umibecestat,,,Small Molecule,Amyloid-Related,Alzheimer's Disease,,"CNP520 is an oral, small-molecule inhibitor of the aspartyl protease BACE designed to reduce Aβ production to prevent or treat Alzheimer's disease. BACE1 is the β-secretase enzyme that cleaves the APP protein to release its C99 fragment, which gives rise to various species of Aβ peptide during its cleavage by γ-secretase.",discontinued,,AlzForum.Therapeutics,umibecestat
vafidemstat,Vafidemstat,https://www.alzforum.org/therapeutics/vafidemstat,,,Small Molecule,Other Neurotransmitters,Alzheimer's Disease,,"ORY-2001 is a dual inhibitor of the transcriptional co-regulator lysine-specific demethylase 1 (LSD1 or KDM1A) and the mitochondrial membrane protein monoamine oxidase B (MAO-B, see MedChemExpress ). It is an oral, brain-permeable small molecule.",ongoing,,AlzForum.Therapeutics,vafidemstat
valacyclovir,Valacyclovir,https://www.alzforum.org/therapeutics/valacyclovir,,,Small Molecule,Other,Alzheimer's Disease,Herpes virus outbreaks,"A thymidine kinase inhibitor, valacyclovir is a prescription drug, and widely available as a generic. Valacyclovir is used to shorten outbreaks of genital herpes or cold sores caused by Herpes simplex virus (HSV) 1 and 2.",ongoing,,AlzForum.Therapeutics,valacyclovir
valproate,Valproate,https://www.alzforum.org/therapeutics/valproate,,,Small Molecule,Other Neurotransmitters,Alzheimer's Disease,"Epilepsy, Bipolar disorder, Migraine","Valproate is an anti-convulsant and mood-stabilizing drug that is FDA- and EMA-approved to treat seizures, manic episodes associated with bipolar disorder, and to prevent migraine headaches. It is also used off-label for other psychiatric conditions.",unknown,,AlzForum.Therapeutics,valproate
vanutide-cridificar,Vanutide cridificar,https://www.alzforum.org/therapeutics/vanutide-cridificar,,,Immunotherapy (active),Amyloid-Related,Alzheimer's Disease,,This is an active immunotherapy strategy. ACC-001 is a conjugate of multiple short Aβ fragments linked to a carrier made of inactivated diphtheria toxin.,discontinued,,AlzForum.Therapeutics,vanutide-cridificar
varenicline,Varenicline,https://www.alzforum.org/therapeutics/varenicline,,,Small Molecule,Cholinergic System,Alzheimer's Disease,Smoking cessation,Varenicline is a medication approved in the United States and many other countries to aid smoking cessation. It is a partial agonist of the α 4 β 2 subtype of the nicotinic acetylcholine receptor (nAChR).,discontinued,,AlzForum.Therapeutics,varenicline
varoglutamstat,Varoglutamstat,https://www.alzforum.org/therapeutics/varoglutamstat,,,Small Molecule,"Amyloid-Related, Inflammation",Alzheimer's Disease,,"PQ912 is an inhibitor of glutaminyl cyclase (QC), aka glutaminyl-peptide cyclotransferase (QPCT). This metalloenzyme is upregulated in the brains of Alzheimer’s disease patients.",discontinued,,AlzForum.Therapeutics,varoglutamstat
vascepa,Vascepa,https://www.alzforum.org/therapeutics/vascepa,,,Small Molecule,Other,Alzheimer's Disease,"Severe hypertriglyceridemia, and to lower risk of cardiovascular events in people with elevated triglycerides","Vascepa is a prescription formulation of omega-3 fat ethyl eicosapentaenoic acid (ethyl-EPA) purified from fish oil. Liquid-filled capsules are taken twice a day with food, at a dose of 4 g per day.",ongoing,,AlzForum.Therapeutics,vascepa
venglustat,Venglustat,https://www.alzforum.org/therapeutics/venglustat,,,Small Molecule,"alpha-synuclein, Other",Parkinson's Disease,,Venglustat is a brain-penetrant allosteric inhibitor of the enzyme glucosylceramide synthase. GCS catalyzes an early step in the synthesis of many glycolipids.,unknown,,AlzForum.Therapeutics,venglustat
verdiperstat,Verdiperstat,https://www.alzforum.org/therapeutics/verdiperstat,,,Small Molecule,"Inflammation, Other","Motor Neuron Disease, Multiple System Atrophy, Primary Progressive Aphasia",,Verdiperstat is an irreversible inhibitor of myeloperoxidase. This enzyme catalyzes the generation of reactive oxygen species by activated microglia and other immune cells.,discontinued,,AlzForum.Therapeutics,verdiperstat
verubecestat,Verubecestat,https://www.alzforum.org/therapeutics/verubecestat,,,Small Molecule,Amyloid-Related,Alzheimer's Disease,,"MK-8931 is a small-molecule inhibitor of BACE1 and BACE2. BACE1 is the β-secretase enzyme that cleaves the APP protein to release the C99 fragment of APP, which gives rise to various species of Aβ peptide during its subsequent cleavage by γ-secretase.",discontinued,,AlzForum.Therapeutics,verubecestat
vg-3927,VG-3927,https://www.alzforum.org/therapeutics/vg-3927,,,Small Molecule,"Amyloid-Related, Inflammation",Alzheimer's Disease,,"VG-3927 is a brain-penetrant, small-molecule agonist of the TREM2 receptor on microglia. TREM2 activation stimulates proliferation and phagocytic function of microglia, which play a central role in Alzheimer's disease pathology.",ongoing,,AlzForum.Therapeutics,vg-3927
vgl101,VGL101,https://www.alzforum.org/therapeutics/vgl101,,,Immunotherapy (passive),"Inflammation, Other",Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia,,"VGL101 is a humanized monoclonal antibody that acts as an agonist for TREM2. This receptor is expressed on microglia and macrophages, and mediates their proliferation and function.",discontinued,,AlzForum.Therapeutics,vgl101
vhb937,VHB937,https://www.alzforum.org/therapeutics/vhb937,,,Immunotherapy (passive),Amyloid-Related,"Alzheimer's Disease, Amyotrophic Lateral Sclerosis",,"VHB937 is a humanized monoclonal antibody to the immune receptor TREM2. TREM2 activation stimulates proliferation and phagocytic function of microglia, which play a central role in Alzheimer's disease pathology.",ongoing,,AlzForum.Therapeutics,vhb937
vodobatinib,Vodobatinib,https://www.alzforum.org/therapeutics/vodobatinib,,,Small Molecule,Other,"Parkinson's Disease, Dementia with Lewy Bodies",,"Vodobatinib is a third-generation c-Ableson tyrosine kinase inhibitor. It is structurally similar to the commercial anticancer agents Dasatinib and Ponatinib ( Antelope et al., 2019 ).",discontinued,,AlzForum.Therapeutics,vodobatinib
vq-101,VQ-101,https://www.alzforum.org/therapeutics/vq-101,,,Small Molecule,"alpha-synuclein, Other",Parkinson's Disease,,"VQ-101 is a small-molecule allosteric activator of the lysosomal enzyme glucocerebrosidase (GCase). Mutations in GBA1, the gene encoding GCase, are the most common genetic cause of Parkinson’s disease.",ongoing,,AlzForum.Therapeutics,vq-101
vy-aadc,VY-AADC,https://www.alzforum.org/therapeutics/vy-aadc,,,DNA/RNA-based,Other Neurotransmitters,Parkinson's Disease,,VY-AADC is an AAV-based gene therapy that was developed by Voyager Therapeutics and evaluated clinically in partnership with Neurocrine Biosciences. It aims to restore the treatment benefit of oral levodopa for people with advanced Parkinson's disease whose treatment response has started fluctuating.,discontinued,,AlzForum.Therapeutics,vy-aadc
vy-tau01,VY-TAU01,https://www.alzforum.org/therapeutics/vy-tau01,,,Immunotherapy (passive),Tau,Alzheimer's Disease,,"VY-TAU01 is a recombinant, humanized IgG4 monoclonal antibody to an epitope in the C-terminus of tau. It is designed to block the spread of pathological tau.",ongoing,,AlzForum.Therapeutics,vy-tau01
vyalev,Vyalev,https://www.alzforum.org/therapeutics/vyalev,,,Small Molecule,Other Neurotransmitters,Parkinson's Disease,Motor fluctuations in advanced Parkinson’s disease,Vyalev is a new levodopa/carbidopa formulation for dopamine replacement therapy. It is the first dopamine therapy to be delivered by 24-hour continuous subcutaneous infusion.,approved,,AlzForum.Therapeutics,vyalev
wve-004,WVE-004,https://www.alzforum.org/therapeutics/wve-004,,,DNA/RNA-based,Other,"Frontotemporal Dementia, Amyotrophic Lateral Sclerosis",,WVE-004 is an antisense oligonucleotide (ASO) targeting the C9ORF72 mutation that causes amyotrophic lateral sclerosis and frontotemporal dementia. The ASO mediates degradation of hexanucleotide expansion-containing C9ORF72 mRNAs.,discontinued,,AlzForum.Therapeutics,wve-004
xaliproden,Xaliproden,https://www.alzforum.org/therapeutics/xaliproden,,,Small Molecule,"Other Neurotransmitters, Other",Alzheimer's Disease,,"Xaliproden is an orally active 5HT1-A receptor antagonist that was being developed by Sanofi. It has been evaluated for the treatment of Alzheimer's disease and amyotrophic lateral sclerosis (ALS), and protection against peripheral neurotoxicity associated with certain cancer chemotherapies.",discontinued,,AlzForum.Therapeutics,xaliproden
xanamem,Xanamem,https://www.alzforum.org/therapeutics/xanamem,,,Small Molecule,Other,Alzheimer's Disease,,"Xanamem is an inhibitor of 11β-hydroxysteroid dehydrogenase type 1, an enzyme in the hypothalamic-pituitary-adrenal (HPA) axis of the body's stress response. 11β-HSD1 converts the stress hormone cortisol to its active form, which binds to glucocorticoid receptors.",ongoing,,AlzForum.Therapeutics,xanamem
xpro1595,XPro1595,https://www.alzforum.org/therapeutics/xpro1595,,,Other,Inflammation,"Alzheimer's Disease, Mild Cognitive Impairment",,"This pegylated protein biologic targets and neutralizes the inflammatory cytokine TNFα. A non-receptor binding variant of TNFα, XPro1595 forms heterotrimers with native soluble TNFα and prevents its interaction with the type 1 TNFα receptor ( Steed et al., 2003 ).",ongoing,,AlzForum.Therapeutics,xpro1595
young-plasma,Young Plasma,https://www.alzforum.org/therapeutics/young-plasma,,,Other,"Inflammation, Other, Unknown","Progressive Supranuclear Palsy, Alzheimer's Disease",,"The rationale behind this treatment approach is that systemic factors present in young blood cross into the brain, where they counteract aging processes and neurodegeneration by modulating neuroinflammation, neurogenesis, and cognitive function. In essence, this approach attempts to rejuvenate the aging brain with infusions of plasma from young adults.",unknown,,AlzForum.Therapeutics,young-plasma
ytx-7739,YTX-7739,https://www.alzforum.org/therapeutics/ytx-7739,,,Small Molecule,Other,Parkinson's Disease,,This is a stearoyl-CoA desaturase inhibitor. SCD catalyzes the rate-limiting step in the production of monounsaturated fatty acids including oleic and palmitoleic acids from saturated fatty acid precursors.,discontinued,,AlzForum.Therapeutics,ytx-7739
zagotenemab,Zagotenemab,https://www.alzforum.org/therapeutics/zagotenemab,,,Immunotherapy (passive),"Tau, Unknown",Alzheimer's Disease,,"Zagotenemab is a humanized anti-tau antibody derived from MCI-1 , Peter Davies' mouse monoclonal antibody against an early pathological conformation of tau. Zagotenemab binds and neutralizes soluble tau aggregates.",discontinued,,AlzForum.Therapeutics,zagotenemab
zervimesine,Zervimesine,https://www.alzforum.org/therapeutics/zervimesine,,,Small Molecule,Amyloid-Related,"Alzheimer's Disease, Dementia with Lewy Bodies",,"Zervimesine/CT1812 is a small-molecule antagonist of the sigma2 receptor. The rationale behind this therapeutic approach is that ligands for the sigma2 receptor complex are negative allosteric regulators that reduce the affinity of oligomeric Aβ for neuronal receptors, and thus interfere with Aβ-induced synaptic toxicity.",ongoing,,AlzForum.Therapeutics,zervimesine
zunveyltm,ZunveylTM,https://www.alzforum.org/therapeutics/zunveyltm,,,Small Molecule,Cholinergic System,Alzheimer's Disease,,Benzgalantamine is an inactive prodrug of galantamine. It was approved by the FDA in July 2024 for the treatment of mild to moderate Alzheimer’s dementia.,approved,,AlzForum.Therapeutics,zunveyltm
